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Abstract     
Although information on variations in healthcare utilisation is increasingly available, 
its constructive use to improve health systems is often hindered by the lack of a clear 
standard to evaluate what is “good“ and “poor“ performance. This thesis investigates 
how regulators and managers of the system might address this lack of a standard. The 
thesis distinguishes between the purpose (to manage ambiguity in the absence of a 
standard or to determine a meaningful standard) and the approach used to achieve 
either purpose (socio-political or technical-evidential). The resulting four types of 
strategies are examined by drawing on concepts and methods from public health and 
epidemiology, health economics, operations research and public administration and 
empirical evidence from England and Scotland. 
To manage ambiguity in the absence of a standard using a socio-political 
approach, the thesis finds that one must overcome a series of barriers including 
awareness, acceptance, perceived applicability and capacity of potential users. 
Clinical and managerial leadership appear to be enabling factors for the use of 
information on variations for strategic problem framing and stakeholder engagement. 
To manage ambiguity in the absence of a standard using a technical-evidential 
approach, the use of ranking intervals and dominance relations obtained from ratio-
based efficiency analysis can help to avoid the forced assignment of a single, 
potentially controversial ranking to each organisation under scrutiny. 
To determine a standard using a technical-evidential approach, estimating 
capacity to benefit in populations provides a theoretically sound and feasible 
benchmark to assess the appropriateness of service utilisation against population 
needs. However, uncertainty about criteria of capacity to benefit and lack of 
epidemiological data remain practical challenges. 
To determine a standard using a socio-political approach, an experimentalist 
governance logic focused on learning and dialogue between central government and 
local organisations can complement a hierarchist logic focused on accountability 
when both the ideal ends and the means for attainment are ambiguous.  
As a whole, the thesis reinforces the insight that both improved technical tools 
and social and political processes are required to make information on variations 
useful to decision-makers. 
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1 INTRODUCTION 
Information on geographic variations in the utilisation of health services is  
increasingly available to policy-makers and managers. These variations are often 
interpreted as a marker of health system performance: as a signal of potential deficits 
in the appropriateness, equity and efficiency of service provision. However, prior 
research has tended to concentrate on the identification and measurement of 
variations rather than their management. The constructive use of this information is 
often hindered by the lack of a clear standard to evaluate what is “good“ and “poor“ 
performance. In the absence of such a standard, not only is it impossible to assess 
whether performance objectives have been achieved but the production and public 
reporting of information on variations also risks encouraging misinterpretation and 
causing harm. It is thus an opportune moment to investigate how regulators and 
managers in charge of planning, auditing and improving health services might 
address this ambiguity about the standard for evaluation.  
 
The thesis includes five studies which aim to shed light on this problem from different 
perspectives. Two of the studies have been published in peer reviewed journals  
(Schang et al., 2014a, Schang et al., 2014b). The next section reviews the rationale for 
measuring variations in the use of health services. Subsequent sections set out the 
research problem, the aim and framework of the thesis, and summarise the 
contribution of the thesis.  
 Why measure variations in the use of health services? 1.1
Over the past decades, analysis of geographic variations in healthcare utilisation, 
expenditure and outcomes has developed into a growing field of research. A recent 
systematic review (Corallo et al., 2014) identified 1,114 studies of medical practice 
variation in OECD countries published between 1990 and 2011. National Atlases of 
Variation in countries including England, the United States, Germany, Spain, the 
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Netherlands, Canada, Australia and New Zealand have documented considerable 
variations in rates of hospital admission and surgical procedures between small areas 
(NHS Right Care, 2012a). At a cross-national scale, projects by the Organisation for 
Economic Co-operation and Development (OECD (Organisation for Economic Co-
operation and Development), 2014) and by the European  Collaborative for 
Healthcare Optimization (Bernal-Delgado et al., 2015) have shown that these 
variations exist both between and within countries. 
 
Growing attention to evidence of variations in healthcare has evolved within a 
context of increasing interest in health system performance assessment more 
generally. Health system performance can be understood as the extent to which a 
health system meets its objectives (Hurst and Jee-Hughes, 2001, WHO, 2000). 
Measuring performance has therefore at its core an evaluative function: to ascertain 
the extent to which objectives such as appropriateness, equity and efficiency in the 
provision of services have been achieved. The importance of measuring health system 
performance is now widely recognised (Smith and Papanicolas, 2012, Smith et al., 
2009). Advances in the quality of data reporting have resulted in unprecedented 
access to information on the operational performance of health systems. This 
information has different potential users and uses (Table 1-1). Taken together, these 
potential uses make performance measurement an essential part of health system 
governance and a key building block for the continuous improvement of health 
services (Berwick, 1996, Smith et al., 2009). 
 
Table 1-1 Potential users and uses of information on performance 
Potential users Potential uses 
Government and regulatory 
authorities 
 Ensuring accountability for the effectiveness and efficiency with 
which resources are deployed.  
 Fostering improvement through appropriate regulations and 
incentives to purchasers and providers. 
Organisations in charge of 
planning and purchasing 
health services 
 Informing the planning of future service requirements. 
 Informing the contracting and management of healthcare 
providers. 
Healthcare providers  Targeting internal quality improvement efforts. 
Service users  Choosing healthcare providers. 
Source: adapted from Smith et al. (2009) and Van der Wees et al. (2014).  
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As Goodman (2009: 749) points out, unwarranted variation in healthcare can be 
understood as “the variation in medical resources, utilization, and outcome that is 
due to differences in health system performance“. Rising interest in evidence of 
geographic variations in healthcare use, as a potential “marker“ of health system 
performance, is underpinned by two main policy concerns: equity concerns and 
concerns about appropriateness and efficiency.  
 
Equity concerns stem from the belief that variations (inequalities) indicate inequities 
(unfair inequalities) in the use of health services. Variations appear to challenge the 
principle of horizontal equity (Oliver and Mossialos, 2004) which stipulates equal 
opportunity of access for equal need. This is a key concern for health systems such as 
the National Health Service (NHS) systems in England, Scotland, Wales and Northern 
Ireland which were founded on the principle of ensuring access to care based on 
need, regardless of ability to pay (Boyle, 2011). Evidence of variations suggests 
however that the type and intensity of care patients receive depends also on their 
place of residence, and associated factors such as supply structures and patterns of 
medical practice in a particular region (Busato et al., 2010, Couchoud et al., 2012). In 
media reports and public communication about variations, concerns about the 
apparent “postcode lottery” in local resource allocation decisions (The Guardian, 
2011, NHS Right Care, 2011, Russell et al., 2013) imply worries that the quality of care 
patients receive depends on chance rather than medical need. 
 
Appropriateness and efficiency concerns have come to the fore in light of increasing 
fiscal pressures on healthcare budgets. The English NHS, for instance, was required to 
generate efficiency savings of about 4% of total annual resources every year between 
2011 and 2015 in order to meet rising demand for health services (Department of 
Health, 2010d). The magnitude of observed variations is often interpreted as a signal 
of widespread overuse and misuse of unnecessary or even harmful care (Maynard, 
2013, Ham, 2013). This argument appeals to decision-makers as demographic 
changes and developments in medical technology challenge the financial 
sustainability of health systems (Busse et al., 2007). The economic crises that have 
affected several European nations add to these concerns (Thomson et al., 2014). 
Although evidence of variations does not necessarily imply evidence of inefficiency 
and inefficiency can exist in a system without there being any regional variations 
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(Göpffarth et al., 2015), tackling variations in medical practice is often cited as an 
opportunity to release resources that can be reinvested into care of higher value 
(Maynard, 2012, Rettenmaier and Wang, 2012, Huesch et al., 2013, Hollingworth et 
al., 2015). 
 
Information on variations in healthcare is thus of interest due to its potential role as a 
signal that resources are not spent to best effect. As the presence of variations 
appears to contradict fundamental health policy objectives related to equity, 
appropriateness and efficiency, the identification of those variations that are 
unwarranted is increasingly recognised as a key policy challenge (OECD 
(Organisation for Economic Co-operation and Development), 2014).  
 Ambiguity about the standard for evaluation 1.2
A fundamental problem in analyses of geographic variations in healthcare, and 
performance comparisons more generally, lies however in defining a meaningful 
standard for evaluation. Following the Oxford English dictionary, the term “standard“ 
is understood here as a “definite level of excellence, attainment, wealth, or the like, or 
a definite degree of any quality, viewed as a prescribed object of endeavour or as the 
measure of what is adequate for some purpose“ (OED, 2015). In short, a standard 
refers to a stipulated normative level of quality or attainment that is used for 
comparative evaluations. In this thesis, the term standard is used interchangeably 
with the terms benchmark, yardstick, norm and reference point. This variation in 
terminology reflects the surprising fact that the notion of what constitutes an 
appropriate standard has not received the focused attention it deserves, even though, 
by definition, there is no way to assess whether system performance is “good enough“ 
except with reference to a standard (Donabedian, 1981). 
 
In order to evaluate the appropriateness of variations in healthcare, it is essential to 
establish a standard of what is meant by “good“ and “poor“ performance. For health 
outcome indicators and some indicators of the care process, ideal levels of attainment 
are obvious. For instance, no patient should have to die from a healthcare-associated 
infection (the ideal rate is zero). If the objective is to ensure equal access to cost-
24 
 
effective care for equal need, then one might say that every person with diabetes 
should receive key interventions such as regular foot checks and eye examinations 
(the ideal rate is 100 per cent).  
 
However, for most indicators that are concerned with the utilisation of health 
services, the standard for evaluation is essentially ambiguous. In the case of 
geographic variations in rates of hip replacement, for instance, it is not clear what a 
given utilisation rate means in terms of the appropriateness of care provided. As 
Robert Evans has pointed out already in 1990, potential users of research on 
variations are therefore confronted with a puzzle: “Are the regions, or institutions, or 
practitioners with high rates over-providing, or are the low ones under-providing, or 
does the ‘best’ rate lie somewhere in the middle (or beyond either end)?” (Evans, 
1990: 127). More than two decades later, a recent systematic review (Mercuri and 
Gafni, 2011) identified a fundamental lack of theoretically sound, empirically 
measurable frameworks to evaluate unwarranted variations in healthcare. As a 
result, resolving Evans’ puzzle continues to present a key hurdle to using information 
on variations to inform decision-making on health services (Appleby et al., 2011, 
Tanenbaum, 2012, OECD (Organisation for Economic Co-operation and 
Development), 2014, Hollingworth et al., 2015).  
 
Addressing ambiguity about the standard for evaluation is important for several 
reasons. First, in the absence of a clear standard, policy-makers and managers forego 
potential insights about health system performance. Information on rates of hospital 
admissions and surgical procedures does, in itself, not allow for normative inferences 
about the value these services confer on people. It is hence not possible to evaluate 
the performance of the health system based on this information if, as stated in section 
1.1, performance is defined as the degree to which objectives such as ensuring the 
provision of services in relation to medical need have been met. 
 
Second, reporting information on variations without a clear standard risks 
encouraging misinterpretation and causing harm. It has long been argued that 
publishing performance information in the public sector may not only have beneficial 
effects but also several unintended consequences (Smith, 1995, Casalino, 1999). In 
the context of variations in healthcare, there is a tendency in public communication 
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about variations to portray regions with comparatively high utilisation rates as being 
afflicted by high levels of inappropriate care and regions with comparatively low 
rates as being characterised by high levels of unmet need (Tanenbaum, 2012).  
 
However, existing evidence does not indicate a systematic relationship between high 
rates of utilisation and high levels of inappropriateness (Keyhani et al., 2012). 
Focusing management attention (solely) on the regions with high rates of utilisation 
so as to reduce presumed “overuse“ seems therefore premature. Making inferences 
about ”good” and ”bad” based on information that is essentially descriptive in nature 
(such as the number of hip replacement operations in Liverpool compared to 
London) is what Rein (1976: 75) calls a “normative leap” that may lead to false 
conclusions about the performance of the systems studied. Consequent attempts to 
reduce variations across the board may eliminate also those variations that exist for 
legitimate reasons, such as responsiveness to population needs and patient 
preferences (Folland and Stano, 1990, Lilford, 2009).  
 
Finally, in a context where resources are inevitably limited, one may question the 
utility of collecting and reporting data that has no clear managerial implications and 
is not directly linked to health system objectives. While there is no shortage of 
performance indicators – the 2012 US Agency for Healthcare Research and Quality 
(AHRQ) National Healthcare Quality and Disparities Reports, for instance, contained 
more than 250 quality indicators – little effort has been dedicated to prioritising the 
reporting of metrics in terms of their likely contribution to population health (Meltzer 
and Chung, 2014). This risks turning measurement into an end in itself rather than 
into a means to foster accountability and improvement (Spiegelhalter, 1999, Goddard 
et al., 2000). 
 
In order to be able to evaluate variations in healthcare and draw implications for 
policy and management, achieving clarity about the standard for evaluation is 
therefore essential. The next section sets out a framework of how this problem might 
be approached and reviews limitations of prior research against this framework. 
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 Aim and framework of the thesis 1.3
The overarching aim of this thesis is to investigate strategies through which policy-
makers and managers in charge of planning, auditing and improving health services 
might address ambiguity about the standard for evaluation. It is proposed here that 
strategies to address this ambiguity can be classified according to two dimensions: 
their purpose and the approach by which this purpose is achieved (Table 1-2).  
 
The purpose of addressing ambiguity about the standard for evaluation can be (i) to 
establish a meaningful standard; or (ii) to manage ambiguity in the absence of a 
standard. The approach by which either purpose is achieved can be (i) socio-political 
(using particular models of governance or management strategies); or (ii) technical-
evidential (using particular metrics or methods for analysis). The resulting four 
categories are explained below in relation to prior research.  
 
Table 1-2 Taxonomy of strategies to address ambiguity about the standard for 
evaluation  
  Approach 
  Socio-political Technical-evidential 
 
 
Purpose 
 
 
Manage ambiguity 
in the absence of a 
standard 
 
Use models of governance or 
processes for decision making 
that recognise ambiguity 
about the standard. 
Use methods for analysis that 
recognise ambiguity about the 
standard. 
Establish 
meaningful 
standards 
Determine standards through 
suitable models of governance 
or ways of decision making. 
Determine standards through 
suitable metrics or methods for 
analysis. 
 
1.3.1 Managing ambiguity with a socio-political approach 
Much of the work that public sector organisations do takes place in challenging 
organisational and political environments. Typically, governments, healthcare 
purchasers and providers are faced with multiple and conflicting demands such as 
the requirement to operate within a budget constraint while seeking to improve the 
quality of services delivered. In such a context, information that lacks clear 
managerial implications in terms of cost reduction, quality improvement or both is 
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easily overlooked. Prior research on the public reporting of comparative clinical 
performance data in Scotland (Mannion and Goddard, 2001, 2003) showed that, in 
the absence of supportive organisational contexts and appropriate incentives, the 
mere disclosure of performance information had little effect on the behaviour of NHS 
Trusts.  
 
Attempts to motivate public sector organisations to engage with evidence of 
variations in healthcare utilisation thus requires an understanding of the barriers 
organisations face in practice and the strategies they might adopt to overcome these. 
As research on guideline implementation (Glasziou and Haynes, 2005) shows, the 
path from evidence to its use in decision making requires potential users to be aware 
of the data, accept its validity, perceive it as being applicable to their situation and 
have the capacity to use the data. However, little research seems to have explored 
these issues in the context of variations in healthcare utilisation. While some work 
exists on strategies adopted by US hospitals to tackle unwarranted clinical practice 
variations (Gauld et al., 2011), there is a lack of studies asking how and to what extent 
managers in charge of planning and purchasing services might make sense of 
information on variations in healthcare.  
 
This category is therefore concerned with building understanding of the practical 
barriers managers of the health system face and of the strategies they use – and might 
use – to make sense of potentially confusing information on variations in healthcare. 
1.3.2 Managing ambiguity with a technical-evidential approach 
A different response to ambiguity about the standard for evaluation is to target not 
(only) the intended users of this information and the environments in which they 
operate, as under a socio-political approach, but to strengthen the ways in which 
metrics are reported. If standards for evaluation are absent or controversial, then 
methods of analysis could be deployed that recognise this ambiguity. 
 
A typical example in the context of healthcare is the ranking of organisations based on 
a composite measure of performance. Since the provision of health services is 
typically required to meet multiple objectives (e.g. treatment appropriateness, equity 
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and responsiveness), composite measures are intended to provide a unified 
assessment of organisational performance across different domains (Smith, 2002). 
However, rankings on the basis of composite measures tend to rely on controversial 
assumptions about the relative weights of component indicators (Cherchye et al., 
2007, Aron et al., 2007, Ferguson et al., 2002, Goldstein and Spiegelhalter, 1996, Kang 
and Hong, 2011, Goddard and Jacobs, 2009, Jacobs et al., 2005). Different techniques 
for determining weights – from simpler trade-off methods including ranking from 
most to least desired indicator and voting techniques to more elaborate 
multiattribute approaches such as conjoint analysis and the analytic hierarchy 
process – often produce different results and each method has distinct advantages 
and disadvantages in terms of feasibility, consistency and validity (Dolan, 1997, 
OECD, 2008, Appleby and Mulligan, 2000). Although it is possible to establish a single 
set of weights, doing so may disguise the underlying value judgements and hence 
limit the credibility and transparency of performance assessments based on 
composite scores (Hauck and Street, 2006). 
 
Moreover, although many performance indicators are constructed as ratios (e.g. 
number of healthcare-associated infections/ 100,000 acute occupied bed days), it is 
often unclear which variables should be employed as denominators. In productivity 
and efficiency analysis, denominators are the inputs (labour, capital, intermediate 
inputs such as drugs and clinical supplies) used to produce particular quality 
measures (Jacobs et al., 2006b, Bojke et al., 2013). In comparisons of healthcare 
quality, the denominator of a ratio should be the population at risk of experiencing an 
event (Romano et al., 2010, Schlaud et al., 1998). Operationalising this principle is 
however far from straightforward (Marlow, 1995). Despite its centrality in healthcare 
quality assessments, little effort has been dedicated to identifying ways how to handle 
potential bias introduced by denominators that either overestimate or underestimate 
the “true” population at risk (Guillen et al., 2011). As a result, one cannot be confident 
that observed variations in healthcare are due to differences in system performance 
(the numerator) or due to misspecified populations at risk (the denominator). 
 
A key research question to be asked in this category is therefore how the reporting of 
information on variations in performance might be strengthened so as to recognise 
the ambiguity about key modelling assumptions. 
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1.3.3 Establishing standards with a socio-political approach 
It can be argued that policy-makers should tackle the ambiguity about the standard 
for evaluation “head-on“ by investing more effort into establishing a meaningful 
standard. This is in fact a core recommendation made by international organisations 
such as the OECD to governments who seek to develop performance metrics (Hurst 
and Jee-Hughes, 2001, Hurst, 2002). After all, one of the legitimate mandates of 
democratically elected governments or relevant regulatory authorities is to define 
priorities and set standards for the health service. 
 
In healthcare, setting targets for local organisations is a form of measuring and 
managing performance that by definition requires the specification of levels of “good“ 
performance. Based on the “targets and terror“ model of governance adopted by the 
Labour government in England between 2001 and 2005, target setting is typically 
conceived as a hierarchical process where central government imposes strict targets 
on local organisations with rewards for achievement and sanctions for failure (Bevan 
and Hood, 2006). 
 
Such a hierarchist model of governance, however, requires “dials” (Carter, 1989): 
accurate measures of performance which unambiguously represent desired policy 
ends (Bevan and Hood, 2006) and whose means of attainment are known and 
available to the organisations under scrutiny (Jacobs et al., 2006a). Many 
performance indicators in social policy, however, are mere ”tin openers”: measures 
which “do not give answers but prompt interrogation and inquiry, and by themselves 
provide an incomplete and inaccurate picture” (Carter, 1989: 134). This holds in 
particular for ”wicked” problems where goals are contested and means for change are 
ambiguous (Rittel and Webber, 1973). Some have therefore argued that setting 
delusively exact targets for wicked problems such as health inequalities obscures 
complex causal networks and necessary value judgements in determining desired 
levels of achievement (Blackman et al., 2009). 
 
A key research question to be asked in this category therefore concerns the 
appropriate model of governance to establish standards and good practice in a 
context of ambiguity over ideal goals and means for attainment. 
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1.3.4 Establishing standards with a technical-evidential approach 
As Smith and Street (2005) point out, articulation of the health system’s objectives is 
an inherently political task. Value judgements about the objectives of a system, and 
corresponding standards for evaluation, cannot be derived from technical analysis 
(Popper, 1948). Nevertheless, research and analysis certainly have a role in the 
development of standards. 
 
Most OECD countries have expressed overarching objectives for their health systems 
through policy documents or legislation. At an abstract level, objectives such as 
ensuring equal access to care for equal need may be widely accepted.  In the United 
Kingdom, provision of services in relation to need (rather than ability to pay or non-
medical factors) is in fact a foundational principle of the NHS (Boyle, 2011). 
Translating this principle into measurable, interpretable indicators of performance is, 
however, a complex endeavour.  
 
Studies of variation in healthcare provision have sought to account for need using 
either of two approaches: clinical audits of care provided (see e.g. Chassin et al., 1987, 
Leape et al., 1990, Keyhani et al., 2008b) or standardisation of rates for variables 
associated with need (such as age, sex, deprivation) (see e.g. Majeed et al., 2002, 
Curtis et al., 2009, NHS Right Care, 2010). The former approach can only detect 
”overuse”, defined as “ineffective care that is more likely to harm than help the 
patient“ (Institute of Medicine, 2001: 47). It cannot identify ”underuse”, defined as 
“the failure to provide services from which the patient would likely benefit“ (Institute 
of Medicine, 2001: 17). The latter approach is essential to enable fair comparisons 
between regions whose performance may differ due to factors that are outside the 
region’s control (Nicholl et al., 2013). However, standardised rates cannot provide a 
benchmark of population need for healthcare, understood as the extent to which 
utilisation of a specific service exceeds or falls short of a level of care that is expected 
to be beneficial for a defined population. 
 
A key research question to be asked in this category therefore concerns the 
appropriate  methods to operationalise health system objectives such as “provision of 
services in relation to need for healthcare” in such a way that resulting estimates can 
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be employed as benchmarks to identify both “overuse” and “underuse” of specific 
interventions. 
1.3.5 Use of the framework in this thesis  
The rationale for the framework described above is to organise thinking about the 
problem of how to address ambiguity about the standard for evaluating variations in 
healthcare utilisation. The resulting four categories of strategies are not meant to be 
mutually exclusive. They might plausibly complement each other. Taken together, 
they offer different perspectives on the research problem and provide the 
overarching frame for the five studies included in this thesis.  
 Contribution of the thesis      1.4
To investigate how policy-makers and managers might address ambiguity about the 
standard for evaluation, this thesis presents five studies (Chapters 2 to 6). These 
studies examine different strategies to manage ambiguity about the normative 
standard. The contribution of each study is highlighted below and summarised in 
relation to the framework in Table 1-3.   
 
Chapter 2 contributes to the health policy literature about practical barriers faced by 
potential users of information on variations in healthcare. To our knowledge, ours 
was the first study that sought to examine to what extent and how healthcare payers 
have used information on small area variation in rates of expenditure, activity and 
outcome in order to improve resource allocation. The study set out a model to frame 
the process of moving from information on variations to its use in decision-making on 
health services (Figure 2-1, Chapter 2). Taking the NHS Atlas of Variation in 
Healthcare in England as a case study, we examined barriers to and types of use of 
this information. Data collection involved a survey among Primary Care Trust (PCT) 
Chief Executives and a telephone follow-up to reach non-respondents (total response: 
53 of 151 of PCTs, 35%). 45 senior to mid-level staff were interviewed to probe 
themes emerging from the survey.  
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The results showed that just under half of the respondents (25 of 53 PCTs) reported 
not using the Atlas, either because they had not been aware of it, lacked staff capacity 
to analyse it, or did not perceive it as applicable to local decision-making. Among the 
28 users, the Atlas prompted further analysis of the reasons for variations. It was also 
used as a visual aid to simplify communication about comparative performance with 
clinicians who perceived maps as a more accessible tool for problem framing than 
complex statistical tables. However, only 18 of the 28 PCTs who had reviewed the 
Atlas also reported concrete actions taken for healthcare planning, contracting or 
service design. Factors that appeared to enable local managers to move beyond the 
data towards decisions about resource allocation and behaviour change included 
agreeing on responsibilities for action and the ability to define and identify those 
variations that were unwarranted. 
 
These findings demonstrate that information on variations can serve as a “tin opener” 
(Carter, 1989) to motivate further analysis and inform strategic planning even in the 
absence of an a priori standard of “good” and “bad” performance. To achieve this, 
however, what is additionally required is leadership on variations and the provision 
of appropriate tools to understand which variations are unwarranted. 
 
Chapter 3 contributes to the technical literature on healthcare performance 
assessment when there are multiple objectives (e.g. Hauck and Street, 2006, Castelli 
et al., 2015). Specifically, the study explores healthcare applications of a robust 
approach to ranking organisations based on a composite indicator of performance in 
a context of ambiguity about choices of weight sets and choices of population 
denominator. To that end, the study adopts a novel ratio-based efficiency analysis 
(REA) technique developed by operations researchers (Salo and Punkka, 2011). 
Previously, REA has been used to assess the efficiency of higher education institutions 
based on multiple inputs and quality measures (Salo and Punkka, 2011).  
 
A key advantage of REA is its ability to use the full set of feasible weights and to take 
into account multiple denominator variables that represent different plausible 
definitions of the “population at risk”. This avoids the need to settle on a single, 
potentially controversial set of weights and on a single, possibly biased denominator 
population. The results (displayed as ranking intervals and dominance relations) 
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allow one to identify organisations which cannot be ranked, say, worse than 4th or 
better than 7th. Using data from the Scottish HEAT target system, the study 
demonstrates the applicability of REA to comparative performance assessment in 
healthcare.  
 
The study is important because it shows that assigning a single performance ranking 
to an organisation may not only be questionable from a policy and management 
perspective, but also unnecessary from a technical perspective. The use of ranking 
intervals and dominance relations provides one possible way to show the impact of 
different modelling assumptions on the results. Because REA is able to make explicit 
and visualise the uncertainty in rankings, the study argues that REA provides a 
method that may help increase the transparency and credibility of performance 
rankings and thus usefully complement existing tools of healthcare evaluators. 
 
Chapter 4 makes an empirical contribution to the identification of “overuse“ and 
“underuse“ of ventilation tube (VT) surgery for otitis media with effusion (OME) 
against an explicit normative standard. Ventilation tubes are an insightful case study 
because they represent a classic case of high variation at a small area level (NHS Right 
Care, 2012b) and because there is a long-standing belief, since the 1980s, that these 
variations represent widespread overuse (Black, 1985c). This belief is supported by 
clinical audits in the US (Keyhani et al., 2008a) and the UK (Daniel et al., 2013) which, 
using different criteria of appropriateness, found that only one in three ventilation 
tubes was provided in line with these criteria. However, audits cannot identify the 
scale of underuse: i.e. patients who would benefit but are not treated. 
 
To identify both overuse and underuse, Chapter 4 develops an epidemiological model 
based on: definitions of children with OME expected to benefit from VTs according to 
guidance from the National Institute for Health and Care Excellence (NICE); 
epidemiological and clinical information from a systematic review; and expert 
judgment. The study finds that the expected population capacity to benefit from VTs 
for OME based on NICE guidance exceeds, by far, the number of VTs actually provided 
in the NHS. About 32,200 children in England would be expected to benefit from VTs 
for OME per year (between 20,411 and 45,231 with 90% certainty). The observed 
number of VTs for OME-associated diagnoses in the NHS in 2010 however was 
34 
 
16,824. Hence, there appears to be substantial net “underuse” of VTs for OME if NICE 
criteria were applied.  
 
These findings are important because they challenge a common policy among 
healthcare payers in England to improve treatment appropriateness by means of 
restricting access to VTs and other procedures that are deemed to be of “low clinical 
value” (Audit Commission, 2011). Our findings demonstrate the potential co-
existence of overuse and underuse at a population level and therefore call for a more 
nuanced policy response.  
 
Chapter 5 examines the feasibility and utility of a specific methodology to assess the 
appropriateness of variations in the use of specific interventions against a measure of 
population need for these interventions. Grounded in a health economic view of need 
for healthcare in relation to the capacity to benefit from healthcare (Culyer and 
Wagstaff, 1993, Culyer, 1995, Stevens and Gillam, 1998, Mooney and Houston, 2004), 
the study defines the concept of population capacity to benefit 𝑃𝐶𝐵𝑖
𝑘 as the number of 
people in some population or region k with a specified condition-intervention pairing 
i which represents the capacity to benefit from some intervention given defined 
characteristics of the health state. The study suggests that estimates of PCB may serve 
as a benchmark to identify potential gaps between need for and utilisation of defined 
interventions. Because these estimates represent a level of care that is expected to be 
beneficial for a specific population, they overcome a key limitation of the 
conventional method to account for need by standardising observed rates of 
utilisation for variables associated with need. 
 
To synthesise the existing state of knowledge, the study reviews empirical 
applications of the PCB concept. The review identified 22 studies published between 
January 1990 and 2015 which applied the PCB approach to nine clinical areas in total, 
including amongst others hip and knee replacement for people with osteoarthritis 
and radiotherapy for different types of cancer. These findings show how the 
theoretical principle of “population need“ for a specific intervention can be 
operationalised in practice using established methods from Health Technology 
Assessment (HTA) and epidemiology. The study is important because it shows the 
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feasibility and utility of attempting to measure capacity to benefit in populations. It 
also highlights persisting challenges with regard to the availability of credible criteria 
of capacity to benefit and accurate and comprehensive data on the incidence of these 
criteria in a population of interest.  
 
Chapter 6 contributes to the public administration literature on models of 
governance for setting performance targets. The study asks how and to what extent a 
more learning-oriented logic of experimentalist governance (Sabel and Zeitlin, 2012) 
might complement hierarchist governance by targets focused primarily on 
accountability. The study postulates (i) that it is possible to disentangle and examine 
empirically the co-existence of hierarchist and experimentalist elements in the same 
performance management regime; and (ii) that the relative emphasis on 
experimentalist as opposed to hierarchist logics differs between policy issues 
depending on the degree of perceived ambiguity over ends and means. 
 
Using a comparative embedded case study design (Yin, 2003), the study compares, 
within the Scottish HEAT target system,  the development of HEAT targets for two 
policy issues which represent opposite ends on a spectrum of ambiguity over goals 
and means. Where ends and means were contested (the case of shifting the balance of 
care for older people; a typical “tin opener”), we find a stronger focus on 
experimentalist ideas in the form of locally agreed targets and a focus on local 
innovation. Where both ends and means seemed obvious (the case of healthcare-
associated infections; an apparent “dial”), hierarchist elements dominated initially. 
However, management style drifted towards the experimentalist realm when rising 
rates of community-acquired infections decreased clarity about effective 
interventions.   
 
To summarise, the thesis approaches the problem of ambiguity about the standard 
for evaluation from an interdisciplinary perspective. It draws on concepts and 
methods from different scientific traditions, including public health and 
epidemiology, health economics, operations research and public administration. As a 
whole, the thesis adds to our knowledge about using information on variations in 
healthcare. It reinforces the insight that both improved technical tools and social and 
political processes are required to make this information useful to decision-makers. 
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Table 1-3  Contribution of the five studies in relation to strategies to address ambiguity about the standard for evaluation 
  Approach 
        Socio-political Technical-evidential 
Purpose 
 
 
 
 
 
Manage 
ambiguity in 
the absence 
of a 
standard 
 
Chapter 2 
• Provides a model to frame the process of moving 
from the measurement of variations in healthcare 
to their management. 
• Investigates barriers along this process faced by 
healthcare payers in England and examines 
strategies to make sense of the information 
locally. 
 
Chapter 3 
• Explores healthcare applications of a robust approach to 
ranking using ratio-based efficiency analysis (REA; Salo and 
Punkka, 2011) based on ranking intervals and dominance 
relations that recognise ambiguity about choices of weights and 
choices of population denominator. 
Establish 
meaningful 
standards 
Chapter 6 
• Examines how an experimentalist governance 
logic focused on learning and dialogue between 
central government and local organisations (Sabel 
and Zeitlin, 2012) might complement a more 
hierarchist philosophy focused on accountability 
when setting performance targets. 
• Contributes an empirically-based characterisation 
of the co-existence and potential complementarity 
of these logics in the Scottish HEAT target system. 
Chapter 4  
• Develops an epidemiological model to investigate overuse and 
underuse in ventilation tube surgery for children with otitis 
media with effusion in England. 
• Shows that underuse and overuse may co-exist and that a more 
nuanced policy is required to increase appropriateness in the 
provision of ventilation tubes. 
  
Chapter 5 
• Defines the concept of population capacity to benefit (PCB) as a 
potential benchmark for population need for defined 
interventions. 
• Critically reviews the feasibility and utility of measuring PCB, 
its generalizability across conditions and persisting challenges. 
 
37 
 
2 FROM DATA TO DECISIONS? EXPLORING HOW 
HEALTHCARE PAYERS RESPOND TO THE NHS ATLAS OF 
VARIATION IN HEALTHCARE IN ENGLAND 
Published as:  
 
SCHANG, L.,a MORTON, A.,a DASILVA, P.b & BEVAN, G.a 2014. From data to decisions? 
Exploring how healthcare payers respond to the NHS Atlas of Variation in Healthcare in 
England. Health Policy, 114(1), 79-87. 
 
 
Author information (for the time when the research was conducted): 
 
a Department of Management, London School of Economics and Political Science, United 
Kingdom 
b NHS QIPP Right Care Programme and NHS Derbyshire, United Kingdom 
 
Correspondence to:  
 
Laura Schang 
Department of Management 
London School of Economics and Political Science 
Houghton Street | London | United Kingdom 
Email: L.K.Schang@lse.ac.uk 
 
 
Key words: resource allocation; small-area analysis; unwarranted variations; regional 
health planning; organisational decision making; quality indicators.
38 
 
Abstract 
 
Purpose: Although information on geographic variations in healthcare is now more 
widely available, relatively little is known about how healthcare payers use this 
information to improve resource allocation. We explore to what extent and how Primary 
Care Trusts (PCTs) in England have used the NHS Atlas of Variation in Healthcare, which 
has highlighted small area variation in rates of expenditure, activity and outcome.  
 
Methods: Data collection involved an email survey among PCT Chief Executives and a 
telephone follow-up to reach non-respondents (total response: 53 of 151 of PCTs, 35%). 
45 senior to mid-level staff were interviewed to probe themes emerging from the survey. 
The data were analysed using a matrix-based Framework approach.  
 
Findings: Just under half of the respondents (25 of 53 PCTs) reported not using the 
Atlas, either because they had not been aware of it, lacked staff capacity to analyse it, or 
did not perceive it as applicable to local decision-making. Among the 28 users, the Atlas 
served as a prompt to understand variations and as a visual tool to facilitate 
communication with clinicians. Achieving clarity on which variations are unwarranted 
and agreeing on responsibilities for action appeared to be important factors in moving 
beyond initial information gathering towards decisions about resource allocation and 
behaviour change.  
 
Conclusions: Many payers were unable to use information on small area variations in 
expenditure, activity and outcome. To change this what is additionally required are 
appropriate tools to understand causes of unexplained variation, in particular 
unwarranted variation, and enable remedial actions to be prioritised in terms of their 
contribution to population health. 
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 Introduction 2.1
Over the past 40 years, medical variation research has largely focused on the 
identification and measurement rather than the management of variations in healthcare. 
Studies in particular from North America and increasingly also from other countries 
show that medical practice varies across regions, and that the magnitude of these 
variations cannot solely be explained by differences in demographic and illness profiles 
of regional populations (Wennberg and Gittelsohn, 1973, McPherson et al., 1982, Paul-
Shaheen et al., 1987, Wennberg, 2010). Evidence of substantial variations in medical 
practice thus challenges the core societal objective of many health systems to provide 
equal access to safe and effective health care for equal need (Evans, 1990, McGlynn, 
1998). But while healthcare payers now have unprecedented access to data about 
variations in health service utilisation and performance, there is little research on how 
payers might actually use this data to improve resource allocation and outcomes. Studies 
so far have focused on shared decision making (O'Connor A et al., 2004, Elwyn et al., 
2010) and behaviour change interventions at a hospital level (Wright et al., 2006, 
Parente et al., 2008, Gauld et al., 2011).  
 
However, the ways in which regional variations data might inform resource allocation at 
a population level by those responsible for the management of the system have not been 
explored. In this article we ask how a healthcare payer in charge of planning and 
purchasing health services for a geographical population might move from data 
awareness to decisions to improve quality and value in healthcare. Realising this basic 
quest may not be straightforward, as Glasziou and Haynes (2005) point out in the 
context of guideline implementation, because the path from research to improved 
outcomes poses a series of hurdles to clinical and managerial decision-makers. Prior to 
acting on the research findings, they need to be aware of and accept the data, perceive 
the data as applicable to their situation, and be able to use the data. These barriers seem 
pertinent to research use in general (Nutley et al., 2007). Data on medical practice 
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variations create the additional conundrum that, as opposed to a guideline, they rarely 
tell the user what to do.  
 
There appear to be two general pathways for taking action on medical practice variation. 
The two principal aims of performance indicator systems stated in the literature relate to 
external control and accountability, and internally focused improvement and formative 
learning (Solberg et al., 1997, Freeman, 2002, Davies, 2005). Similarly, Carter (1989) 
distinguishes between “dials” that show achievement against targets, and “tin openers” 
that simply indicate potential problems and then lead to in-depth analysis and action. 
For both types of indicators, action would require agreement on who is responsible for 
leading investigation and change, and how to identify and remedy the causes underlying 
those identified variations. A key feature of classic variations research, as presented in 
Atlases of Variation (NHS Right Care, 2010, The Dartmouth Institute, 2012, Nolting et al., 
2011, Bernal-Delgado et al., 2014), is however the essential ambiguity over the meaning 
of observed variations. Generally this data does not allow for direct inferences from 
relative rates of activity to good or bad performance of the entities under investigation. 
As optimal performance is not identified, this data thus differs from benchmarking 
where all organisations are compared with the “best” performer (Bogan and English, 
1994). In this case, geographic variations data is likely to serve as a “tin opener” rather 
than as a “dial”. As Evans (1990) pointed out, dealing with the uncertainty over how to 
address practice variations would thus first require defining and operationalising which 
part of the observed variations, if any, is unwarranted.  
 
Figure 2-1 suggests a model to frame the process of translating evidence of geographic 
variations into decisions to shape resource allocation and planning. This model 
comprises two main stages. The first stage is informed by the literature on guideline 
implementation (Glasziou and Haynes, 2005) and research use (Nutley et al., 2007) and 
consists of a series of prerequisites for staff in a healthcare purchasing organisation to be 
in a position to use such evidence: that they are aware of its existence, trust the 
information it provides, can see its relevance to them and are capable of using this 
information. The second stage is structured around the pathway for using the 
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information (Evans, 1990): identifying unwarranted variation, agreeing who will be 
responsible for action, identifying causes and appropriate remedies, and making 
decisions on resource allocation. 
 
Figure 2-1   A framework for moving from data on geographic variations to 
resource allocation decisions 
 
Sources: adapted from Glasziou and Haynes (2005) and Evans (1990). 
 
This model frames the questions our research sought to answer. As a case study we used 
the NHS Atlas of Variation in Healthcare, which in its first edition from November 2010 
highlighted variation in expenditure, activity and outcomes across a wide range of 
clinical areas at the level of Primary Care Trusts (PCTs), the local payers in England (NHS 
Right Care, 2010). Our aim was to examine: (1) the extent to which PCTs met the 
prerequisites for using the NHS Atlas; and (2) how they were using the NHS Atlas in local 
decision making. We emphasise that most of this study was done before the publication 
of the second edition of the Atlas. We would expect awareness and capacity to use 
information on variations to increase over time and see this study as helping with both. 
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 Materials and methods 2.2
2.2.1 Setting 
At the time of study (July 2011–March 2012), the planning and delivery of health 
services in the National Health Service (NHS) in England was entrusted to 151 PCTs. 
They received a fixed financial allocation for their local populations (median size 
284,000, ranging from under 100,000 to over one million people; Office for National 
Statistics (2011)) with reference to a national resource allocation formula that aimed to 
estimate an equitable distribution of funds against needs across the country (Boyle, 
2011). Within allocated resources, PCTs were responsible for: improving health and 
reducing health inequalities, securing access to comprehensive, effective and efficient 
services, and appropriately responding to the healthcare needs of their populations. 
They were responsible for commissioning health services across all service sectors 
(public health, primary care services including dentistry, pharmacy and optometry, 
community health services, social care, mental health, elective and acute hospital care) 
and were required to engage in (Department of Health, 2006): 
 
1) Strategic planning: assessing needs, reviewing service provision, deciding 
priorities. 
2) Procuring services: designing services, shaping the structure of supply, managing 
demand for services. 
3) Monitoring and evaluation: supporting patient choice, managing performance, 
seeking public and patient views. 
 
The English NHS at the time of study was under expenditure constraints and required to 
generate efficiency savings of about 4% of total annual resources every year between 
2011 and 2015, in order to meet rising demand for health services (Department of 
Health, 2010d). The proposed organisational reform outlined in the government White 
Paper Equity and Excellence: Liberating the NHS of July 2010 (Department of Health, 
2010a) entailed the abolition of PCTs in April 2013, to be succeeded by general 
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practitioner-led Clinical Commissioning Groups. Thus, although information on 
variations has potential to help managers understand and focus on areas for efficiency 
savings in their local health economy, to be invested in areas of higher value, PCTs were 
likely to be distracted by their looming abolition. 
2.2.2 The NHS Atlas of Variation in Healthcare 
Since Glover’s seminal study on variation in tonsillectomy rates among British school 
children in 1938 (Glover, 1938), research has repeatedly documented regional variation 
in medical practice in England (e.g. McPherson et al., 1982, Price et al., 1992, Congdon 
and Best, 2000, Majeed et al., 2002, Appleby et al., 2011). Our focus was specifically on 
the NHS Atlas of Variation in Healthcare, because this Atlas for the first time highlighted 
variation in expenditure, activity and outcome across a large range of clinical areas at 
PCT level and was thus likely to be particularly relevant within a commissioning context. 
Inspired by the US Dartmouth Atlas, the NHS Atlas was developed by the Department of 
Health’s national Quality, Innovation, Productivity and Prevention (QIPP) programme, a 
large scale transformational programme intended to address these four major challenges 
confronting the NHS (Department of Health, 2010d), through the Right Care workstream. 
The first NHS Atlas, published in November 2010 (NHS Right Care, 2010), consists of 34 
maps of variation (2011 Atlas: 71 maps; NHS Right Care (2011)). These maps represent 
the relative position of PCTs in quintiles across selected indicators, standardised for age 
and sex. The topics were selected in consultation with the National Clinical Directors as 
being of importance to their clinical specialty; for instance in terms of volume, cost, 
patient outcomes, or recent trends in delivery patterns. 
 
The NHS Atlas was primarily targeted at those who manage and allocate resources for 
healthcare; commissioners and clinicians. Its objective was to provide information in 
ways that would stimulate local investigation into unwarranted variation in the NHS, its 
underlying causes, and remedial action. Given the complexity and variety of the different 
kinds of variations reported in the NHS Atlas, there was neither ranking nor evaluation 
of the performance of NHS organisations; nor were there any links with (external) 
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financial incentives. This differs from NHS star ratings (2000–2005), and the Annual 
Health Check (2006–2009) which gave annual summative aggregate scores of 
performance (Bevan, 2011); and more recent care quality targets that clearly define 
successful achievement (Department of Health, 2010c). The NHS Atlas carefully avoids 
rating PCTs as “good” or “bad” performers based on high, middle or low indicator values. 
Targets or “optimal” rates of activity are not defined. However, in the wide-ranging 
media echo to the NHS Atlas, several think tanks, academics, charities and politicians 
interpreted the magnitude of regional variations as indications of unwarranted variation, 
and urged PCTs and the government to take action (Jeffreys, 2010, The Guardian, 2011, 
Mays, 2011). 
2.2.3 Study design  
The first part of data collection involved an email survey with open-ended questions 
among the Chief Executives of all 151 PCTs. Given the low response (18 of 151 of PCTs, 
12%), non-respondents were followed-up by telephone (total response: 53 of 151 of 
PCTs, 35%). The data were collected in two waves (Wave I: July to August 2011; Wave II: 
October 2011 to March 2012). The survey was designed to gain an indicative overview of 
whether the Atlas was used, why or why not, in what form and by whom, and to identify 
potential interviewees (see Appendix 2-A for the questions asked). The second part of 
the research involved interviews based on a semi-structured protocol in order to probe 
themes emerging from the survey (see Appendix 2-B for the questions asked). 
 
Interviewees were chosen if they had used the Atlas or, if nobody in the organisation had 
used it, based on their job roles relevant to using such data. Both users and nonusers of 
the Atlas were interviewed as representatives of their organisations. If they were unsure 
whether others had used the NHS Atlas they asked other colleagues if they had. If at least 
one person reported using the NHS Atlas, the PCT was recorded as a “user”. A working 
definition of “use” of the Atlas was that PCT staff reported some form of engagement 
with the material. Before the interviews, permission for tape-recording was obtained. In 
total, 45 interviews with senior to mid-level executives involved in public health, 
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commissioning and knowledge management from 29 PCTs were undertaken face-to-face 
or via telephone between October 2011 and March 2012. The interviews were 
transcribed verbatim and, guided by the conceptual framework, reviewed iteratively 
with the survey results to identify and confirm emergent themes. Themes were analysed 
using the Framework approach (Ritchie and Spencer, 1994), a matrix based method to 
construct and organise an index of central themes and subthemes, and thereby facilitate 
a synthesis of the findings by theme and by respondent. The recruitment of interviewees 
was stopped when a stage of saturation was reached; that is when no new themes 
emerged after several further interviews (Robson, 2002). 
 
 Results 2.3
2.3.1 Characteristics of respondents 
Table 2-1 shows the characteristics of the responding PCTs for Waves I and II, overall, 
and in comparison to all 151 PCTs. Responding PCTs were significantly larger in terms of 
median population size than the totality of PCTs. There was no significant difference 
between responders and all PCTs in terms of the Index of Multiple Deprivation and 
rurality. Overall, the survey achieved representation of PCTs from all five major 
geographic Strategic Health Authority (SHA) regions in which PCTs are situated. 
However, PCTs from London were underrepresented while PCTs from Midlands and East 
were overrepresented. 
 
 
46 
 
Table 2-1 Response rates and sample characteristics (2010 data) 
 Wave I  
(July 2011–Aug 
2012) 
Wave II  
(Oct 2011–March 
2012) 
TOTAL SAMPLE TOTAL PCT 
POPULATION 
Number of PCTs 17 36 53 151 
Median 
population size 
(range) 
362,345  
(100,843 -  
1,114,366) 
389,456  
(179,344 -  
1,296,814) 
378,907*  
(100,843 -  
1,296,814) 
284,000  
(91,304 - 
1,296,814) 
Index of Multiple 
Deprivation 
(mean score; 
range) 
20.53  
(11.34 - 41.13) 
22.75  
(8.81 - 41.01) 
21.81  
(8.81 - 41.13) 
23.64 
(8.81 - 45.31) 
Rural PCT 3 (17%) 13 (36%) 16 (30%) 50 (33%) 
Predominantly 
rural1 
1 (6%) 10 (28%) 11 (21%) 24 (16%) 
Significant 
rural2 
2 (11%) 3 (8%) 5 (9%) 26 (17%) 
Geographic 
location 
    
London 3 2 5  (9%)* 31 (21%) 
North of 
England 
4 6 
10 (19%) 36 (24%) 
Yorkshire and 
the Humber 
1 4 
5 (9%) 15 (10%) 
Midlands and 
East 
7 13 
20 (38%)* 39 (26%) 
South of 
England 
2 11 
13 (25%) 30 (20%) 
* Significant difference in means at 95% confidence level based on one sample mean comparison t-test 
(population size) and, respectively, the one sample test of proportions (rurality and geographic location). 
 
2.3.2 Prerequisites for using the NHS Atlas  
PCTs can be classified into four groups of “non-users” (groups 1.1–1.4), according to the 
account they gave for not using the NHS Atlas, and “users” (group 2). As the survey 
results (Figure 2-2) suggest, the number of PCTs appears to decline along these stages 
from awareness to actual use. Emerging themes from the qualitative analysis (Table 2-1) 
point to possible underlying reasons, as reported by PCT staff.  Most PCTs were aware of 
                                                                    
1 Definition: more than or equal to 50% of their population in rural settlements and larger market towns. 
2 Definition: more than or equal to 26% but less than 50% of their population in rural settlements and 
larger market towns. 
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the NHS Atlas (44 of 53 PCTs, group 1.1). Those who had not been aware of the Atlas, 
despite it being distributed to all PCTs and the relatively large media echo following its 
publication, referred to being distracted by the structural reorganisation which reduced 
their attention to information about healthcare delivery.  
 
Group 1.2 was aware of and accepted the NHS Atlas data as generally valid and reliable, 
although several respondents cautioned about taking the data at face value. In contrast, 
staff in three PCTs perceived these regional comparisons not as credible due to 
differences in local management processes, for example in coding patterns, and some 
noted their preference to work with local data. All PCT respondents recognised 
unwarranted practice variations as a challenge. This challenge was frequently linked to 
the NHS-wide economic constraints and the need to meet rising demand with fewer 
resources. However, only 37 PCTs (group 1.3) perceived the Atlas as applicable to their 
local situation. The main reasons for perceived limited applicability were the difficulty of 
(i) inferring from observed variations what ought to be done along care pathways and 
(ii) discerning the relationship between relative rates of activity and absolute scale of 
impact on population health outcomes and total service expenditure. Six PCTs who 
viewed the NHS Atlas as applicable to local decision making noted organisational 
constraints to use. In particular, annual priorities for action had already been agreed 
prior to publication of the Atlas and PCTs lacked staff capacity to tackle new issues. 
Among 31 PCTs (group 1.4) who reported the capacity for using the Atlas, three PCTs 
had only recently been able to make this capacity available. These PCTs were planning to 
use the second NHS Atlas published in December 2011. Overall, at the time of study, just 
over half of the respondents (28 of 53 PCTs, group 2) had thus translated the perceived 
need to tackle regional variations into actual use of the NHS Atlas. 
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Figure 2-2 Survey responses to the NHS Atlas 
 
 
n= 53 Primary Care Trusts. 
2.3.3 Using the NHS Atlas in local decision making 
Among the users (group 2; 28 of 53 PCTs), a first basic response to the NHS Atlas was to 
review all maps in order to gain an overview over the PCT’s relative position across a 
range of indicators. PCT staff seemed predominantly concerned to understand where 
they were “outliers”; indicators on which the PCT was in the highest or lowest quintile of 
rate of expenditure, activity or outcome relative to the national average. Qualitative 
themes on uses of the NHS Atlas in local decision making, and factors complicating and 
enabling its use, are illustrated in Table 2-1 and explained in more detail below.  
 
The initial interpretation of outlier positions tended to be indicative rather than 
prescriptive. As respondents noted, the outliers shown in the NHS Atlas helped them to 
identify areas to focus on in their local health economy. Several interviewees referred to 
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the concept of triangulation inasmuch as a view on variation complemented various 
other national and local sources of data (e.g. workforce, financial, activity and outcome 
data insofar as it was available). In their entirety, these multiple pieces of evidence could 
then help to frame strategic challenges for the PCT. As public health staff in twelve PCTs 
pointed out, the NHS Atlas supported learning about strategic problems both internally 
and externally with clinicians. While the Atlas sometimes confirmed existing local 
suspicions rather than providing new information to PCT staff, map-based visualisations 
did help to communicate this understanding to clinicians who were not familiar with the 
statistical data, thus placing it on the management agenda. Messages from the NHS Atlas 
were then locally disseminated through newsletters, the Annual Public Health report, 
integration into evidence-into-practice packages or presentations to clinicians. 
 
Beyond the description and illustration of variations, the evaluation of what were 
perceived as unwarranted variations appeared to be painstaking. As interviewees 
explained, they attempted to draw as much as possible on existing outcomes research 
and cost-effectiveness guidance. Further indications of unwarranted variations related to 
perverse incentives induced by payment systems, and hospital admissions perceived to 
be avoidable with timely diagnosis and treatment in primary care. For most PCTs, a 
position in the highest or lowest quintile served as but one indication of unwarranted 
variation that was further explored with other data sources. In turn, however, many 
PCTs associated a position in the medium quintile with a lower priority for any action. In 
some PCTs, this was because a position around the national average was, implicitly, 
equated with an appropriate rate of activity. These PCTs appeared to take the NHS Atlas 
at face value rather than as a prompt for further investigation. In other PCTs, in contrast, 
respondents conceded that limited staff capacity prevented them from exploring all 
possible sources of unwarranted variation. These respondents pointed out that, although 
a position in the medium quintile might not be optimal, they had decided to start 
exploring areas where they were outliers, relative to peers, because these areas might 
provide larger opportunities to reveal wasteful spending or underinvestment. While PCT 
respondents confirmed the difficulty of defining and identifying unwarranted variation, 
they also pointed out that this challenge had to be considered within the wider problem 
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of where they should start in improving resource allocation by investing limited funds 
more wisely in order to improve outcomes. 
 
Agreements on responsibilities for action appeared to be decisive in using variations 
data for local decision making. For the few target-like indicators in the NHS Atlas, where 
existing clinical guidance would stipulate preferably high values, six PCTs emphasised 
the importance of involving clinicians at an early stage, as they would ultimately allocate 
healthcare resources. In two PCTs, for example, maps of variation showing less than 30% 
of patients with diabetes had received nine key care processes, as opposed to over 70% 
in the best PCT, helped to convince general practitioners that not only performance was 
unacceptably poor, in relative and absolute terms, but also that improvements were 
possible. PCT staff perceived the NHS Atlas as a “catalyst which motivated clinicians to 
take action sooner than they might have done otherwise” (Director of Commissioning, 
PCT22). 
 
Among the 28 PCTs where staff had reviewed the Atlas, 18 engaged in further in-depth 
analysis of possible causes underlying variation. An essential factor appeared to be 
leadership; both in terms of support from the executive management and local 
champions from the PCT and clinicians who took the analyses forward. The development 
of structures to use data on variations also appeared to be important. Some PCTs noted 
the increasing role of Priority Forums to engage multiple stakeholders in order to 
improve value, in terms of the relationship between expenditure and health outcomes, in 
resource allocation. At an operational level, these PCTs had also established regular 
meetings with providers from primary and secondary care, in order to agree local 
objectives for action and foster continuous monitoring and feedback against these 
objectives at hospital or practice levels. In contrast, in PCTs which did not report further 
action on the observed variations, interviewees also frequently noted a lack of Executive 
and Board level support, public health and analytical capacity to address the observed 
variations. 
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Table 2-2 exemplifies some of the different logics for moving from information on 
variations to in-depth analysis and decisions about resource allocation. An approach to 
understanding variations in high-level aggregate indicators, such as total spending on a 
disease area as in PCT A, was to break down the data into the underlying procedures and 
settings of care. The objective was to identify the specific drivers of expenditure in a local 
health economy. Understanding variations in activity involved the exploration of specific 
hypotheses regarding commissioning policies and supplier behaviour, as in PCTs B and 
C. Depending on the particular causes identified as underlying variations in practice, 
PCTs decided whether changes in planning, contracting or service design would be 
necessary. 
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Table 2-2 Qualitative responses to the NHS Atlas 
Theme  Sub-theme  Example/illustration 
   
1.1. 
Awareness of 
the data 
Distraction due to 
organisational 
reforms 
“The development of CCGs [Clinical Commissioning Groups, 
successors of PCTs as from April 2013] left little room for 
anything else, such as improving services . . . we were 
mainly concerned with getting the new structures going” 
(Chief Operating Officer, PCT4) 
1.2. 
Acceptance of 
the data 
Local management 
processes seen as 
too different 
“If you look at geographic differences in spending patterns, 
there may be distortions, in the ways costs are allocated . . . 
for example PCT spending on cancer may differ depending 
on the ways hospice costs are taken into account” (Director 
of Public Health, PCT7) 
 Preference to work 
with local data 
“I prefer to work with raw and more detailed local data, for 
many reasons. . . the data in the Atlas has been transformed 
and aggregated, which makes it sometimes difficult to 
understand what is in, and what is out . . . surely you can 
look up some of these issues in the meta-data [a file 
published by Right Care detailing the data sources and 
calculations of Atlas data] . . . but there is also the time lag 
of 1-2 years in the Atlas data, which is understandable as it 
takes time to do an Atlas, but at local level we have moved 
on since then, and have more recent data in some areas” 
(Information Analyst, PCT14) 
1.3.  
Perceived 
applicability 
of the data 
Single indicators 
versus pathways of 
care 
“The Atlas is rather narrow in its focus on single indicators 
. . . what does this mean for the entire pathway, from 
community, primary to hospital care . . . is this variation in 
a single indicator actually meaningful, what does it mean 
for the pathway?” (Public Health Analyst, PCT3) 
 Other criteria 
besides the 
magnitude of 
variation 
“Looking at variations only can be misleading if you want 
to improve services. There may be large scope for 
improvement even for those in the top quintile nationally. 
Then of course some areas are simply too difficult to 
improve. So it’s not just about reducing variations but 
about where to start if you want to improve population 
health” (Director of Public Health, PCT6) 
“What I want to know is: where do we have the largest 
potential for efficiency savings, that don’t harm patients . . . 
the Atlas alone can’t tell me that” (Financial Director, 
PCT12) 
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Theme  Sub-theme  Example/illustration 
1.4.  
Ability to use 
the data 
No staff capacity to 
use NHS Atlas 
“We had already agreed priorities for action when the Atlas 
was published, and had no further resources and analysts 
to tackle new issues” (Medical Adviser, PCT9)                                                 
2. Use of the 
NHS Atlas 
Strategic problem 
framing 
“Surely the Atlas alone is not enough but we use it to 
triangulate with other evidence. This helps us to see where 
we have most potential to improve, mainly financially” 
(Head of Performance, PCT5) 
 Problem 
communication 
“The maps often confirmed our existing local suspicions. 
But they helped a lot to illustrate to GPs [general 
practitioners] where we stand compared to other PCTs” 
(Public Health Analyst, PCT13) 
“We used the Atlas to visualise problems to clinicians, in an 
accessible format . . . this in turn served as a catalyst which 
motivated clinicians to take action sooner than they might 
have done otherwise” (Director of Commissioning, PCT1) 
Challenges in 
using the NHS 
Atlas 
Unclear basis for 
evaluating 
unwarranted 
variation 
“There is not always a clear-cut definition what variation is 
bad... usually we take NICE [National Institute for Health 
and Care Excellence] guidance as a basis, if it is available 
for this area” (Public Health Analyst, PCT1) 
“Variation is “unwarranted” for us if we could have avoided 
it with better organisation of the service, or better provider 
payment... but my concern is that we don’t always know 
what better payment or delivery should look like” 
(Commissioning staff, PCT2) 
 Role of the national 
average as an 
implicit reference 
point 
“We were in the middle for most indicators . . . so nothing 
alarming really” (Medical Adviser, PCT24) 
“It’s difficult to know where to start . . . we also don’t have 
the resources to do everything. So we mainly looked at 
areas where we were large outliers . . . if you are very 
different from others, it’s likely that something goes wrong 
in your PCT. But for respiratory disease we are around the 
national average for most indicators in the Atlas and still I 
think we could improve a lot” (Public Health Analyst, 
PCT2) 
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Theme  Sub-theme  Example/illustration 
Enabling 
factors for 
coordinating 
further 
analysis and 
action 
(Internal) 
responsibilities for 
action: 
Management 
structures and 
clinical 
involvement 
“We have regular performance management meetings 
together with local clinicians to agree service objectives, 
and who does what . . . and then we monitor progress 
towards these objectives. The Atlas fit in naturally into our 
existing structures” (Director of Commissioning, PCT16) 
“It’s key to have some structures to get local clinicians on 
board, to have a team that visits the practices, talks to 
clinicians . . . asking them regularly about variations and 
why this local health economy might differ from others” 
(Director of Commissioning, PCT25) 
 Leadership and 
high-level support 
“The PCT Board gave great support in using the Atlas . . . 
they discussed the Atlas at one of the Board meetings, and 
appointed a person to champion work into variations” 
(Public Health Analyst, PCT21) 
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Table 2-3 Case studies 
 PCT A PCT B PCT C 
Data from the 
NHS Atlas 
PCT A was in the 
highest national 
quintile for total 
spending on cancer 
care 
PCT B was in the highest 
national quintile for rates of 
cataract surgery 
PCT C was in the 
highest national 
quintile for magnetic 
resonance imaging 
[MRI] activity 
Evaluating 
unwarranted 
variation and 
its causes 
NHS Atlas data was 
disaggregated using 
data from the regional 
Quality Observatory: 
from total spending at 
regional level to 
patterns of spending 
across procedures and 
across settings of care 
The cancer care team 
identified two main 
drivers of 
unwarranted 
variation: 
1. Multiple charging for 
treatment events due 
to four separate 
charges for 
chemotherapy 
2. High levels of  
emergency admissions 
both at active 
treatment stage and at 
the end of life 
Comparisons with 
neighbouring PCTs showed a 
lower clinical threshold for 
cataract surgery in PCT B 
(6/12 versus 6/9 in the 
worse eye) 
Reasoning about  
unwarranted variations was 
based on two main 
observations: 
1. The current clinical 
threshold was at the lower 
end of the driving standard 
set by the Driver and Vehicle 
Licensing Agency (between 
6/9 and 6/12) 
2. A large national audit had 
shown that one in three eyes 
with a pre-operative visual 
acuity of 6/9 either had no 
benefit or a poorer outcome 
post-operatively. In eyes 
with a pre-operative visual 
acuity of 6/12, only one in 
eight did not improve 
 
In one of the regular 
performance 
management meetings 
between PCT staff and 
hospital medical and 
operating managers, 
clinician discretion 
was identified as a 
likely driver of 
variation.  
A retrospective audit 
was undertaken to 
compare clinical 
guideline 
recommendations 
with actual practice.  
The audit showed 
clinicians complied 
with current guidance 
in prompting the 
provision of MRIs 
Responsibilities 
for action 
Monitoring by the PCT 
and regular 
performance meetings 
between the Director 
of Commissioning and 
local physicians 
Review by the PCT’s public 
health team as a basis for 
review by the PCT’s 
Priorities Forum 
Joint leadership by the 
PCT’s commissioning 
team, the medical 
director and operating 
officer of the acute 
hospital 
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 PCT A PCT B PCT C 
Analysis and 
decisions on 
actions 
Cancer-care specific 
decisions included: 
1. The revision of 
contracts to ensure 
appropriate payment 
2. Commissioning of 
new community 
services including 
Palliative Care Co-
ordination and Rapid 
Response Teams to 
decrease the burden 
on hospital emergency 
facilities 
The Priorities Forum (which 
advises the PCT on the 
treatments that should be 
given high or low priority 
and comprises public health 
and commissioning staff, 
primary and secondary care 
representatives, a lay 
representative and a 
librarian) agreed: 
1. To increase the clinical 
threshold for cataract 
surgery to the 6/12 level 
2. To introduce special 
clauses for occupations in 
which small gains in 
binocular visual acuity can 
be essential to the ability to 
work (e.g. watchmakers, 
microsurgeons) to prevent 
inequities 
Current practice and 
relatively high rates of 
MRI utilisation were 
considered to be 
appropriate 
 
 Discussion 2.4
2.4.1 General comments and impact of this study 
Internationally, there is a growing policy interest in and information on geographic 
variations in healthcare. In a rising number of countries including Canada, England, 
Germany, Spain, the Netherlands, New Zealand and the United States, Atlases of 
Variation have either been or are being developed to raise awareness of regional 
differences in patterns of expenditure, activity and outcomes. But although healthcare 
payers have unprecedented access to variations data, how to use such information to 
improve decisions about the value of resource allocation remains little understood. 
Even the Dartmouth Atlas of Health Care (The Dartmouth Institute, 2012), the oldest 
Atlas of Variation published on a regular basis since 1995, has not been examined in 
terms of its impact on healthcare decision-making. Although data from the Atlas was 
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allegedly used to underpin political statements in recent healthcare reform  debates 
(White, 2011), the routes through which this information might influence decision-
making has received less attention. This lack of systematic impact analysis seems 
surprising given the importance afforded to information on variations. 
 
The findings of this study suggest some general lessons for using Atlases of Variation. 
Detailed recommendations for policy-makers, in terms of further development of the 
NHS Atlas, and for managers and users of the information (“5 questions to ask 
yourself when looking at the NHS Atlas“) are provided in Appendix 2-C and 2-D, 
respectively. These recommendations were developed by the PhD author on behalf of 
NHS Right Care. They were used to inform further production and dissemination of 
future Atlases (NHS Right Care, 2011). While some of these recommendations will be 
specific to the English NHS, most will have generic relevance also to other countries.  
2.4.2 Three lessons for using information on variations 
Below we emphasise three general lessons that have emerged from the findings of 
this study. First, publishing an Atlas of Variation may have great merit in stimulating 
the search for and understanding of variations, but it may not be sufficient for 
achieving an impact on decision-making about resource allocation. Generic hurdles to 
using research evidence – such as awareness, acceptance and perceived applicability 
of the data (Glasziou and Haynes, 2005, Nutley et al., 2007) – also appear to be 
relevant for geographic variations research. Once these barriers have been overcome, 
it appears that Atlases of Variation can serve as a “tin opener” (Carter, 1989) to 
inform strategic planning by healthcare payers. They may also help communicate 
strategic problems to clinicians.  
 
However, additional factors appear to be necessary for moving beyond an initial stage 
of gathering and communicating data towards subsequent stages of the decision-
making process where data are analysed and action is taken. On the one hand, 
decision-makers will have to achieve some clarity and consistency on the definition 
and operationalisation of the concept of unwarranted variation. The current paucity 
of corresponding scientific frameworks identified in a recent systematic review  
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(Mercuri and Gafni, 2011) argues this challenge. On the other hand, agreements on 
responsibilities for action and leadership also appear to influence the uptake of 
variations data. Although all 53 participants in this study emphasised addressing 
unwarranted practice variations as an opportunity to reduce inappropriate use of 
resources within increasingly tight economic constraints, only 18 of 28 PCTs who had 
reviewed the Atlas were also able to coordinate further analysis and action. This is a 
missed opportunity. 
 
Second, who should lead in identifying and acting on variations in medical practice, 
and how other stakeholders should be involved, is increasingly becoming an issue as 
the public availability of geographic variations data continues to grow. The NHS Atlas 
mainly addresses commissioners and clinicians. Given the regionalised planning and 
purchasing structure, this perspective seems relatively straightforward for England, 
as the level of analysis – the Primary Care Trust – is thus consistent with the locus of 
responsibility for action. In countries with competitive social health insurance 
systems, in contrast, a regional level of analysis tends to conflict with more dispersed 
responsibilities for action. In Germany, for instance, no institutionalised bodies exist 
to exercise cross-sectorial planning and purchasing for geographically defined 
populations (Ettelt et al., 2012). While the NHS Atlas is mainly targeted at health 
service professionals, a recently published German Atlas of Variation seeks to create 
pressure for change by targeting citizens and the wider public (Nolting et al., 2011). 
Further research might examine how a given health system context shapes the uses 
and users of data on variation in health service performance, and the respective 
interactions between stakeholder groups in identifying and addressing unexplained 
variations. 
 
Third, the findings also illustrate the difficult relationship between relative rates of 
service provision and treatment appropriateness. The purpose of an Atlas of 
Variation is to reveal variations, and among the respondents to this study, attention 
logically tended to focus on the top and bottom “outliers”. The downside of 
stimulating action based on outliers was some indication of false assurance derived 
from an average position. However, research does not suggest a systematic 
relationship between high, average and low rates of activity and rates of 
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inappropriate utilisation at a regional level (Leape et al., 1990, Chassin et al., 1987, 
Keyhani et al., 2012). Simulation studies also suggest that considerable variations at 
lower provider levels of analysis may in some cases be averaged out at a higher 
regional level of analysis (Diehr et al., 1990). While an outlier position can be a 
powerful trigger for further scrutiny, healthcare payers thus need to be wary of not 
conceiving the national average as an implicit reference point or even target; the 
danger is complacency. 
 
To prevent an overemphasis on individual outliers, future research may need to move 
from the measurement of single indicators towards a more systemic view of variation 
and its management. This may include not only the linkage of all three domains of 
quality of care – structure, process and health outcomes (e.g. Donabedian, 1978, 
1988) – but also a ”value for money” framework which relates the outcomes achieved 
to the resources deployed (National Audit Office, 2011). Possible starting points may 
be the modelling of patients’ pathways across all settings of care (Porter, 2010, Porter 
and Teisberg, 2006) and, at a population level, the modelling of  population health 
gain from implementing alternative interventions in relation to the required 
expenditure (Airoldi et al., 2014). Future research may need to focus more strongly 
on developing requisite models and designing them in such a way that they can easily 
be applied by health service professionals. 
2.4.3 Limitations 
This study was constrained by two main classes of limitations; those inherent to 
qualitative research, and those specific to this study. Interview-based research is 
well-suited to explore personal experiences and perceptions known only to the 
people involved (Patton, 1990). However, potential inaccuracies may arise due to 
poor recall and misrepresentation of facts, when respondents give answers they 
assume the interviewer wants to hear (Robson, 2002). Interviews with multiple 
respondents per PCT, if possible, and an emphasis on the open-ended, non-directive 
character of the interview questions were intended to address these challenges.  
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A study-specific challenge was the potential for selection bias. It remains unclear 
whether the non-respondents to this study lacked the capacity to participate in the 
research, in light of the large scale structural reorganisation of the NHS at the time of 
study, or whether they were not interested in the topic of variations in healthcare. 
Despite the wide spectrum of responses to the NHS Atlas illustrated in this study, the 
respondents may have been more motivated or even pioneers in engaging with 
geographic variations data compared to their peers. PCTs who reported using the 
NHS Atlas also tended to be of a larger size (responsible for median populations of 
about 378,907, compared with the national median size of 284,000 people; Office for 
National Statistics (2011)) or tended to be collaborating with a University. 
Presumably these PCTs thus had access to greater analytic capacity than the 
“average” PCT. This issue deserves greater attention in future research, considering 
that the new Clinical Commissioning Groups (CCGs) introduced by the Healthcare 
Reform Bill are will involve even smaller populations and thus possibly lead to even 
lower capacity for data analysis and strategic planning. 
 
Overall, the survey achieved geographic coverage across all regions in England. The 
underrepresentation of PCTs in London may, according to the survey respondents, be 
due in part to the additional pressure perceived by PCTs situated in the capital in the 
context of healthcare reform. In contrast, the overrepresentation of PCTs in Midlands 
and East is likely due to the fact that one PCT (Lincolnshire) appeared particularly 
motivated to use information from the NHS Atlas and disseminated positive 
experiences to neighbouring PCTs. This issue merits further research so as to 
understand the routes through which good practice might diffuse across geographic 
areas. 
 
 Conclusions 2.5
Based on a case study from England, we have explored key considerations and 
challenges along the process of moving from data on geographic variations in medical 
practice towards decisions to improve the value of resource allocation. Explicit 
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attention to these and other factors may help governments and payers understand 
the pathways through which this information might inform decision-making. Our 
findings illustrate that an Atlas of Variation can support healthcare payers in framing, 
communicating and prompting the search for strategic problems, but that its mere 
publication may not be sufficient to influence decision-making even in an ideal 
context where responsibilities for planning and purchasing health services across 
sectors are integrated in one regional organisation. The provision of appropriate 
tools to help planners understand what variation is unwarranted, and to prioritise 
remedial actions on the basis of their contribution to population health, should be a 
key focus for promulgators of variations data. 
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 Commentary in relation to the organising matrix of strategies 2.7
to address ambiguity about the standard for evaluation 
This Chapter has explored how policy-makers and managers might manage 
ambiguity about the standard for evaluation with a socio-political approach. The 
Chapter has provided a model to frame the process of moving from the measurement 
of variations in healthcare to their management. On this basis, the Chapter has 
investigated barriers along this process faced by healthcare payers in England and 
examines strategies to make sense of the information locally.  
 
The findings demonstrate that information on variations can serve as a “tin opener” 
(Carter, 1989) to motivate further analysis and inform strategic planning even in the 
absence of an a priori standard of “good” and “bad” performance. To achieve this, 
however, what is additionally required is leadership on variations and the provision 
of appropriate tools to understand which variations are unwarranted. 
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 Appendix 2.8
2.8.1 Appendix 2-A. Survey questions: LSE/ Right Care study on the NHS 
Atlas of Variation in Healthcare 
Dear Chief Executive 
 
As you are aware there is an increasing focus on dealing with variation in the NHS 
and in particular eliminating unwarranted variations.  
 
The first step to this is the understanding of variation as an issue for patients, 
clinicians and managers all coming at it a different way. The NHS Atlas of Variation 
has been successful in highlighting variation.  
 
The Right Care workstream has commissioned LSE to examine how local 
commissioners use the NHS Atlas. The aim is to understand how the NHS Atlas might 
be applied, as a tool for change, within a local health economy, for example in terms of 
stimulating discussion with clinicians, promoting further analysis and action. These 
experiences will be published by the Right Care team to support local health 
organizations in identifying and addressing unwarranted variation in healthcare. 
 
We would be delighted if your PCT Cluster and forming CCGs participated in this 
project. This will be an opportunity for sharing ways that your organisation uses the 
NHS Atlas as a tool in its decision making process relative to its peers. An output of 
your participation could include us doing a presentation to staff or board and/ or 
provide a written report for internal use.  
 
We would be grateful if you could take the time to answer the following 
questions or if you could ask relevant colleagues to answer them: 
 
1. Are you aware of the NHS Atlas of Variation in Health Care published in November 
2010 as part of the QIPP Right Care Programme? 
 
2. Has your Board considered the findings of the NHS Atlas of Variation?  
 
3. Have you or your colleagues used the information provided by the NHS Atlas in 
some form?  
 
4. If nobody in your organisation has used the Atlas, could you describe why not? 
 
5. Do you use the NHS Atlas? If so, could you briefly state how you use it?  
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6. Could you briefly state in what form the publication of the NHS Atlas has stimulated 
new action, and/or supports existing work? For instance, does the NHS Atlas support 
your work related to  
• Strategic planning and evaluation 
• Contracting of providers 
• Engagement of clinicians, patients or the wider public? 
 
7. How do you think could the NHS Atlas be developed to be more useful for your 
organisation? How could the NHS Atlas be improved? 
 
8. Would you be willing to be interviewed to share your experiences about barriers 
and enablers of using the NHS Atlas of Variation? If yes, please could you provide 
your name and email address or telephone number? 
 
Individual interviewees could of course remain anonymous if they wish.  Your 
participation is valued and we would highly appreciate to hear from you as soon as 
possible.  
 
Please contact Laura Schang under L.K.Schang@lse.ac.uk or 07586250538. We would 
also be very grateful if you could notify colleagues or indicate potential interview 
partners for us to contact.  
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2.8.2 Appendix 2-B. Interview guide  
 
Your experiences in using the NHS Atlas of Variation are invaluable in enabling 
learning across Primary Care Trust Clusters and forming Clinical Commissioning 
Groups. Our aims are to use your experiences to improve outcomes for patients and 
to help develop future versions of the NHS Atlas. 
 
The Right Care work stream has commissioned LSE to develop case studies of how 
different stakeholders use the NHS Atlas. The aim is to understand how the NHS Atlas 
might be applied, as a tool for change, within a local health economy, for example in 
terms of stimulating discussion with clinicians, promoting further analysis and action.  
These case studies will be published by the Right Care team to support local health 
organizations in identifying and addressing unwarranted variation in healthcare. 
 
We would like to discuss with you 
 
 Looking backward –The situation or problem:  
o What issues did you encounter in 2011 and in previous years which 
made it important or helpful to use the NHS Atlas of Variation and other 
comparative information? 
o Were these special concerns and/or linked to a particular stage in the 
commissioning cycle? 
 
 What action was taken:  
o How did you go about identifying what variation ‘matters’ in your 
region? 
o What tools and processes you use to explain medical practice variation, 
and  
o How did you define whether these causes were ‘warranted’ or 
‘unwarranted’? 
o What did you do about unwarranted variation? 
 
 Stakeholders: How were/ are different stakeholders involved in the process 
of identifying and acting on (unwarranted) practice variations? Such as 
o Public health professionals? 
o Clinical Commissioning Group/ commissioning leaders? 
o GP? 
o Hospital clinical and managerial teams? 
o Other stakeholders? 
 
 What happened as a result:  
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o what expected and unexpected changes the NHS Atlas (and other 
sources of evidence) triggered or supported in terms of  
 awareness of and attitudes towards unwarranted variation 
among clinicians/ providers,  
 changes in commissioning and/or public health policies, service 
design and clinical practice  
 quantifiable results (e.g. service volume, referral patterns, 
patient outcomes, savings) 
 
 Enablers and barriers:  
o What levers enabled you in using information on variations effectively? 
o What facilitating factors you experience(d) in identifying and acting on 
(unwarranted) practice variation and how you attempted to overcome 
them? 
 
 Looking forward: How do you intend to use the NHS Atlas 2.0 and other 
information on variations in 2012 in the future?  
o For example, in what stage(s) of the commissioning cycle?  
o Might there be a review of the Atlas requested by the Board, etc?  
o How do you decide on the variations (e.g. disease areas, primary or 
secondary care) to be addressed first, and why?  
o Will there be a review/ policy for the entire PCT Cluster, and/or will 
you look at lower levels and how? 
 
 Might you be able to share graphs/ diagrams, such as charts used for 
planning and commissioning and in working with clinicians, to illustrate your 
work on unwarranted variations? 
 
Contact: To facilitate learning between PCT Clusters we would also like you to 
consider us sharing the name of your PCT Cluster and a contact if possible. 
 
Additional interviews: Can you suggest additional people at different levels whom 
we might approach for sharing their experiences, such as the  
1. Director of Public Health,  
2. Director of Commissioning,  
3. Medical Director,  
4. Public Health Analysts,  
5. GPs/ clinical commissioning group leaders 
 
 
Thank you so much for your time! 
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2.8.3 Appendix 2-C. Recommendations for policy-makers: Development of 
the NHS Atlas 
 
1. Include several units of analysis: The provision of data at a regional (PCT) 
level only will be too coarse for local decision-making and service planning. 
Future versions of the NHS Atlas should therefore enable the disaggregation of 
data from PCTs to Clinical Commissioning Groups, individual practices and 
hospitals,  
(i) to enable comparison e.g. of admission rates at different levels of 
analysis; and  
(ii) to inform the identification of PCT-wide and of provider-specific 
priorities. 
 
2. Revisit the choice and organisation of indicators: The core purpose of the 
NHS Atlas should be clarified. This core purpose should then ideally inform the 
selection of indicators. While different purposes may not necessarily be 
mutually exclusive, depending on the core purpose, the criteria for selecting 
indicators may differ:  
(iii) The NHS Atlas as a system performance tool: Indicators should 
ideally be chosen in relation to the commissioning envelope of 
PCTs/CCGs. They could be organised according to high-level 
programme budget categories, and key sub-indicators underneath. 
Wider coverage of areas and indicators would be important to enable a 
more comprehensive view of performance. 
(iv) The NHS Atlas as a tool to identify and realise opportunities for 
cost savings: Indicator selection could thus focus on resource-intensive 
procedures as well as on procedures of high-variation across the 
country. 
(v) The NHS Atlas as a tool to track patient pathways: This would 
include grouping indicators in a meaningful way, e.g. in terms of patient 
pathways for long-term conditions would improve the relevance of the 
data to local decision-making. 
(vi) The NHS Atlas as a tool to stimulate curiosity: Indicator selection 
could thus focus new indicators each year to maintain salience. 
 
3. Ensure a transparent and robust methodology: This includes giving renewed 
consideration to the following areas:  
a. More detailed meta-data: Specify the individual disease codes 
allocated to programme budget categories to facilitate analysis of 
apparent outliers.  
b. Access to data tables: Provide the underlying data as public use files 
such that possible users can check the data. 
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c. Disease-specific weighting: The standardised rates draw on overall 
age, sex and need weighted populations. However, as the patterns of 
need, age and sex vary across diseases and different areas of 
healthcare, a disease-specific weighting may be more appropriate (e.g. 
per 1,000 people with a cancer diagnosis). For musculo-skeletal 
conditions, the apparently higher levels of spending in PCTs with older 
age profiles might be explained by the much stronger correlation of 
musculo-skeletal conditions with age than this was the case with other 
programme budget categories. 
 
4. Provide analytic tools: Being an outlier in terms of a given utilisation rate can 
affect very few cases in total with therefore little practical significance. Where 
rates are based on low prevalence this should be demonstrated. Furthermore, 
the following aspects could be strengthened: 
a. Relative scale of benefits: Demonstrate the scale of cost savings and 
improved health outcomes that could be achieved by reaching the top-
quintile in empirical terms (compared to the ‘best’ PCTs) or in 
theoretical-normative terms (compared to what could be achieved). 
b. Correlations: Enable further analysis of relationships between 
different indicators e.g. drug spend versus hospital spend versus 
community spend. 
c. Expanded overviews over possible reasons for variation should be 
provided. 
d. Trends: A means of tracking change will be important to identify trends 
over time.  
e. Profiles: Enable pulling a single file showing the overall position for a 
PCT (SHA, CCG) in the interactive version, complementing the separate 
thematic overviews. A download option for charts and improved 
resolution for screen capture should be provided. 
 
5. Facilitate dissemination, learning and action: The publication of the NHS 
Atlas should be linked to the planning cycles of PCTs to enable incorporation 
into next year’s commissioning and provision strategies. In addition, the 
following aspects should be addressed: 
a. Wide and ongoing dissemination: Conduct follow-up meetings and 
events to disseminate the NHS Atlas more widely and remind of its 
availability. 
b. Standard means of posting enquiries into the data could help to 
identify whether PCTs had already looked into their apparent high or 
outlier position, to demonstrate the reasons identified for this position.  
c. Case studies of how other organisations have made use of the NHS 
Atlas information could inform local learning and should be 
disseminated at a national scale. 
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2.8.4 Appendix 2-D. Recommendations for managers: “5 questions to ask 
yourself when looking at the NHS Atlas“ 
 
Understanding variations in healthcare can be time-consuming and complex. This 
complexity should not impede PCT boards to tackle unwarranted variation. Doing 
nothing is not an option at a time when the NHS has to make unprecedented savings 
while enhancing value from the budget allocated to healthcare. 
 
PCT boards might ask themselves 5 questions when looking at the NHS Atlas (see 
list). This might provide a structure to guide commissioners to take action. It might be 
a starting point to break down the question: what does this indicator mean for what 
my organisation should do, tomorrow?   
 
A word of caution is required for high and low (“outlier“) values in the NHS Atlas. 
Outlier values may indicate areas where PCTs are falling behind, compared to peer 
organisations. At the same time, even the good end of the empirical spectrum might 
offer large scope for improvement. Commissioners should be mindful of not making 
average values a priority, as the national average is not necessarily the optimal rate of 
expenditure or activity. Despite this risk the NHS Atlas might help commissioners to 
ask whether high rates of a particular intervention are beneficial for patients. The 
resources invested in activity that exceeds the national average might yield larger 
health gains if they were allocated to better-value care, for example to meet unmet 
needs in this or in another group of patients. 
 
 
1. What sort of indicator is this? 
(a) High-level aggregate indicator e.g. mental health or cancer programme 
budget spending 
(b) Rate of activity e.g. hip replacements per 1000 people 
(c) Compliance with effective care standard e.g. proportion of eligible patients 
treated in stroke units 
(d) Health outcome e.g. coronary heart disease mortality (negative), cancer 
survival rate (positive) 
 
2. Where does my health economy sit on this indicator compared to peers? 
(a) For high-level aggregate indicators, if ranking is high or low, then break 
down the indicator into activity included in this indicator (e.g. procedures, 
prescribing) 
(b) For rates of activity, if ranking is high or low, then investigate where in your 
health economy this outlier activity occurs 
70 
 
(c) For indicators which measure compliance with effective care standards, 
if ranking is low, then investigate where in your health economy this outlier 
activity occurs 
(d) For negative (positive) health outcome indicators, if ranking is high (low), 
then investigate where in your health economy this outlier activity occurs 
(e) Otherwise, comparative analysis does not suggest that this indicator should 
give cause for concern 
 
3. Where in my health economy does this outlier expenditure, activity or 
outcome (not) occur? 
(a) For expenditure and activity data, drill down to provider level (GP practice, 
hospital, community provider) using e.g. NHS Comparators, Quality 
Observatory data 
(b) For outcome data, look at patient sub-groups e.g. by geographic area, socio-
economic status (e.g. income, education, occupation) or age group 
 
4. What might explain the variation? 
(a) Demand factors e.g. patient decisions, GP decisions, illness, commissioning 
priorities 
(b) Supply factors e.g. service design, clinical decisions, government policy, 
resource availability, payment structures 
(c) Determinants beyond the health system 
(d) Data inaccuracy 
 
5. How might we move towards the right treatment rate if the variation is 
unwarranted? 
(a) Use a systematic appraisal approach such as Program Budgeting & Marginal 
Analysis or Decision Conferencing 
(http://www.health.org.uk/publications/commissioning-with-the-
community/) to prioritise investment   
(b) Review and implement regional and national guidelines (e.g. NICE, Royal 
Colleges) 
(c) Inform and engage providers through discussions, physicians profiling, peer 
education, clinical practice guidelines, financial incentives  
(d) Inform and engage patients through decision aids and shared decision-
making  
for treatments with large trade-offs for patient quality of life or life expectancy 
(e) Network with other commissioners to exchange best practices e.g. via the 
Health Investment Network and review policies for commissioning and 
provision 
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Abstract 
 
Composite indicators of healthcare quality typically embed contentious assumptions. 
This includes, in particular, the choice of weights of constituent indicators to obtain a 
single number. Moreover, although many comparative measures are constructed as 
ratios, the choice of denominator is often ambiguous. The conventional approach is to 
determine a single set of weights and to choose a single denominator, although this 
involves considerable methodological challenges. This study examines an alternative 
approach to handle ambiguity about weights and choices of denominator in 
composite indicators which considers all feasible weights and can incorporate 
multiple denominators. We illustrate this approach with an application to 
comparative quality assessments of Scottish Health Boards. The results (displayed as 
ranking intervals and dominance relations) allow one to identify Boards which 
cannot be ranked, say, worse than 4th or better than 7th.  Such rankings give policy-
makers a sense of the uncertainty around ranks, and the extent to which action is 
warranted. 
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 Introduction  3.1
The increasing complexity of health systems and the multidimensionality of health 
system performance have reinforced calls for the production of composite measures 
of performance (WHO, 2000, Healthcare Commission, 2005, CMS, 2009, Carinci et al., 
2015). Summarizing the information contained in diverse indicators in a single index 
and ranking organisations or countries on that basis has the potential to present the 
“big picture“, by highlighting in a unified way to what extent the objectives of health 
systems related to health outcomes, treatment appropriateness, access and other 
dimensions have been met (WHO, 2000, Smith, 2005). Rather than having to identify 
a trend across a range of separate indicators, a single number may be easier to 
interpret and thus offer a rounded evaluation of performance. As such, summary 
measures may seem an attractive approach to strengthen accountability, facilitate 
communication with the public and focus improvement efforts on poorly performing 
organisations (Goddard and Jacobs, 2009, Smith, 2002). 
 
However, there are several arguments against the use of composite indicators. 
Fundamentally, aggregate measures may disguise the sources of poor performance 
and thus obscure the best focus for remedial action (Smith, 2002). Rankings based on 
composite measures are typically also highly sensitive to methodological choices, in 
particular to the choice of weights attached to constituent indicators (see e.g. Jacobs 
et al., 2005, Reeves et al., 2007, Gravelle et al., 2003, OECD, 2008). In their analysis of 
hospital performance based on star ratings in the English NHS, Jacobs et al. (2005) 
show, for instance, how subtle changes in the weighting system lead some hospitals 
to jump almost half of the league table. However, the techniques by which weights are 
determined are unlikely to be straightforward. In addition, although many 
comparative quality measures are constructed as ratios, it is not necessarily obvious 
which indicators should be employed as denominators (Schlaud et al., 1998). In the 
context of low-birthweight survival rates, Guillen et al. (2011) illustrate how the 
choice of population denominator results in considerable variation depending on 
whether survival is reported relative to all births; live births; or neonatal intensive 
care unit admissions. 
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These concerns are critical especially when rankings have serious consequences for 
the rankees. For example, six of the Chief Executives of the twelve lowest ranked 
hospitals in England’s star rating system (the so-called “dirty dozen“) lost their jobs 
as a result (Bevan and Hamblin, 2009). It has been argued that France and Spain’s 
apparently high ranking in the WHO’s 2000 assessment of health systems 
substantially diminished pressure for reform in these countries (Navarro, 2000). In 
Medicare’s Premier Hospital Quality Incentive Demonstration, a pay-for-performance 
scheme based on a composite quality score, hospitals below the ninth decile faced a 
2% deduction in their Medicare payment (CMS, 2009). With such high stakes, 
understanding whether ranks are robust to alternative assumptions seems critical.   
 
We here examine a methodological strategy to handle ambiguity about weights and 
choices of denominator in composite indicators of performance. We make two main 
contributions. First, we demonstrate the use of an approach to ranking organisations 
based on ranking intervals and dominance relations which accounts for the full set of 
feasible weights. This avoids the need to settle on a single, potentially controversial 
set of weights as it is required for instance in data envelopment analysis (DEA), in 
which weights are chosen such that each organisation appears in its best possible 
light (Cherchye et al., 2007). Feasible weights are less restrictive and thus potentially 
better able to increase transparency and to acknowledge lack of information about 
the “correct” set of weights. The ranking intervals obtained with this approach can be 
said to be robust in the sense that they reflect the full range of rankings that the 
entities under comparison may attain when weights are selected from their 
respective feasible weight sets. Second, we highlight the problem of choice of 
denominator in ratio-based measures of performance and how it might be tackled 
through the use of ranking intervals. We provide an empirical application to 
healthcare quality comparisons of Scottish Health Boards. 
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 Challenges in developing composite indicators of healthcare 3.2
quality  
A composite indicator is commonly expressed as an additive model based on a 
weighted sum of a set of performance indicators: 
                                                                      𝐶𝑘 =  ∑ 𝑤𝑗  𝑥𝑗𝑘
𝐽
𝑗=1           (1) 
where J is the number of indicators, wi is the weight attached to indicator j, and xi  the 
score on indicator j  for organisation k. Composite measures of this form require 
choices about (i) the set of indicators included; (ii) the methods used to transform the 
constituent indicators (in order to achieve a common unit of measurement); (iii) the 
weights applied; (iv) any specific aggregation rules used; and (v) potential 
adjustments for environmental or other uncontrollable influences on performance. In 
addition (vi), although many healthcare quality indicators that are used to construct a 
composite indicator are reported as ratios, the choice of denominator is not always 
straightforward. 
The focus of this study is on problems (iii) and (vi), how to handle ambiguity about 
the choice of weights and the choice of denominator. Below we set out the conceptual 
background and problems with conventional strategies to handle these problems. In 
the empirical application, we explain and justify the approaches taken to problems 
(i), (ii), (iv) and (v).  
 
3.2.1 Valuation of multiple healthcare quality measures  
Healthcare performance measures are heterogeneous and multidimensional. 
However, without a functioning market, there is no price mechanism for comparison. 
To aggregate different indicators into a summary measure of performance, weights 
are required which – analogous to prices – should represent the opportunity cost of 
achieving improvements on each individual measure by capturing the relative value 
attached to an extra unit of it (Smith, 2002). 
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In practice, arriving at explicit trade-offs between different healthcare quality 
measures – and thus exact specifications of weights – is highly contentious. First, it is 
often unclear whose preferences should be elicited. Weights used often reflect a single 
set of preferences, although the evidence suggests substantial heterogeneity in 
preferences between and within groups of policy-makers, patients and the public 
(Smith, 2002, Decancq and Lugo, 2012). Making precise judgments about the relative 
value of sub-indicators to the composite is typically both politically controversial and 
cognitively demanding, thus triggering reluctance among respondents to agree on a 
set of weights.  
 
Second, there is no consensus on a single best method how to elicit weights. Different 
techniques for valuing health(care) outcomes – from simpler trade-off methods 
including ranking from most to least desired indicator and voting techniques to more 
elaborate multi-attribute approaches such as conjoint analysis and the analytic 
hierarchy process – tend to produce different results and each method has distinct 
advantages and disadvantages in terms of feasibility, consistency and validity (Dolan, 
1997, OECD, 2008, Appleby and Mulligan, 2000). 
 
To circumvent perceived difficulties with normative approaches to set weights, data-
driven weighting systems are frequently used. For example, data envelopment 
analysis (DEA) – one of the most widespread methods to compare organisations with 
multiple outputs and inputs (Hollingsworth and Street, 2006) – uses empirically 
derived, flexible weights, following a “benefit of the doubt“ approach. It is however 
questionable whether data-driven weights reflect meaningful trade-offs between 
performance domains (Decancq and Lugo, 2012). There is no logical reason why an 
organisation necessarily values most some performance domain because it performs 
relatively well on it: data-driven approaches thus are confronted with the 
impossibility to derive values from facts (Popper, 1948). 
 
The conventional recommendation to address ambiguity about weights, and the best 
method to elicit weights, is to conduct extensive sensitivity analysis on the chosen 
weights (Jacobs et al., 2005). However, traditional sensitivity analysis is problematic 
insofar as the choice of ranges of weights typically depends on the analyst. This form 
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of sensitivity analysis thus corresponds to a “blind search” which is not explicitly 
oriented towards changes in ranks and the maximum and minimum plausible ranks 
an organisation can attain. 
3.2.2 Choice of denominators  
Healthcare quality measures are often reported as ratio measures where a specific 
quality measure is divided by some measure of population. Not all comparative 
assessments of healthcare quality require necessarily a denominator. So-called 
“never events”, events which are deemed to be entirely preventable, are reported as 
absolute numbers without reference to a denominator (NHS England, 2015). 
However, typically a ratio-based measure is used in order to make entities of 
different sizes comparable and to establish a common currency unit in which 
performance is assessed as “good” or “poor” relative to other organisations. 
 
To construct ratio-based quality measures, the denominator should represent the 
best available proxy for the population at risk (Romano et al., 2010, Schlaud et al., 
1998). However, the population at risk of experiencing a specific event is not always 
obvious. Consider two health authorities A and B with the same number of healthcare 
associated infections (HAIs) but a lower number of bed days in authority A. On a 
simple ratio measure of HAIs/ 1,000 bed days, authority B would seem to score 
better, but this conclusion would be warranted only if there were no groups at risk of 
HAIs other than hospitalised populations. However, if the numerator also included 
community-acquired infections, then a narrowly defined denominator such as 
hospital bed days would underestimate the actual number of exposed individuals (in 
particular, it ignores populations in non-acute hospital settings exposed to HAI e.g. in 
geriatric wards, nursing homes). A comprehensive denominator, such as total 
population, in contrast, would overestimate the population at risk by including 
individuals facing no or a negligible risk of experiencing the event (Marlow, 1995).   
 
In addition, the use of bed days as the denominator may be problematic insofar as it 
might penalize Boards which succeed in reducing length of stay (another frequent 
health policy objective). Such Boards would then appear to have poorer performance 
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on HAIs. Yet, the use of total population as the denominator does not account for 
Boards with a high number of hospitalised populations. These populations may 
plausibly have a higher risk of acquiring an HAI than general populations, since they 
are typically sicker and thus more susceptible to infection. 
 
To address ambiguity about the choice of denominator, it is clearly essential to define 
the unit of analysis and, on this basis, the correct denominator. For system-level 
comparisons, population might be appropriate; for hospital comparisons, total 
admissions or bed days. Ideally, one would therefore specify a numerator that is 
unambiguously linked to one single denominator (McKibben et al., 2005); for 
example, by excluding community-acquired infections that are present on admission 
to hospital from the numerator. In practice, it is however often difficult to distinguish 
between HAIs that were present on admission and those acquired during a hospital 
stay (Naessens and Huschka, 2004, Zhan et al., 2007).  
 
Since there will always be some uncertainty about the correct population at risk, it 
makes sense to consider different denominators since that enables a more complete 
perspective on the outcome of interest (Guillen et al., 2011). To do this, one could 
produce multiple ratios between all reasonable numerator and denominator 
combinations. However, the manual comparison of multiple performance ratios 
quickly becomes unwieldy. In a situation with, say, four numerators and three 
denominators, one would obtain 12 performance ratios for each entity under 
scrutiny.  
 Methods  3.3
3.3.1 Ranking intervals and dominance relations for all feasible weights 
We here examine the use of an alternative approach to handle ambiguity about 
choices of weights and choices of denominator. Rather than specifying explicit 
weights (that are subsequently subjected to sensitivity analysis), this approach 
consists in developing ranking intervals and dominance relations which consider the 
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full set of feasible weights. The approach is also able to handle different choices of 
denominator variables.   
 
We adopt a ratio-based efficiency analysis (REA) technique (Salo and Punkka, 2011). 
Suppose there are K Decision-Making Units (DMUs – the entities to be evaluated) that 
have N different measures for the numerator of a ratio and M measures for the 
denominator of a ratio. The values of the nth numerator and the mth denominator of 
the kth DMU are 𝑦𝑛𝑘  ≥ 0 and 𝑥𝑚𝑘 ≥  0, respectively. Thus, the possible performance 
ratios of the DMU k are 𝑦𝑛𝑘/𝑥𝑚𝑘 , where 𝑛 = 1, … , 𝑁 and 𝑚 = 1, … , 𝑀. 
 
REA enables the aggregation of different numerators and denominators in a summary 
measure of performance. The relative importance of the nth numerator and the mth 
denominator is captured by nonnegative weights 𝑢𝑛 and 𝑣𝑚, respectively. The 
aggregated performance ratio of DMU k is defined as 
𝐸𝑘(𝑢, 𝑣) =
∑ 𝑢𝑛𝑦𝑛𝑘𝑛
∑ 𝑣𝑚𝑥𝑚𝑘𝑚
 .     (2) 
 
To examine the pairwise relations between DMUs, REA uses the concept of 
dominance: DMU 𝑘 dominates DMU 𝑙 if the performance ratio of DMU 𝑘 is at least as 
high as that of DMU 𝑙 for all feasible weights and there exist some weights for which 
its performance ratio is strictly higher. If a dominance relation exists between two 
DMUs, one can be confident that for any set of assumption, one DMU outperforms the 
other. The dominance relation between DMUs 𝑘 and 𝑙 is determined by the pairwise 
performance ratio 
𝐷𝑘,𝑙(𝑢, 𝑣) =
𝐸𝑘(𝑢,𝑣)
𝐸𝑙(𝑢,𝑣)
 .     (3) 
 
The maximum and the minimum of 𝐷𝑘,𝑙(𝑢, 𝑣) over all feasible weights provide upper 
and lower interval bounds on how well DMU 𝑘 performs relative to DMU 𝑙. Thus, if 
the minimum of 𝐷𝑘,𝑙 is greater than one, DMU 𝑘 dominates DMU 𝑙. The dominance 
structure is computed with linear programming. 
 
The ranking interval indicates the best and worst performance rankings a DMU k can 
attain relative to other DMUs over all feasible weights. The best ranking  is 
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determined by the minimum number of other DMUs with a strictly higher 
performance ratio. For instance, the best ranking as third for a given DMU means that, 
no matter how the weights are selected, there are at least  two other DMUs with a 
strictly higher performance ratio. If for some feasible weights the performance ratio 
of a DMU is higher than or equal to the ratio of any other DMU, then its best ranking 
will be one. The worst ranking is computed similarly. 
3.3.1 Method strengths and limitations 
There are several innovative characteristics, and distinct advantages, to this 
approach. First, the aggregation of numerators and the denominators is achieved 
without fixing the weights of constituent indicators. By comparing the relative 
magnitude of the performance ratios between DMUs with all feasible weights, one can 
produce robust information about the performance of DMUs in the sense that the 
resulting intervals reflect the full range of rankings that DMUs may attain for feasible 
weight sets. 
 
Second, REA calculates pairwise comparisons between DMUs rather than comparing 
each DMU to an efficient frontier as in DEA or stochastic frontier analysis. This makes 
REA results more robust than frontier-based results, since the introduction or 
removal of an outlier DMU can substantially change the location of the efficiency 
frontier (Banker et al., 1986). Pairwise dominance relations obtained from REA, in 
contrast, cannot change if a new DMU is added and the ranking intervals can shift by 
no more than one ranking at the end points. 
 
Third, because the REA uses no efficient frontier, there is no minimum number of 
DMUs needed to conduct performance comparisons. For DEA, Banker et al. (1986) 
have proposed the simple rule of thumb that the number of DMUs should be at least 
three times the number of variables. This is problematic since the number of 
indicators typically far outstrips the number of organisations. REA, in contrast, is 
based on pairwise comparisons only. It thus requires a minimum of only two DMUs 
and there is no upper limit to the number of indicators. 
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It is important to point out that, where the choice of denominator is relatively 
unambiguous, ratio-based analysis is not necessary. One can calculate individual 
performance rates for the respective indicators and aggregate them as a weighted 
sum as in equation (1). This is akin to evaluating the numerator of the performance 
ratio (2).  
 
In this study, we use a ratio-based analysis in order to illustrate robustness to 
different choices of denominator. However, it is important to recall that ratio-based 
measures have possible limitations. In particular, the use of a ratio function assumes 
constant returns to scale in the sense that it does not account for structural 
differences (such as a higher share of fixed costs) between organisations. This 
assumption implies that, in evaluating organisational performance, one does for 
instance not allow an organisation a comparatively higher number of healthcare-
associated infections (in terms of the performance ratio, e.g. per 100,000 population) 
only because it relatively small in size. However, in the context we examine here – 
Scottish Health Boards, as outlined below – this assumption seems justified since 
these Boards are allocated resources in line with a formula which seeks to 
compensate for structural differences so as to ensure a level playing field across 
organisations. 
 
Ratio measures may be preferred when there is primarily a concern with evaluation  
(examining which organisations obtain higher or lower performance ratios) rather 
than explanation (examining why organisations achieve particular performance 
outcomes, as in regression analysis). Alternatively, one could identify empirically the 
population at risk by means of a regression model akin to a production function, 
where a specific quality measure is analysed as a function of different possible 
populations at risk. Variables with positive coefficients have an influence on the 
quality measure in question and could thus be interpreted as populations at risk. The  
scope of this paper, however, is limited to highlighting the problem of choice of 
denominator and to examining the implications for comparative evaluations and 
organizational rankings. 
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3.3.2 System context and data  
Selection of indicators.  We here illustrate the robust ranking interval approach 
with an application to the comparative quality of Scottish Health Boards. In Scotland, 
responsibility for the allocation of resources is decentralized to 14 territorial Boards. 
The ultimate objectives of these Boards are to protect and improve the health of their 
populations through planning for and delivering health services (Scottish 
Government, 2014). To construct a composite indicator of the quality of care 
provided by Scottish Health Boards, we confined ourselves to indicators used in the 
HEAT target system. This existing performance management system is used by the 
Scottish Government to assess the performance of Health Boards.  All indicators used 
here (Table 3-1) come from the official performance measurement system, but are 
not meant to represent an exhaustive set of health system objectives. To address the 
two problems examined in this study, we use two data sets: 
 
 Data for part I: To examine robustness to choices of weights and dominance 
relations, we analyse six indicators from the HEAT target system which are 
intended to measure Health Boards’ relative degree of achievement in 
ensuring appropriate and accessible treatment. This analysis is based on an 
additive model which is akin to analyzing the numerator of the performance 
ratio in equation (2). 
 
 Data for part II: For most of the six quality indicators, the correct 
denominator variable is quite straightforward. However, as discussed in 
section 3.2.2, for healthcare-associated infections, the choice of denominator 
may be ambiguous. To examine robustness to alternative choices of 
denominator (here, the population at risk of experiencing an infection), we 
relate the number of healthcare-associated infections to hospitalised and 
general populations. This analysis relies on the more complex ratio-based 
model in equation (2). 
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Data transformation. To avoid mixing different units of measurement and to achieve 
scale invariance, data were normalized to the [0;1] range by dividing each value by 
the maximum value for a given indicator.  
 
Environmental adjustment. The 14 Health Boards differ in terms of various 
environmental factors that are beyond the control of Boards but that might influence 
observed performance on the chosen indicators. Such factors include, in particular, 
demographic, epidemiological and regional structures. However, in Scotland, such 
factors should be fully compensated for within the funding mechanism. Health Boards 
are allocated resources based on a formula that explicitly takes account of variations 
in healthcare needs that arise as a result of age and sex composition, morbidity, life 
circumstances and other factors; and excess costs of delivering services in some 
(especially rural) regions that are deemed unavoidable (ISD Scotland, 2010b). Thus, 
Boards with older and sicker populations have already been compensated to take 
account of the greater healthcare needs of their populations so that they can ensure 
the same level of quality.  We acknowledge that the risk adjustment provided by this 
formula is not perfect. However, following this line of argument, it is not 
unreasonable to assume that Boards are comparable with respect to the performance 
indicators analysed here. 
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Table 3-1 Variables and descriptive statistics 
 Definition Mean SD Min Max 
 
Data for part I: robustness to choices of weights and dominance relations 
18WRTTa Number of patient 
journeys from referral to 
treatment over 18 
weeks (among patients 
seen) per 100,000 RTT 
patient journeys from 
referral to treatment 
(among patients seen) 
9,858 8,791 1,851 30,603 
4-hour A&E 
waitinga 
Number of recorded 
A&E waits lasting over 4 
hours per 100,000 A&E 
attendances 
9,412 10,096 859 31,731 
Emergency 
admissionsa 
Number of emergency 
admissions among +75 
years per 100,000 
population 
13,419 9,274 4,107 37,256 
MRSA/MSSAa Number of MRSA/MSSA 
infections per 100,000 
population 
137 107 24 413 
C.difficilea Number of Clostridium 
difficile infections per 
100,000 population 
164 116 42 399 
Delayed 
dischargesa 
Number of bed days lost 
due to delayed 
discharges  per 100,000 
occupied bed days 
131 99 13 373 
 
Data for part II: robustness to choices of denominator 
 
Quality indicator (numerator variable) 
      
C.difficilea Number of Clostridium 
difficile infections 
164 116 8 399 
 
Population indicators (denominator variables) 
Total 
populationb 
Resident population 
(mid-year estimates) 
475,232 318,214 113,880 1,214,587 
AOBDa Number of acute 
occupied bed days 
113,244 98,182 20,723 365,951 
      
Sources: aHEAT target system; bNational Records of Scotland. All data are for 2012/13. 
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Table 3-2 Comparative performance of Boards on the constituent six quality 
indicators, based on rates per 100,000 shown in Table 3-1 
  
18WRTT 
4-hour 
A&E 
waiting 
Emergency 
admissions 
MRSA/MSSA C.difficile 
Delayed 
discharges 
A Ayrshire & 
Arran 
 8,691   8,312   3,646   23   49   3  
B Borders  6,204   3,267   3,612   21   44   2  
C Dumfries & 
Galloway 
 6,170   5,987   3,130   27   36   7  
D Fife  6,899   4,559   2,725   35   26   11  
E Forth Valley  15,123   8,238   2,513   26   14   9  
F Grampian  9,343   3,812   2,239   25   24   10  
G  Greater 
Glasgow & 
Clyde 
 8,523   6,956   3,061   34   33   5  
H Highland  5,817   2,199   2,825   17   24   9  
I Lanarkshire  5,551   8,667   2,671   24   35   5  
J Lothian  12,293   9,172   2,495   30   42   10  
K Orkney  2,649   1,663   2,661   9   84   5  
L Shetland  2,209   730   2,555   13   34   9  
M Tayside  8,701   1,119   2,964   36   50   5  
N Western 
Isles 
 4,876   1,666   3,320   4   123   18  
 Max  15,123   9,172   3,646   36   123   18  
 Min  2,209   730   2,239   4   14   2  
 SD  3,475   3,090   424   10   28   4  
 Mean  7,361   4,739   2,887   23   44   8  
 
 
3.3.3 Weight restrictions on quality measures 
An advantage of REA is its ability to address incomplete information about weight 
specifications by using the full set of feasible weights. This can be an attractive option 
when one assumes complete ignorance about the relative value of averting particular 
events. However, while an elicitation of cardinal preferences over “how much” worse 
a, say, MRSA infection is compared to, say, an emergency admission may not feasible 
(e.g. due to high cognitive demands) or desirable (e.g. due to biases introduced by 
specific elicitation methods), it may be possible to obtain statements about which 
events are worse than others. Introducing plausible weight restrictions based on 
ordinal preferences can be useful because this recognises people’s ability to provide 
limited preference information about the relative badness of particular events 
without imposing implausibly exact weights. Restrictions on weights can reasonably 
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be used to prevent inconsistencies with accepted views on the relative importance of 
measures analysed (Allen et al., 1997, Pedraja-Chaparro et al., 1997).  
 
For illustrative purposes, the research team arrived at a set of ordinal weights 
through pairwise comparisons of any two quality measures, along the lines “If you 
could avoid either an emergency admission to hospital or an MRSA infection, which 
event would you rather avoid”. Corresponding to their relative badness, events were 
ranked as follows (from worst=1 to least bad=6):  
1. an MRSA/MSSA infection;  
2. an emergency admission3;  
3. a clostridium difficile infection;  
4. having to wait longer than 18 weeks from referral to treatment;  
5. having to wait more than 4 hours in A&E4;  
6. a delayed discharge. 
 
Another challenge in flexible weighting systems is that the final composite score may 
be heavily influenced by an indicator that is considered of marginal importance in the 
wider health system context (Goddard and Jacobs, 2009). We here made the 
(illustrative but reasonable) assumption that avoiding a particular event can at most 
have half of the overall value attached to avoiding an event of each of the six quality 
measures. This resulted in the following proportional weight restrictions: avoiding an 
event of the worst healthcare quality measure cannot be more than ten times as 
valuable as avoiding an event of the least bad quality measure (since with six 
indicators, a ratio of 1/10 means that one quality measure can have at most half of 
the weight mass). 
 
To examine robustness to different choices of denominator (part II), no weight 
restrictions were used. In efficiency analysis, denominator weights have a clear 
interpretation, since they indicate the substitutability between different types of 
                                                                    
3 We assumed an avoidable admission e.g. for acute exacerbation of COPD that could have been 
prevented with timely primary care. 
4 We assumed a condition where patients are in mild to moderate discomfort. 
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inputs (labor, capital, other intermediate inputs). In quality comparisons, 
denominators represent different populations at risk. However, denominator weights 
lack a clear interpretation as in efficiency analysis since it is hard to think about 
trade-offs between different populations at risk. To simplify the methodology, the 
analyses in part II therefore do not use any weight restrictions. In part I, there are no 
denominator variables since the analysis relies on rates as model variables (see Table 
3-1). 
 Results 3.4
3.4.1 Robustness to choices of weights: Unrestricted and restricted ranking 
intervals for feasible weight sets 
Figures 3-1 to 3-3 illustrate the use of ranking intervals to handle ambiguity about 
choices of weights assigned to performance on the different indicators. They also 
show what the most critical assumptions are with respect to weights. The ranking 
intervals show the possible rankings that Boards can attain. The wide ranking 
intervals for measures of quality across all feasible weights (Figure 3-1) suggest 
considerable sensitivity to feasible choices of weights. If one adds ordinal weight 
restrictions (Figures 3-2) and ordinal and proportional weight restrictions (Figure 3-
3), then variations in performance appear to be manifested more clearly.   
 
The width of the ranking interval reflects the impact of different assumptions about 
changes in weights. A small interval suggests that a Board’s performance is robust to 
alternative modelling assumptions. For example, Board L (Figure 3-2) is ranked 3rd 
or higher no matter which assumptions are used. The interval bounds show the 
impact of modelling assumptions on relative ranks. Thus, one can be confident that 
Board F, for example, cannot be ranked worse than 7th and not better than 3nd. 
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Figure 3-1 Performance rankings without weight restrictions
 
 
Figure 3-2 Performance rankings with ordinal weight restrictions
  
Figure 3-3 Performance rankings with ordinal and proportional weight 
restrictions
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3.4.2 Dominance relations and comparative scope for improvement  
Based on pairwise comparisons, the REA results can be displayed in a unified way as 
a dominance relation (Figure 3-4): insofar as Boards are more superordinate or 
“higher up”, their relative performance is more robust to changes in the weights 
attached to the constituent indicators of performance. This graph suggests that the 
three island Boards NHS Orkney (K), Shetland (L) and Western Isles (N) are top 
performers since they are not dominated by any other Board. In turn, the Boards NHS 
Ayrshire and Arran (A), Fife (D), Greater Glasgow and Clyde (G), Lothian (J) and 
Tayside (M) are dominated by the other Boards.  
 
There are two main reasons for this differentiation status. First, a Board’s 
performance on the indicators that are used to construct the composite measure play 
a role (Table 3-2). For instance, although NHS Western Isles scores worst, by far, on 
rates of clostridium difficile infections, all three island Boards perform comparatively 
better than the rest of Scotland on MRSA/MSSA infections, 4-hour A&E waiting times 
and 18WRTT. Second, the ordinal weight restrictions used influence the dominance 
relations. In this example, performance on MRSA/ MSSA infections is weighted more 
highly than performance on emergency admissions, which in turn receives a higher 
weight than performance on c.difficile, and so on. Indeed, inspection of the underlying 
data (Table 3-2) suggests that the five Boards who appear at the bottom of the 
dominance graph perform comparatively worse on MRSA/ MSSA infections and 
emergency admissions. Nevertheless, their poor overall differentiation status is the 
result of poor performance on several (up to four different) indicators and thus not 
exclusively the result of the weighting scheme.  
 
Table 3-3 shows the radial improvements needed for some Board X (depicted by row) 
that is dominated by some Board Y (depicted by column) to improve its performance 
(i.e. decrease its rates, since these are all “lower is better” indicators) so as not to be 
dominated. This means, for instance, that Board A needs to reduce its rates on all the 
indicators by 8 % so as not to be dominated by Board B. If a cell is empty, then Board 
X is not dominated by Board Y. Looking horizontally, one can see, for instance, the 
improvements that would be needed for the five worst performing Boards J, G, D, M, A 
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to become non-dominated by the better-performing Boards. Looking vertically, one 
can identify the distance that differentiates each Board from the national leaders, 
Boards K, L and N. 
 
Figure 3-4 Dominance graph for Scottish Health Boards, based on ordinal and 
proportional weight restrictions  
 
Table 3-3 Comparative scope for improvement needed to reach another target 
or reference Board in Scotland 
Dominated 
Board 
 Target or Reference Board 
 
  A B C D E F G H I J K L M N 
  
Ayrshire & 
Arran 
A  8 %    2 %  25 % 2 %  22 % 36 %  2 % 
Borders B         9 %   14 % 27 %   
Dumfries & 
Galloway 
C  <1 %     7 %  21 %   15 % 31 %   
Fife D  3 %     11 %  24 %   17 % 32 %   
Forth Valley E       7 %  12 %   3 % 21 %   
Grampian F         6 %    15 %   
Greater 
Glasgow & 
Clyde 
G  9 % 8 %   16 %   29 % 11 %  22 % 36 %  2 % 
Highland H             10 %   
Lanarkshire I        12 %    6 % 23 %   
Lothian J  4 % 2 %  6 % 18 %  23 % 11 %   18 % 33 %   
Orkney K                
Shetland L                
Tayside M  8 %    4 %  20 %   25 % 36 %    
Western Isles N                
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3.4.3 Ratio-based analysis: Robustness to choice of denominator 
The correlation between rates of clostridium difficile infections per population 
compared to bed days as the denominator is low (r = 0.15537). This suggests that the 
choice of denominator will make a difference to the relative ranks Boards may attain. 
Table 3-4 examines robustness to different choices of denominator. Although most 
Boards seem to perform either relatively well (Forth Valley, Grampian, Greater 
Glasgow and Clyde) or relatively poorly (Tayside, Ayrshire and Arran) on either of the 
two denominators, for some Boards different assumptions about appropriate 
denominators lead to notable rank reversals. The three island Boards appear to 
perform distinctly better when infections are measured relative to bed days while 
NHS Borders, Lanarkshire, Fife and Highland jump up the ranking for a population 
denominator. 
  
Table 3-4 Performance on healthcare associated infections (HAIs; includes 
C.difficile) relative to different choices of denominator 
Board Per 100,000 bed 
days 
 Per 100,000 Total 
population 
Ranking interval for 
bed days and 
population  Number 
of HAIs 
Rank Number 
of HAIs 
Rank difference 
compared to bed 
days 
Shetland 55 1  34 -5 1-6 
Forth Valley 78 2  14 +1 1-2 
Grampian 105 3  24 +1 2-3 
Greater 
Glasgow & 
Clyde 
109 4  33 -1 3-4 
Orkney 114 5  84 -8 5-13 
Highland 124 6  24 +3 3-6 
Western 
Isles 
140 7  123 -7 7-14 
Fife 155 8  26 +4 4-8 
Dumfries & 
Galloway 
161 9  36 +1 8-9 
Lanarkshire 162 10  35 +3 7-10 
Lothian 177 11  42 +2 9-11 
Tayside 195 12  50 0 12 
Ayrshire & 
Arran 
211 13  49 +2 11-13 
Borders 241 14  44 +4 10-14 
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 Discussion 3.5
We have focused on two pervasive sources of ambiguity, in the sense of a lack of 
knowledge about the best modelling choices, which make the use of composite 
measures for robust performance comparisons in healthcare difficult: How should 
different indicators be weighted to obtain an aggregate measure of performance? 
What is the “correct“ denominator in ratio-based performance indicators? As Jacobs 
et al. (2005) note, two possible implications to respond to the uncertainty inherent in 
composite indicators would be to dismiss composite indicators altogether and 
instead estimate relative performance separately for each objective (an example of 
this is Hauck and Street’s (2006) multivariate multilevel approach that requires no 
aggregation and weighting of multiple objectives at all); or to invest considerable 
resources into more sophisticated modelling, such as by means of elaborate 
preference elicitation or by seeking to estimate meaningful weights from existing 
health service information.  
 
In a context where information is inevitably incomplete but policy-makers might still 
be interested in an overall measure of health system performance (OECD, 2008), we 
have demonstrated how the REA technology offers a third way that openly provides 
indications of the uncertainty inherent in the valuation of objectives and choices of 
denominators. The approach is essentially based on agnosticism: When there are 
multiple reasonable denominators which each highlight aspects of performance – 
such as that an organisation can deliver high-quality in terms of few quality measures 
relative to hospitalised and/or general populations – then analysts need not restrict 
themselves to a single denominator. Our results reinforce the insight that healthcare 
quality may be best thought of as a collection of possible rates depending on how the 
population denominator is specified rather than as a single “right“ rate (Guillen et al., 
2011). Ranking intervals based on multiple denominators thus may enable a more 
complete account of performance.  
 
Similarly, if we know that healthcare quality measures are heterogeneous but are 
ignorant of the best method to weight them, then methods to construct a composite 
indicator of performance need to capture that lack of knowledge. Sensitivity analysis 
93 
 
on weights is not a new idea; several prior attempts – especially in the 
multidimensional well-being literature – include explicit use of ranges of weights (e.g. 
Zhou et al., 2010); computation of multiple weighting schemes (e.g. Osberg and 
Sharpe, 2002); and global sensitivity analysis (e.g.   Saltelli et al., 2008).  
 
The REA approach adds to this work in two ways. First, consideration of incomplete 
information is built into the very structure of the model. Ranking intervals give 
policy-makers a sense of the uncertainty around ranks, indicating the extent to which 
action is warranted. Our results show that, when one assumes complete ignorance 
about the relative weights assigned to different indicators, then it is essentially 
impossible to differentiate the performance of Scottish Health Boards (Figure 3-1). In 
other words, one cannot say which Boards perform comparatively better or worse. 
Regulatory action solely based on such rankings would thus clearly be premature. 
 
However, once some reasonable ordinal and proportional weight restrictions are 
applied, organizational performance appears much clarified. Clearly, the choice of 
weight restrictions may differ between groups of people: different individuals may 
come up with different orderings or proportionate weights concerning the relative 
badness (or goodness) of particular events. However, if some restrictions can be 
established (e.g. based on existing consensus or medical evidence of disease severity), 
then they may provide useful insights. When an organisation consistently appears at 
the bottom (Board G) or at the top (Board L; in Figure 3-2) whichever set of weights 
is used, this may provide a stronger rationale for policy intervention. It supports the 
notion that settling on a unique set of weights may not always be necessary to inform 
judgments in many situations (Foster and Sen, 1997). 
 
Second, ranking intervals and dominance relations appear to offer relatively intuitive 
ways to synthesise key messages contained in disparate indicators. This may help to 
communicate in a unified way the results of comparative assessments to policy-
makers, possibly addressing the limitations of frontier-based approaches such as DEA 
and stochastic frontier analysis whose complexity has tended to limit their practical 
influence outside academic circles (Hussey et al., 2009, Hollingsworth and Street, 
2006). Visualisation of uncertainty also mitigates the loss of transparency due to 
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opaque methodological choices made about the valuation of objectives (Hauck and 
Street, 2006). Whether REA can live up to these expectations in practice remains to 
be seen, but some promising experiences from public sector education institutions 
(Salo and Punkka, 2011) suggest that REA may usefully complement existing methods 
of healthcare evaluators. 
 
REA-type analyses are likely to be particularly useful under conditions where: (i) 
there are concerns about rank reversals due to sensitivity to outliers and the 
introduction or removal of DMUs (since pairwise comparisons make REA results 
relatively robust to these biases); (ii) the audience are policy-makers and managers 
rather than academics (since results such as being “30% below the efficient frontier“ 
may not be easily accessible to non-technical audiences and REA requires no concept 
of an efficient frontier); and (iii) there are relatively few DMUs (since no large 
number of DMUs is needed to construct an efficient frontier and “peer groups“ as in 
DEA).  
 Implications for policy and research 3.6
The agnosticism implied in the REA approach may come at a price of incomplete 
orderings (in the form of wide ranking intervals). This will depend on the extent to 
which weight restrictions are used; and on the correlation between indicators. These 
factors are linked, because strongly correlated indicators will make rankings less 
sensitive to different sets of weights (Foster et al., 2012). The appropriate degree of 
correlation will depend on the purpose of the analysis. For policy-makers and 
managers, wide ranking intervals simply reinforce the need to be cautious in using 
comparative assessments based on composite indicators for definitive judgments 
rather than as signals to motivate further analysis.  
 
Dominance relations that are based on pairwise comparisons between Boards 
provide comparative performance assessments one can be confident about. Since 
dominance relations indicate that some DMU 𝑘 performs at least as well as some 
other DMU 𝑙 for all feasible weights and there exist some weights for which it 
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performs strictly better, this information could, for instance, be used for setting 
performance targets across all the indicators included in the analysis. Since 
improvements on some indicators may require less effort than others, indicator-
specific improvements would also be informative. However, this would require a 
different approach. A recent study by Gouveia et al. (2015) employs slack-variables 
which define the variable-specific distance to the efficient frontier. This helps to 
estimate the improvements required for a DMU to reach the best comparative 
performance level. However, this approach does not indicate the improvements 
needed to reach some specific, non-efficient DMU as it is possible with the approach 
used in our study. This is particularly relevant from a managerial and policy 
perspective and an important strength of our approach, since the top performing 
organisation may not always be the most meaningful (and practically feasible) 
benchmark for another organisation that performs considerably worse. 
 
Finally, it is essential to re-emphasize the importance of the other methodological 
choices (listed in section 3.2) that must be made when constructing a composite 
measure of performance. This concerns, in particular, the initial selection of 
indicators and any adjustment for environmental constraints on performance. If 
important indicators are not included in the analysis, then any performance 
evaluation will be meaningless. To mitigate dangers of omitting important variables, 
or including irrelevant variables (Smith, 1997), the set of performance metrics will 
need to reflect a country’s definition of valued quality measures of the health service 
(Dowd et al., 2014).  
 
With regard to uncontrollable influences on performance, in Scotland the funding 
formula mechanism is designed to enable all NHS Boards to produce equal levels of 
performance. Since this formula takes account of differences in population and other 
geographic characteristics (e.g. rurality), it can be argued that prior adjustment has 
already been carried out via the funding system (Jacobs et al., 2006b). However, the 
degree to which this argument holds depends on the context of analysis as well as the 
degree to which the formula accurately and comprehensively compensates for 
uncontrollable determinants of performance. While for Scottish Health Boards the 
funding formula argument may hold, it may not hold for hospital-level analyses 
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within these Boards since patients visiting these hospitals are likely to differ in 
relation to a number of additional case-mix variables.  
 
Furthermore, as Smith (2003) notes, formula funding is fraught with challenges and 
imperfections, such as that performance criteria have proved hard to include in the 
formula. This means that poor quality of care which increases levels of morbidity 
might be ‘rewarded’ with higher levels of funding. In Scotland, the issue is further 
complicated by a policy called ‘differential growth’ where actual allocations to Boards 
do not entirely follow the formula. Instead, annual real-terms growth for Boards who 
are above parity (i.e. above their target share estimated by the formula) is lower than 
for Boards who are below parity until the formula-based funding distribution is 
achieved (ISD Scotland, 2010a). Finally, although several techniques exist to adjust 
for environmental variables (reviewed by Jacobs et al., 2006b: 115-17 in the context 
of DEA-type analyses), there is no universally accepted “best” method to tackle this 
problem in a satisfactory way. As a result, the link between resource allocation and 
performance measurement remains complex and an important avenue for future 
research. 
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 Commentary in relation to the organising matrix of strategies 3.2
to address ambiguity about the standard for evaluation 
This Chapter has explored how policy-makers and managers might manage ambiguity 
about the standard for evaluation with a technical-evidential approach. The Chapter 
has explored healthcare applications of a robust approach to ranking based on 
ranking intervals and dominance relations that recognise ambiguity about choices of 
weights and choices of population denominator. 
 
A key problem remains the choice of healthcare quality measures. The indicators 
against which the performance of Scottish Health Boards is assessed, and which we 
have used here, focus on adverse events patients experience, thus embracing the 
imperative that healthcare should do no harm. However, measuring health system 
performance also requires some concept of the benefit: the good that is produced by a 
health system. Since health outcomes are a function of activities of the health system 
and exogeneous (e.g. lifestyle, demographic and socio-economic) factors, measures of 
health system performance should ideally indicate the “value-added” (Goldstein and 
Spiegelhalter, 1996): the health gain or incremental healthcare outcome conferred to 
patients that is attributable to the workings of the health system. In practice, 
operationalising this concept remains however difficult due to limited information on 
the counterfactual i.e. the health status in the absence of the health intervention 
(Jacobs et al., 2006b).  
 
Using activities rather than health outcomes may offer insights into healthcare 
performance if a clear link between activities and health gain exists (Jacobs et al., 
2006b). However, activity-based analyses often suffer from limited information about 
treatment appropriateness not only at a patient level (e.g. whether cataract surgery 
was clinically indicated) but also at a population level (e.g. whether all patients with 
capacity to benefit from cataract surgery also had access to the procedure). Chapters 
4 and 5 explore this issue further by examining a technical-evidential methodology to 
establish a meaningful standard in the form of population capacity to benefit. 
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Abstract 
 
Objectives: To investigate the gap between need for and utilisation of ventilation 
tube (VT) insertions for otitis media with effusion (OME) in children in England. This 
procedure is known to be “overused” from audits of care provided, as only one in 
three VT insertions conform to the appropriateness criteria by the National Institute 
for Health and Care Excellence (NICE); but audits cannot identify the scale of 
“underuse“: i.e. patients who would benefit but are not treated.  
 
Methods: To explore both “underuse” and “overuse“ of VTs for OME we developed an 
epidemiological model based on: definitions of children with OME expected to benefit 
from VTs according to NICE guidance; epidemiological and clinical information from a 
systematic review; and expert judgement. A range of estimates was derived using 
Monte Carlo simulation and compared with the number of VTs actually provided in 
the NHS in 2010.  
 
Results: About 32,200 children in England would be expected to benefit from VTs for 
OME per year (between 20,411 and 45,231 with 90% certainty). The observed 
number of VTs for OME-associated diagnoses however was 16,824.  
 
Conclusions: The expected population capacity to benefit from VTs for OME based on 
NICE guidance appeared to exceed, by far, the number of VTs actually provided in the 
NHS. So, while there is known overuse, there also may be substantial underuse of VTs 
for OME if NICE criteria were applied. Future investigations of unwarranted variation 
should therefore not only focus on patients who are treated, but consider potential to 
benefit at the population level. 
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 Introduction  4.1
Systems of healthcare in countries that are under severe fiscal pressures (Thomson 
et al., 2014) seek to do more for less: to increase the benefits from healthcare and 
reduce its costs. There is evidence of large and persistent variations in medical 
practice across small areas, which have been documented in various countries 
(Corallo et al., 2014). This evidence is generally seen as an indication of “overuse“: 
i.e. where reductions in rates of treatment could release resources with gains in 
health (Ham, 2013). In England, commissioners are allocated budgets for their 
populations and have to develop policies for services for which they are and are not 
prepared to pay. One such policy seeks to reduce unwarranted variation by 
restricting access to procedures listed as being of “low clinical value“ (Audit 
Commission, 2011). However, due to the lack of an objective reference point against 
which to evaluate overuse (defined as “ineffective care that is more likely to harm 
than help the patient“; Institute of Medicine (2001: 47) or underuse (defined as “the 
failure to provide services from which the patient would likely benefit“; Institute of 
Medicine (2001: 17)), information on variations remains essentially ambiguous 
(Evans, 1990). The purpose of this article is to investigate unwarranted variations by 
modelling the scale of underuse or overuse of ventilation tubes (VTs; grommets) for 
children with otitis media with effusion (OME) in England.  
 
VT insertions are a classic case of high geographic variation. Variations in England 
have been documented since the 1980s (Black, 1985b) and have persisted: in 
2010/11 there was about eight-fold variation across 151 commissioners with a 
mean population of about 300,000 (NHS Right Care, 2012b). VTs have been listed by 
commissioners as a “low value“procedure (Audit Commission, 2011), which seeks to 
restrict referrals by general practitioners (GPs). Despite that, VT insertions remain 
one of the most frequent surgical interventions in children: with over 32,000 
insertions in 2010/11, of which 23,500 were among children younger than 14 years 
(NHS Information Centre, 2011). Clinical audits in the United States (Keyhani et al., 
2008a) and the United Kingdom (Daniel et al., 2013), using different criteria of 
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appropriateness, found that only one in three VT insertions were appropriate, 
suggesting substantial “overuse“.  
 
However, audits of care delivered cannot address the scale of “underuse” of VTs for 
OME. We therefore developed an epidemiological model to estimate the number of 
children with capacity to benefit from VTs for OME, if NICE guidance (NICE 
Guidance, 2008) were being followed, and compared this with the number of VTs 
actually provided in England. The study population are children aged 2 to 8 years. 
4.1.1 Recommended clinical pathway   
OME is defined as an effusion in the middle ear cleft, in the absence of signs of acute 
inflammation. It may cause conductive hearing loss which, if persistent, can affect 
speech and language development, educational performance and behaviour 
(Simpson et al., 2007). By the age of four years, about 80% of children have had 
episodes of OME (Zielhuis et al., 1990d). As OME is transitory for most children, the 
NICE clinical pathway (Figure 4-1) recommends an initial period of active 
observation over three months and repeat audiological testing at the end of this 
period.  
 
At that stage, it is recommended that VTs are offered to children younger than 12 
years who meet three core criteria: (1) bilateral OME with (2) a hearing level in the 
better hearing ear of 25 to 30 db hearing level or higher that (3) is documented over 
a period of three months. The crucial point is that NICE guidance does not define VTs 
as an intrinsically “low value“ procedure, but recognises their value in relation to a 
set of evidence-based criteria. In exceptional cases, VTs may also be offered if 
clinicians judge the impact of OME-related hearing impairment on the child’s 
development, well-being or social functioning to be substantial (NICE Guidance, 
2008).  
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Figure 4-1 Conceptual model: NICE pathway of care 
 
 
Explanation:  
(1) The model starts with a population of children at risk of developing OME.  
(2) Of these children, some will develop bilateral OME with a hearing level of +25 db.  
(3) The recovery rate determines the proportion of children recovering and returning to 
the susceptible population. The remaining (persistent) cases present in primary care.  
(4) Children who are referred to specialist care undergo formal assessment and 
diagnosis.  
(5) Patients for whom a diagnosis of OME is confirmed after three months “watchful 
waiting“ have a capacity to benefit from VTs for OME and should be considered for 
surgical intervention according to NICE guidance. 
Legend:  
Boxes represent mutually exclusive, collectively exhaustive states in which parts of the 
population of children find themselves. 
Arrows represent the transition probabilities (incidence and recovery rates) and the 
waiting times that link the states. 
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 Methods  4.2
Based on the NICE criteria, our epidemiological model to estimate population 
capacity to benefit from VTs for OME is formulated below. The modelling 
assumptions are summarised in Table 4-1. The parameters, their definition and 
estimation are given in Table 4-2. 
4.2.1 Epidemiological model 
1) Incidence: The number of new cases of OME in any given year, N(OME), is 
determined by the annual age-specific cumulative incidence (risk) Ij of OME 
multiplied by the susceptible population in a given age group Sj, summed over all 
eligible age groups j. The subgroup of cases with bilateral OME and a hearing level at 
NICE threshold level is expressed by 
𝑁 (𝑂𝑀𝐸) = ∑  (Sj ∗ Ij ∗ P (HL|Bilateral OME) ∗  P(Bilateral OME |OME))
12
𝑗=0
 
2) Disease process: We model the probability of OME persisting at time t from the 
onset of OME as an exponential process (adapted from Zielhuis et al. (1990c)) of the 
form 
P (OME | t) =  
1
 2
t
m
   
3) Capacity to benefit from VTs for OME: As OME is transitory, the population 
with capacity to benefit will diminish as time passes since the onset of OME. 
Population capacity to benefit from VTs for OME is estimated as 
PCB (t) = P (OME | t) * N (OME) 
4.2.2 Data sources and extraction 
To estimate parameter values, we carried out a systematic literature review 
according to PRISMA guidelines (Moher et al., 2009) (see Appendix 4-A for details of 
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the search strategy and data extraction, Appendix 4-B for the rationale for the study 
inclusion criteria).  
4.2.3 Setting and population 
The setting is the National Health Service (NHS) in England. The population includes 
children younger than 12 years covered by NICE guidance. However, as we were 
unable to find incidence studies that met our inclusion criteria for the age groups 0, 
1, 4 and 9 to 12 years, we focused the analysis on children aged 2 to 8 years 
(extrapolating the incidence for 4-year olds from 3-year olds) which is the age group 
with the majority of VT insertions (0 to 12 years: 19,805; 2 to 8 years: 16,824 
procedures with OME-associated diagnoses in 2010/11; NHS Information Centre 
(2011)). To estimate the susceptible population, the total population of children has 
been corrected for an estimate of OME prevalence (Appendix 4-C). We focused on 
children meeting the three NICE core criteria for VT insertion. The number of 
exceptional cases, which are identified through clinical judgement, was not 
modelled. This means that estimates from our epidemiological model are probably 
conservative and underestimate the number of children with capacity to benefit 
from VTs. 
4.2.4 Model validation 
All modelling assumptions were iteratively refined in consultation with the Project 
Steering Group. During an expert workshop in September 2012, ten participants 
with complementary expertise in audiology, ENT, general practice and epidemiology 
were invited to conduct a structured “walk-through” (Eddy et al., 2012: 846) to 
examine the model’s overall structure and individual components. The group judged 
the model to be a fair representation of the NICE care pathway and of the disease 
process governing OME given the existing evidence base. 
4.2.5 Sensitivity analysis 
Data retrieved from the literature raised the issue of potential for bias in terms of 
internal validity (the extent to which the design of original studies ensured accurate 
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measurement of the parameters of interest) and external validity (the extent to 
which studies conducted e.g. two decades ago in a different setting were applicable 
to the present UK context). While we recognise the relevance of the literature-based 
data, we felt the different sources of uncertainty in the evidence would merit 
supplementing this with expert judgement. We followed a structured approach to 
expert elicitation (O'Hagan et al., 2006).  We provided the panel of experts with the 
literature-based estimates, encouraged discussion and elicited fractiles of subjective 
probability distributions. We then used these estimates in a Monte Carlo simulation 
performed in @RISK 5.0 to gain an insight into the impact of the combined 
uncertainty in parameter estimates on the modelling results (Briggs et al., 2012). 
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Table 4-1 Modelling assumptions 
Assumption Comment 
Exponential disease 
process  
For the population level an exponential and rate-constant recovery process is 
applied based on Zielhuis et al. (1990c). The authors found a good fit (r2 = 
0.98) between the exponential model  estimated with Kaplan-Meier technique 
and the empirical data from a prospective cohort study (n=816 children with 
valid measurements). For a discussion of the epidemiological models for 
representing the natural course of OME see Zielhuis et al. (1990a). However, 
this may mask the few children suffering from highly persistent OME. At the 
individual level, OME may also be more episodic. 
Stationary population   Assumes a stable age distribution within each age group and year (based on 
mid-year population estimates). 
t 
 
Total waiting time t represents a parameter that reflects demand- and supply-
side aspects of patient utilisation behaviour, access and referral policies and 
the organisation of care delivery.  
Is varied over a range to account for uncertainy in three distinct sub-intervals: 
 t1,  time to presentation in primary care: Seeks to account for the time 
lag for detecting hearing loss associated with OME. As OME is an often 
asymptomatic or “silent“ condition, conductive hearing loss is likely 
to be noted by parents, teachers or carers only after some time (if at 
all).  
 t2, time from presentation in primary care to diagnosis in specialist 
care:  According to the NHS Constitution, patients have a right to be 
seen by a consultant within maximum 18 weeks after referral 
(Department of Health, 2010b). This is a political rather than clinical 
standard. It also refers to maximum not to optimum waiting times. 
National HES data confirms a median waiting time of 7.3 weeks (51 
days) for grommets (NHS Information Centre, 2011) from the 
decision to admit to actual admission (excluding days of deferment 
and suspension).   
 t3, time from diagnosis to confirmation: supposed to be 3 months 
according to NICE guidance. 
Incidence is 
represented as a 
function of age 
Age-based incidence rates are used as the association of OME with age is well-
established and most reliably documented (Zielhuis et al., 1990b).  
Incidence rates are at 
a population level 
and include both first 
and recurrent cases 
About 50% of children recovering from OME experience a further episode of 
OME (Fiellau-Nikolajsen, 1983, Zielhuis et al., 1990c). However, due to the 
often asymptomatic character of OME, even robust incidence studies cannot 
rule out the possibility that a child has previously suffered from OME. 
Modelling history of OME could thus lead to an overestimation of cases. 
Therefore incidence rates used in the model do not differentiate between first-
time and recurrent cases and are assumed to include both. 
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Assumption Comment 
Measurement of 
incident cases 
The studies used to estimate the incidence of OME were based on screening 
intervals of 3 months (Zielhuis et al., 1990d) or 4 months (Williamson et al., 
1994). This will underestimate transient cases occuring and recovering during 
this successive screening intervals. However, the assumption is justified 
insofar as OME is considered a disease occuring only after several weeks of 
middle ear pathology (Zielhuis et al., 1990a). 
Seasonal variation in 
incidence is averaged 
out over one year. 
While the incidence of OME is known to be higher in winter (Fiellau-
Nikolajsen, 1983), the incidence data used in the model and the model quality 
measure represent an annual average. 
Fixed proportion of 
bilateral OME. 
Reflects the nature of the data that  has been collected at (discrete) screening 
time points; although  at individual level, children may switch between 
unilateral and bilateral states. 
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Table 4-2 Model parameters 
Parameter Definition 
Base value 
used in model 
References 
Distribution for 
sensitivity analysis 
Lower quartile; 
upper quartile c 
      
Sj Number of susceptible children in 
age group j at risk of developing OME 
in a given year (reference year 2010). 
See the Appendix 4-B 
 
- - 
Ij Age-specific cumulative incidence 
(risk) of transiting to the OME state 
over a period of one year by year of 
age. Diagnosis based on type B 
tympanogram by the Jerger 
classification and otoscopy. 
    
2 0.350 Zielhuis et al. (1990d) β (1.93;1.93;0.15;0.54)     0.280;0.420 
3 0.160 Zielhuis et al. (1990d) β (1.93;1.93;0.06;0.25)     0.128;0.192 
4 0.160 a β (1.93;1.93;0.06;0.25)     0.128;0.192 
5 0.278 Williamson et al. (1994) β (1.93;1.93;0.12;0.43)     0.222;0.334 
6 0.151 Williamson et al. (1994) β (1.93;1.93;0.06;0.23)     0.121;0.181 
7 0.111 Williamson et al. (1994) β (1.99;1.99;0.04;0.17)     0.088;0.133 
8 0.065 Williamson et al. (1994) β (1.93;1.93;0.03;0.11)     0.056;0.084 
P (Bilateral OME | 
OME) 
Conditional probability of bilateral 
OME given a diagnosis of OME. 
0.4 Williamson et al. (1994) β (303;455)     0.38;0.41 
P (HL | Bilateral 
OME) 
Conditional probability of a hearing 
level of +25dBgiven a diagnosis of 
bilateral OME. 
0.35 
 
Sabo et al. (2003) β (11;11)         0.3;0.4 
m Median time to recovery (“half life“ of 
OME) 
3 months 
(three-month 
recovery rate of 
0.5) 
Thomsen and Tos (1981); 
Fiellau-Nikolajsen (1983);   
Tos (1984); Zielhuis et al. 
(1990c) 
 
 
 
 
Used as deterministic value in the model as 
found to be consistent across different 
settings and time periods by various studies. 
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Parameter Definition 
Base value 
used in model 
References 
Distribution for 
sensitivity analysis 
Lower quartile; 
upper quartile c 
      
t Total waiting time t from OME onset  t1 + t2 + t3  See Table 4-1 Varied over a range 
from 0 to 25 weeks 
 
t1 Time from OME onset to presentation 
in primary care 
1 month b   
t2 
Time from presentation in primary 
care to formal diagnosis  
1 month b   
t3 
Time from formal diagnosis to offer 
of treatment (active observation or 
“watchful waiting“) 
3 months NICE Guidance (2008)    
 
Estimates from clinical expert panel:  
(a) extrapolating the incidence for 3-year olds;  
(b) reflecting ideal circumstances;  
(c) based on structured probability elicitation (O'Hagan et al., 2006).
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 Results  4.3
Figure 4-2 illustrates the combined uncertainty in the expected incidence of bilateral 
OME with a hearing level of +25 db. Based on 10,000 iterations of the simulation 
model and given the set of input distributions, the resulting distribution of the 
expected incidence ranges between 63,800 and 143,600 cases per year in England 
with 90% certainty (mean estimate: 102,083 cases). These results from the Monte 
Carlo simulation are used to model the expected number of children with capacity to 
benefit from VTs for OME as the total waiting time from the onset of OME is varied 
over a range.  
Since OME is transitory, the expected population capacity to benefit from VTs for 
OME depends on the total waiting time from the onset of OME to the point where 
treatment is considered (Figure 4-3). NICE guidance recommends a three-month 
period of active observation following the first formal diagnosis. Thus, if we were to 
assume the first outpatient appointment took place instantaneously after the onset of 
OME, then the mean estimate of children for whom VTs would be clinically indicated 
would be approximately 51,000 (at t=3 months; between 32,400 and 71,800 with 
90% certainty). There is currently no national guidance on the recommended waiting 
time from the onset of OME until the first outpatient appointment (waiting time 
intervals t1 and t2 in Figure 4-1). Since our model aims to provide a benchmark of 
expected care, rather than a reflection of actual practice, our assumptions about the 
length of these intervals (Table 4-2) represent clinically “ideal“ circumstances based 
on expert group consensus. Assuming a one-month buffer period before parents 
become concerned about the symptoms of OME and visit a GP and another month 
before children have their first outpatient appointment, we would expect 
approximately 32,200 children to benefit from VTs for OME (at t=5 months; 90% 
certainty interval 20,411 to 45,231). This contrasts with an observed number of 
16,824 VTs that were actually provided for OME-associated diagnosis codes in the 
age group of 2 to 8 years in 2010/11 in England. As can be seen in Table 4-3, even if 
we were to assume coding inaccuracies in VTs coded with OME-associated diagnoses, 
the conclusions would be unaffected. 
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Figure 4-2 Monte Carlo simulation of expected annual incidence of bilateral 
OME with a hearing level of +25 dB in England  
 
Legend:  
x-axis: expected annual incidence of bilateral OME with +25 dB hearing level in England (2010). 
y-axis: frequency of observing a particular quality measure value based on 10,000 iterations of the 
simulation model. 
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Figure 4-3 Expected number of children with capacity to benefit from VTs for 
OME depending on total waiting time in England (reference year 2010, age groups 
2 to 8 years)* 
 
*Given different starting estimates of the total annual incidence of bilateral OME with hearing level of 
+25dB for the age groups 2 to 8 from the Monte Carlo simulation (Figure 4-2) of approximately 
102,083 cases (mean estimate); 63,800 cases (lower 5% bound); and 143,600 cases (upper 95% 
bound). 
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Table 4-3 Observed VT insertions in England, 2010/11 
Observed VT insertions Count 
Total admissions 32,716 
Day case 29,566 
Age 0-14 23,459 
Age 0-12, OME-associated diagnosis codes 
(2010/11)* 
19,805 
Age 2-8, OME-associated diagnosis codes (2010/11)* 16,824 
 
Source: NHS Information Centre. Main procedures and interventions: 4 character. Hospital Episode 
Statistics for England. Inpatient statistics, 2010-11.  
* Procedure code D15.1 Myringotomy with insertion of ventilation tube through tympanic membrane 
for DIAG1=H652: Chronic serous otitis media or H653: Chronic mucoid otitis media or H654: Other 
chronic nonsuppurative otitis media or H659: Nonsuppurative otitis media, unspecified. Both as 
primary and secondary procedure (e.g. besides adenoidectomy); including both elective and 
emergency admissions, in- and outpatient cases. 
 
 Discussion  4.4
This study shows that the expected capacity to benefit from VTs for OME among 
children in England, according to NICE guidance, exceeds the number of VTs that 
were actually provided in the NHS. Our model hence reveals the possibility of 
underuse of VTs for OME at the aggregate national level. However, the findings also 
need to be interpreted in the light of the roughly eight-fold variation in treatment 
rates across PCTs in England (NHS Right Care, 2012b), which suggests that overuse 
might still occur in some regions.  
114 
 
4.4.1 Strengths and weaknesses of the study  
The model draws on evidence-based clinical guidance to obtain an indicative estimate 
of the scale of potential underuse or overuse of VTs in a given population. This 
estimate does not represent the “right (treatment) rate“, which would also depend on 
informed patient choice. It attempts to approximate a level of treatment that the NHS 
would be expected to offer to patients, if NICE criteria were accepted as a valid basis 
for identifying patients with capacity to benefit from VTs. We recognise that NICE 
criteria can only be approximate predictors of benefit from VTs for hearing outcomes, 
especially for cases located just above or below the +25 dB hearing level threshold, 
with even more uncertainty over the impact of VTs on childhood development and 
the child’s quality of life. Thus, from a normative standpoint, our model can only give 
an approximate estimate of how many VTs “should“ be offered, which may change 
once better predictors of benefit become available.  
The model uses best available evidence identified through a systematic review. The 
shortage of high-quality studies meeting our inclusion criteria did not allow for a 
meta-analysis, and we have demonstrated the consequent uncertainty in our 
parameter estimates and their combined impact on the modelling results by Monte 
Carlo simulation. The observed number of VTs provided covers patients treated in the 
NHS; unfortunately we were unable to obtain estimates of the scale of private practice 
in England. However, total private sector expenditure on healthcare in the UK (2011) 
is 17.2% (Office for National Statistics, 2012) which would not substantially affect the 
conclusions of our study.  
4.4.2 Findings in relation to studies of utilisation 
Our study using a population model complements utilisation-based studies of 
treatment appropriateness. A recent multi-centre study in England found that only 
32.2% of VTs inserted complied with the three core NICE criteria, while 54.8% of VTs 
were provided on the basis of exceptional circumstances (Daniel et al., 2013). Although 
NICE guidelines explicitly encourage the provision of VTs also beyond the three core 
criteria if clinicians judge the impact of OME on the child’s development and social 
functioning to be substantial (NICE Guidance, 2008), the apparent reframing of 
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“exceptions“ under clinical guidance as the “rule“ in clinical practice does raise 
questions over treatment appropriateness. This study adds to these findings by 
illustrating that, while there may be deviation from NICE core criteria, which could 
either reflect patient-oriented treatment or overuse of VTs, unmet clinical need 
according to these core criteria may be present simultaneously. 
There are three possible lines of explanation for the divergent findings between the 
Daniel et al. study, which found overuse of VTs, and this study, which identifies a net 
underuse at the population level. These explanations are as follows: 
Explanation 1: The model is biased. The model depends on a number of assumptions 
(see Tables 4-1 and 4-2) and limitations (see section 4.4.1). In particular, the 
epidemiology of OME is complex (Zielhuis et al., 1990a) and the use of age-specific 
incidence rates in this study may not have been able to account for other predictors of 
incidence. However, as highlighted in Appendix 4-B, much care was taken in specifying 
the selection criteria for the studies. To enhance external validity of the data, for 
instance, data only from areas with similar climate conditions was chosen since climate 
is a known risk factor for OME (Rovers et al., 2004). As a result of comprehensive 
sensitivity analysis across all model parameters at the same time, one can be confident 
that the model estimates are reasonable. 
Explanation 2: The Daniel et al. (2013) study is biased. While the epidemiological 
model has England-wide coverage, the Daniel et al. (2013) study examined only five 
hospital centres (Derbyshire Hospitals NHS Trust, Nottingham University Hospitals 
NHS Trust, Royal Free Hampstead NHS Trust London, Sherwood Forrest Hospitals NHS 
Trust, and United Lincolnshire Hospitals NHS Trust). It is possible that these five 
centres were exhibiting an unusually high level of inappropriate insertions of 
ventilation tubes. Therefore, they may not have been representative of England as a 
whole. Furthermore, the use of clinical audits of patients who were treated suffers from 
a fundamental methodological limitation: per definition, such audits are not able to 
identify patients who would benefit but who did not access healthcare in the first place 
or failed to be referred in time by their GP. 
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Explanation 3: Both studies show a true, complementary aspect of the reality of 
healthcare delivery. There are several good reasons why the apparent co-existence of 
both overuse and underuse is a genuine phenomenon rather than a statistical artefact. 
On the one hand, there are three logical explanations for an apparent underuse of VTs 
as identified by our model. First, as parents, teachers and nurseries may fail to 
recognise hearing loss associated with OME (Rosenfeld et al., 1998), it is possible that 
many patients do not present to primary care in the first place. Second, GPs may lack 
the knowledge or capacity to diagnose OME correctly. In a recent UK-based study, 
participating GPs correctly identified OME only in 53% of cases, which is not much 
higher than chance (Buchanan and Pothier, 2008). This means that, on average, a GP 
misses every second child with OME. At a national scale, this factor alone would 
provide a plausible explanation of why the expected population capacity to benefit 
from VTs was twice as high as the observed rate of utilisation. Third, the finding of 
apparent underuse is consistent with the “low value“ policy among healthcare 
commissioners in England  which has entailed restricting access to VTs (Audit 
Commission, 2011). This means that GPs might be inclined to avoid or delay referrals 
even for patients for whom NICE guidance would recommend a referral.  
On the other hand, there are several possible explanations for Daniel et al.’s (2013) 
finding that, once patients have been referred to specialist care, surgeons may have a 
tendency to insert VTs even if the three NICE ‘core criteria’ have not been met. First, as 
Daniel et al. (2013) point out, it may be the case that surgeons perceive the NICE 
guidelines as overly restrictive. There may hence be an attempt to take into account the 
patient’s situation as a whole and personalise care to what surgeons perceive to be in 
this particular patient’s best interest. Second, economic incentives to increase rates of 
surgery may play a role. This may be particularly relevant given the increasing financial 
pressures and challenging economic environments faced by many NHS hospitals (Hurst 
and Williams, 2012). Third, parental preferences might influence the decision to 
operate. It has long been argued that some socio-economic groups, allegedly the 
relatively well-off middle class patients, might exercise their ‘voice’ and demand 
treatment even though objectively they are not in medical need (Le Grand, 2007). For 
these reasons, it seems plausible to suggest that the English NHS is likely to suffer from 
117 
 
both overuse and underuse with respect to VTs for OME. Further empirical analysis is 
necessary to examine these factors. 
4.4.3 Policy implications  
An increasingly common policy among healthcare commissioners in England  is to 
label VTs per se as “overused” and “low value“ (Audit Commission, 2011) and hence 
restrict access to the procedure. Our findings highlight the possibility of substantial 
“underuse” among children in England for whom VTs are deemed beneficial and thus 
call for a more nuanced policy response. Because there is no evidence of a systematic 
relationship between high rates of utilisation and high rates of inappropriateness 
(Keyhani et al., 2012), we need a policy that tackles overuse by clinical audit of 
treatment, and ensures access to effective care for children suffering from persistent 
bilateral OME with a degree of hearing loss that is disabling and may affect their 
health and development. This policy would use the ideas of epidemiologic 
surveillance of medical care (Caper, 1987) to enlarge the framing of clinical 
appropriateness from audits of services delivered to population capacity to benefit. 
Understanding the number of people who might be expected to benefit, given local 
population characteristics and clinical guidance, has relevance also for other high-
volume services such as cataract surgery, joint arthroplasty or spinal procedures: it 
could help widen clinical concerns from individual patients towards the entire 
population who could (not) benefit and should hence (not) be offered a procedure. 
This policy would require investments in: (1) recommended intervention criteria 
that are more directly related to patient benefit, based on evidence from everyday 
practice (high-quality clinical databases rather than RCTs) on the real-world impacts 
of surgery on health outcomes compared to a control group; and (2) good 
information on disease epidemiology. 
4.4.4 Implications for research and quality improvement 
To explain the discrepancy between observed VT provisions and the expected 
number of VTs offered, a multi-faceted qualitative and quantitative approach 
involving commissioners, professionals and families is needed to identify barriers 
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along the whole pathway and then design interventions for improvement. As 
parents, teachers and nurseries may fail to recognise hearing loss associated with 
OME (Rosenfeld et al., 1998), it is possible that many patients do not present to 
primary care in the first place. GPs, school nurses and health visitors need the 
knowledge and capacity to identify patients with suspected OME and ensure timely 
referral and diagnosis according to NICE criteria. In a recent UK-based study, 
participating GPs correctly identified OME only in 53% of cases, which is not much 
higher than chance (Buchanan and Pothier, 2008). Since VTs feature widely as a “low 
value“ procedure (Audit Commission, 2011), GPs might also tend to withhold 
referrals even for patients for whom VTs could be a clinically and cost-effective 
option. Delays in care and a long history of “watchful waiting“ in community services 
may thus, in practice, exceed the two-month interval from the onset of OME to 
formal diagnosis which we assumed as a clinically “ideal“ benchmark in our model. 
To overcome fragmentation, GPs, audiologists and ENT specialists need to work 
together to ensure early recognition and referral of children with capacity to benefit 
from treatment. Patients and carers deliberately choosing non-surgical treatment 
alternatives, such as hearing aids or medical management, may also in part explain 
the apparent discrepancy between “expected“ and “observed“. However, many 
patients and carers may not be given the opportunity to discuss and understand 
their options for treatment, resulting in uninformed use of other care. Future 
research might therefore also examine regional variations in patient preferences and 
approaches to shared decision-making (Elwyn et al., 2010) and how these add to, or 
interact with, differences in local commissioning criteria and socio-economic 
inequalities.  
 Conclusions 4.5
This study has examined the case of VTs for OME which, although known to be 
“overused“ based on audits of care provided, also seem to be substantially 
“underused” at a population level in England based on NICE guidance. Because 
overuse and underuse may co-exist as sources of unwarranted variation, clinicians 
and managers should examine if all children who would be expected to benefit from 
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VTs for OME also have access to the procedure. The study is of one condition in 
England but raises an important general issue over using studies of medical practice 
variations to inform policies to reduce overuse and thus release resources to meet 
rising demand in times of austerity. To maximise benefits for patients within resource 
constraints, policies where medical practice varies ought to tackle overuse by 
auditing care that is provided, and underuse by assessing capacity to benefit in 
populations.  
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 Commentary in relation to the organising matrix of strategies 4.1
to address ambiguity about the standard for evaluation 
This Chapter has explored how policy-makers and managers might establish 
meaningful standards for evaluation with a technical-evidential approach. To this end, 
the Chapter has developed an epidemiological model to investigate overuse and 
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underuse in ventilation tube surgery for children with otitis media with effusion in 
England. The Chapter has shown that underuse and overuse may co-exist and that a 
more nuanced policy is required to increase appropriateness in the provision of 
ventilation tubes. 
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 Appendix 4.2
4.2.1 Appendix 4-A. Systematic literature review: Search strategy and data 
extraction 
A systematic literature review was carried out using the databases PubMed, DARE, 
Scopus, Web of Science and the Cochrane Library (timespan: all available years; 
restriction to studies in English language). After removing duplicates, 1302 studies 
were screened independently by the first and second authors based on pre-defined 
criteria. To be eligible, studies needed to (i) be population-based screening studies; 
(ii) have a prospective design; (iii) follow defined case finding and diagnostic 
methods; (iv) provide incidence rates by year of age; and (v) be conducted in Europe 
or North America. The detailed rationale for each criterion is stated in Appendix 4-B. 
Study selection was discussed among members of the research team, with the 
Project Steering Group and during a workshop with UK-based clinical and 
epidemiological experts. Those studies judged to be in line with the selection criteria 
were retained.  
Database Search criteria 
Number 
of results 
DARE 
(("otitis media with effusion" OR "glue ear" OR "non suppurative otitis media" OR 
"serous otitis media" OR "secretory otitis media" OR "middle ear effusion" OR 
"purulent otitis media with effusion")) AND (("prevalence" OR "incidence" OR 
"epidemiology" OR "occurrence")) AND (("child*" OR "kid*" OR "infan*")) 
15 
Cochrane 
library 
( "otitisQUOTESPACEmediaQUOTESPACEwithQUOTESPACEeffusion" OR 
"glueQUOTESPACEear" OR 
"nonQUOTESPACEsuppurativeQUOTESPACEotitisQUOTESPACEmedia" OR 
"serousQUOTESPACEotitisQUOTESPACEmedia" OR 
"secretoryQUOTESPACEotitisQUOTESPACEmedia" OR 
"middleQUOTESPACEearQUOTESPACEeffusion" OR 
"purulentQUOTESPACEotitisQUOTESPACEmediaQUOTESPACEwithQUOTESPACEe
ffusion" ) and ( "prevalence" OR "incidence" OR "epidemiology" OR "occurrence" ) 
and ( "child*" OR "kid*" OR "infan*" ) not ( 
"acuteQUOTESPACEotitisQUOTESPACEmedia" OR 
"recurrentQUOTESPACEacuteQUOTESPACEotitisQUOTESPACEmedia" ) not ( 
"adult*" ) NOT ( "animal*" ) NOT ( "cleftQUOTESPACEpalate" OR 
"down'sQUOTESPACEsyndrome" OR "downQUOTESPACEsyndrome" ) in Cochrane 
Database of Systematic Reviews" 
57 
Web of 
science 
 
Topic=(("otitis media with effusion" OR "glue ear" OR "non suppurative otitis 
media" OR "serous otitis media" OR "secretory otitis media" OR "middle ear 
effusion" OR "purulent otitis media with effusion")) AND Topic=("prevalence" OR 
"incidence" OR "epidemiology" OR "occurrence") AND Topic=(("child*" OR "kid*" 
OR "infan*")) NOT Topic=(("acute otitis media" OR "recurrent acute otitis 
635 
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Database Search criteria 
Number 
of results 
media”))NOT Topic=("adult*")NOT Topic=("animal*")NOT Topic=(("cleft palate" 
OR "down's syndrome" OR "down syndrome")) Refined by: Languages=( ENGLISH 
) AND [excluding] Subject Areas=( PHYSICS OR URBAN STUDIES OR PLANT 
SCIENCES OR HISTORY ) Timespan=All Years. Lemmatization=On    
PubMed 
(((((("otitis media with effusion"[All Fields] OR "glue ear"[All Fields] OR "non 
suppurative otitis media"[All Fields] OR "serous otitis media"[All Fields] OR 
"secretory otitis media"[All Fields] OR "middle ear effusion"[All Fields] OR (("otitis 
media, suppurative"[MeSH Terms] OR ("otitis"[All Fields] AND "media"[All Fields] 
AND "suppurative"[All Fields]) OR "suppurative otitis media"[All Fields] OR 
("purulent"[All Fields] AND "otitis"[All Fields] AND "media"[All Fields]) OR 
"purulent otitis media"[All Fields]) AND effusion[All Fields])) AND 
("prevalence"[All Fields] OR "incidence"[All Fields] OR "epidemiology"[All Fields] 
OR "occurrence"[All Fields])) AND ("child*"[All Fields] OR "kid*"[All Fields] OR 
"infan*"[All Fields])) NOT ("acute otitis media"[All Fields] OR "recurrent acute 
otitis media"[All Fields])) NOT "adult*"[All Fields]) NOT "animal*"[All Fields]) 
NOT ("cleft palate"[All Fields] OR "down's syndrome"[All Fields] OR "down 
syndrome"[All Fields]) AND ("humans"[MeSH Terms] AND English[lang]) 
538 
Scopus 
(ALL(("otitis media with effusion" OR "glue ear" OR "non suppurative otitis media" 
OR "serous otitis media" OR "secretory otitis media" OR "middle ear effusion" OR 
"purulent otitis media with effusion")) AND ALL(("prevalence" OR "incidence" OR 
"epidemiology" OR "occurrence")) AND ALL(("child*" OR "kid*" OR "infan*")) AND 
NOT ALL(("acute otitis media" OR "recurrent acute otitis media")) AND NOT 
ALL(("adult*")) AND NOT ALL(("animal*")) AND NOT ALL(("cleft palate" OR 
"down's syndrome" OR "down syndrome"))) AND (LIMIT-TO(LANGUAGE, 
"English")) AND (EXCLUDE(SUBJAREA, "AGRI") OR EXCLUDE(SUBJAREA, "PHYS")) 
947 
123 
 
4.2.2 Appendix 4-B. Study inclusion criteria   
Inclusion criteria Rationale Exclusion criteria 
(i) Population-
based screening 
study 
For valid estimates of incidence, the denominator 
should include all, or a representative sample of, 
individuals at risk.  
As regards hearing loss: most literature focuses on 
clinical populations which are likely to, on average, 
experience higher levels of hearing loss than 
children with OME in the general population. The 
model therefore uses epidemiological data on 
hearing loss from a community-based study (Sabo 
et al., 2003: 44).  
1) Utilisation-based studies (i.e. with the number of people actually visiting the 
doctor as the denominator): A single hospital or practice cannot usually be 
assumed to provide care for a well-defined population that is representative of a 
larger group (Fiellau-Nikolajsen, 1983). 
2) Trial-based studies: Results may be difficult to generalise to a general 
population setting if particular groups are over- or underrepresented. 
3) Studies with high-risk populations e.g. pre-term babies on intensive care units, 
exclusive focus on children in daycare. 
4) Clinical specialist populations (for estimating the proportion of hearing loss 
among all OME cases): If the denominator are children who have already been 
referred to ENT (Haggard, 2009, Fria et al., 1985, Ungkanont et al., 2010) this 
may either lead to overestimation (due to selectivity of more severe cases) or 
underestimation (due to bias in detection and presentation among parents and/ 
or gaps in referral from primary care). 
5) Self-report studies: As regards incidence and hearing loss, parents have been 
shown to be inaccurate in their judgments regarding the presence of hearing 
loss that may accompany an episode of OME (Rosenfeld et al., 1998). 
(ii) Prospective 
design 
OME often presents asymptomatically, which 
complicates retrospective diagnosis of OME. 
 
 
 
Retrospective designs (e.g. parent interviews or analysis of doctor consultations): 
These will substantially underestimate the true incidence of OME (Roland et al., 
1989) and are thus not a reliable case finding design for OME. 
124 
 
Inclusion criteria Rationale Exclusion criteria 
(iii) Case finding 
methods and 
diagnosis 
The recommended diagnostic algorithm for OME 
combines impedance audiometry (tympanometry) 
with pneumatic otoscopy (Rovers et al., 2004). 
OME is diagnosed when tympanometry reveals a 
flat curve (relative gradient less than 0.1, type B) or 
middle ear pressure between -399 to -200 daPa (C2 
curve), when the tympanic membrane has no or 
reduced mobility, or fluid or air bubbles are evident 
behind the ear drum (Simpson et al., 2007). 
Studies that do not provide correspondingly defined case finding and diagnostic 
methods. 
(iv) Stratified by 
year of age  
Incidence of OME is known to vary considerably by 
age (Zielhuis et al., 1990b). 
Studies that report only aggregate (e.g. five-year) rates since these are likely to 
obscure key variations in incidence across age groups. 
(v) Studies 
conducted in 
Europe or North 
America 
Incidence of OME may be influenced by climatic 
settings (Black, 1985a). 
Studies conducted in different climatic settings than England. 
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4.2.3 Appendix 4-C. Estimation of susceptible population 
For valid estimations of incident cases, children with prevalent OME at the beginning 
of the study period need to be subtracted from the total population to obtain an 
estimate of the susceptible population (i.e. the population at risk). This is because the 
denominator of the cumulative incidence is defined as the number of children at risk 
at beginning of the study period rather than the total population (Morgenstern et al., 
1980). Point prevalences are taken from population-based studies. The estimates are 
lower than those reported in a review by Zielhuis et al. (1990b) which may be due to 
the amalgamation of point and period prevalences (time frames over which 
prevalence was measured were not reported) in their review. 
 
j 
Age 
group 
Pj 
Point prevalence 
(%) 
 
Reference 
Nj 
Total population 
Sj = Nj-( Nj*Pj) 
Susceptible population 
2 10.61 
Tos 
(1984) 
667,185 596,423 
3 9.8 
Fiellau-
Nikolajsen 
(1983) 
640,232 577,489 
4 8.8 
Fiellau-
Nikolajsen 
(1983) 
620,326 565,737 
5 10 
Fiellau-
Nikolajsen 
(1983) 
606,770 546,093 
6 6.1 
Fiellau-
Nikolajsen 
(1983) 
598,725 562,203 
7 3.04 
Tos 
(1984) 
577,767 560,183 
8 1.11 
Tos 
(1984) 
560,460 554,233 
Source: Own calculation based on Office for National Statistics (2011) population data. 
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Abstract 
 
Background: The conventional approach to account for population needs in studies 
of geographic variation in healthcare is to standardise utilisation rates for variables 
associated with need (e.g. age, deprivation). However, this approach provides no 
benchmark of the extent to which actual utilisation meets the appropriate level of 
care. This paper examines the concept of population capacity to benefit (PCB) based 
on criteria of capacity to benefit from a particular intervention and their prevalence 
and incidence in the population of interest.  
 
Methods: Studies following the PCB approach were identified from a keyword search 
of the PubMed, Scopus, Web of Science and Cinahl databases. 
 
Results: 22 studies from the United Kingdom, Ireland, Canada and Australia were 
identified which estimated population requirements for hip and knee replacement, 
radiotherapy, coronary revascularisation, cataract surgery, dental care, 
prostatectomy, stroke care and ventilation tube surgery. Criteria of capacity to benefit 
were obtained from consensus panels, guidance endorsed by professional 
associations or Health Technology Assessment institutions. Fifteen studies 
extrapolated epidemiological information from other contexts but only six studies 
assessed the consequent uncertainty through sensitivity analysis. Estimated 
population benchmarks varied depending on the chosen criteria and threshold values 
for intervention and whether patient preferences where taken into account.  
 
Conclusion: Measuring PCB provides a theoretically sound complement to 
standardised rates but is unlikely to produce a single unambiguous “right rate“ of 
population need. Progress with evidence-based guidelines, population surveillance 
systems and better use of established methods to handle uncertainty create scope to 
overcome some of the hurdles faced by studies in the 1990s and 2000s. National 
agencies should consider developing population benchmarks for resource-intensive 
conditions and use these to support regional healthcare planning and surveillance.  
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 Introduction          5.1
Geographic variations in rates of hospital admission, surgical procedures and 
resource supply have been widely documented within countries in the form of 
national Atlases of Variation in England, Germany, Spain, the Netherlands, the United 
States and many other countries (Corallo et al., 2014) and in cross-national projects 
by ECHO (Bernal-Delgado et al., 2015) and the OECD (2014). These variations 
challenge the goal of many health systems in Europe to ensure equal opportunity of 
access for equal need. They are often interpreted as a signal of widespread overuse of 
unnecessary or even harmful care and underuse of effective care that fails to meet 
population needs (Appleby et al., 2011, OECD (Organisation for Economic Co-
operation and Development), 2014).  
 
The conventional method to account for population needs in analyses of variations is 
to standardise crude utilisation rates for variables shown to be associated with 
population need for care, such as age, sex and area-level deprivation. This is essential 
to enable fair comparisons between regions whose performance may differ due to 
factors that are outside the region’s control (Nicholl et al., 2013). For example, 
geographic variations in rates of hip replacement should be standardised at least by 
age, as regions with a higher proportion of older people would be expected to have a 
higher incidence of osteoarthritis and thus higher rates of need for joint replacement 
than regions with younger age distributions, ceteris paribus.  
 
This paper is motivated by the problem that such standardised rates can however not 
provide a benchmark of population need for healthcare, defined as the extent to 
which utilisation of a specific service exceeds or falls short of a level of care that is 
expected to be beneficial for a defined population. The directly age-standardised rate 
is the rate of utilisation in a region that would be expected if  that region had the same 
age structure as an (arbitrarily chosen) standard population (Breslow and Day, 
1987). This hypothetical estimate does not indicate the number of people with 
capacity to benefit from a particular intervention to gauge “how much” scope there is 
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for reducing or expanding service levels commensurate with region-specific needs for 
care.  
 
As Tversky and Kahneman (1991) have shown, a common psychological response is 
to anchor judgement on the reference points that are provided in a set of data. In the 
absence of a reference point for local need, research shows that health service 
managers are tempted to evaluate their region’s performance in relation to the 
national average as the reference point, inferring that an above-average position 
suggests “overuse“ while a below-average position suggests “underuse” (Schang et al., 
2014b). However, the average utilisation rate, adjusted for variables associated with 
need, has no normative justification as a benchmark of population need for care. 
There is also little empirical evidence that above-average intervention rates entail a 
higher proportion of ineffective care. A systematic review of studies of overuse in the 
United States (Keyhani et al., 2012) found that high and low use areas showed similar 
levels of inappropriate procedures. This problematises the comparative approach 
(Bradshaw, 1972) to inferring the degree to which actual utilisation meets population 
needs from the distribution of standardised utilisation rates. The lack of a normative 
benchmark of population needs therefore limits the usefulness of information on 
variations for healthcare planning (Mercuri et al., 2013). 
 
The aim of this paper is twofold: To define the concept of population capacity to 
benefit (PCB); and to examine its feasibility and usefulness to identify underuse or 
overuse relative to a population’s need for a specified intervention based on a review 
of empirical applications. The next section defines the PCB concept and delineates it 
from alternative conceptions of “need“. Subsequently, the methods and results of the 
literature review are presented. Finally, implications for policy are discussed.  
 Theoretical background  5.2
5.2.1 How to define “need for healthcare“?  
Epidemiology has traditionally focused on measuring the burden and distribution of 
disease in populations (Ezzati et al., 2004). The basis for ascribing a “need” to a 
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person is thus evidence of a poor initial health state (Hasman et al., 2006). However, 
not every need for health entails a need for healthcare (Culyer and Wagstaff, 1993). 
The magnitude of health deficits (i.e. gaps between actual and desired health status) 
is hence not equivalent to the level of health services required to improve population 
health (Culyer and Wagstaff, 1993, Wright et al., 1998, Mooney and Houston, 2004). 
This may be, firstly, because no effective interventions exist to prevent, cure or care 
for a health problem. Secondly, effective interventions that exist may fall outside the 
remit of health systems. For instance, policies to tackle inequalities in life expectancy 
between socio-economic groups may be found largely in employment and education 
sectors and in the physical and social environment (McQueen et al., 2012, 
Mackenbach, 2012). The definition of a “need for healthcare” thus requires the ability 
to address a health problem within the boundaries of the health system. 
 
In addition to comparatively defined need mentioned in the introduction, Bradshaw 
(1972) proposed three further types of need: felt need (wants, desires); expressed 
need (vocalised wants or use of services); and normative need (which is assessed in 
relation to a desirable standard). The first three types are problematic insofar as they 
risk confusing the concepts of need, preference and utilisation. The next paragraphs 
thus focus on normative standards of need for healthcare. Two fundamental 
challenges in their definition are reviewed: the choice of an underlying value basis 
and of the desired level of the standard. Against these considerations, a definition of 
need for healthcare in the context of unwarranted variation in healthcare utilisation 
is provided. 
 
A natural basis to define “need for healthcare” is the capacity to benefit from 
healthcare (Culyer and Wagstaff, 1993, Culyer, 1995, Stevens and Gillam, 1998). This 
view requires the availability of effective interventions which are likely to improve 
clinical outcomes (e.g. physical functioning) or quality of life (e.g. less pain and 
anxiety). Within the paradigm of evidence-based medicine, the guiding question is 
thus whether the balance between benefits and risks of an intervention is expected to 
produce a net benefit. As Hasman et al. (2006) point out, need for some healthcare 
intervention has to be expressed as a condition-intervention-pairing: that is, a health 
state (e.g. severe osteoarthritis with moderate pain and functional impairment) for 
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which a particular intervention (e.g. total hip replacement) is deemed to enable gains 
in health. 
 
A sole focus on effectiveness in defining need ignores however the potential for an 
inefficient use of limited resources (Cochrane, 1972, Acheson, 1978, Culyer, 1995, 
Mooney and Houston, 2004). Culyer (1995) defines need for healthcare therefore as 
“the minimum amount of resources required to exhaust a person’s capacity to 
benefit” (Culyer, 1995: 728). This health economic definition has two important 
implications and, arguably, advantages. First, if similar benefits can be achieved with 
medical intervention (e.g. a visit to the doctor) and without medical intervention (by 
patience and watchful waiting), then one cannot assert the presence of a “healthcare 
need”. This may be the case for many typically self-limiting conditions such as mild 
headaches and common colds. Second, an intervention cannot be said to be as 
“needed” as another intervention which is equally effective but requires less 
resources for its delivery (Culyer, 1995). Thus, while under a medical effectiveness 
paradigm one would be indifferent to the choice between a branded and a generic 
drug (with identical bioactive ingredients), under an economic evaluation paradigm 
the cheaper generic drug obviously dominates. 
 
Notably, Culyer’s definition implies a maximum level of capacity to benefit as the 
standard against which need is assessed: a “need” for services can be said to exist up 
to the point where capacity to benefit is exhausted. In reality, however, need for 
health or social care interventions may instead be defined in relation to an acceptable 
or “normal“ functioning range (Hasman et al., 2006: p.149f.). In the United Kingdom, 
for instance, Department of Health (1991) guidance defined need for care 
management as the “requirements of individuals to enable them to achieve, maintain 
or restore an acceptable [added emphasis] level of social independence or quality of 
life, as defined by particular care agency or authority” (p.12f.). Following this view, a 
funding agency may thus recognise a person’s need for physiotherapy premised on 
restoring the ability to participate in activities of daily living, but not necessarily a 
need for athletics training to prepare for the Olympics. 
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Clearly, not every healthcare need as defined by the prevalence of avoidable (by the 
health system) ill health must necessarily be funded by a public or private payer. 
Determining what is meant by “acceptable“ or “normal“ is a value judgement that may 
result in different conclusions in different societies. The range and intensity of health 
services that can be provided is inevitably constrained by the resources that are 
available and by how much a society or an individual is prepared to spend on 
healthcare rather than, say, education or pensions (Papanicolas and Smith, 2014). 
 
Extending Culyer’s definition to the population level, a population’s need for 
healthcare can be understood as the minimum amount of resources required to 
exhaust a population’s capacity to benefit. Population capacity to benefit 𝑃𝐶𝐵𝑖
𝑘 is 
defined here as the number of people in some population or region k with a specified 
condition-intervention pairing i which represents the capacity to benefit from some 
intervention given defined characteristics of the health state.  
 
For the purpose of evaluating the appropriateness of rates of utilisation against 
population need for specified interventions, this definition has several advantages: (i) 
it is derived from the fundamental objective of a health system to produce benefit in 
some form (defined depending on a society’s values e.g. in terms of potential gains in 
health or quality of life); (ii) it relates need for healthcare to the share of the 
distribution of ill health that is amenable to the range of available and cost-effective 
preventive, acute or chronic health services; and (iii) it provides a measure of need 
that is not contaminated by regional variations in the supply and demand for 
healthcare.  
 
5.2.2 Relationship between need as capacity to benefit, healthcare supply 
and demand 
As further discussed below and illustrated in Figure 5-1, it is worthwhile to highlight 
the relationship between need (as estimated by PCB), supply and demand for 
healthcare. PCB is not entirely independent of the supply of healthcare, in terms of 
the general stage of technological development. In particular, the presence of a 
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capacity to benefit requires the existence of a specific technology to treat the 
underlying condition. In turn, if new effective technologies are identified (or if 
existing technologies that were deemed effective are recognised to be ineffective 
based on new evidence), then PCB estimates will change. Thus, PCB is related to 
supply in the sense of a “general” existence of medical technologies to treat a 
condition. 
 
However, provided that some effective medical technology exists “at large” (e.g. in the 
form of a national guideline as produced by NICE that is applicable across the entire 
country), then the number of people with a capacity to benefit from this technology 
does not depend on the local degree of access to or availability of this technology. 
Suppose, for instance, that there are no orthopaedic surgeons on the Isle of Skye to 
provide hip replacements. Clearly, this does not necessarily mean that no island 
resident might benefit from hip replacements.  
 
The critical point for the purpose of this paper is that PCB estimates are independent 
of regional variations in levels of supply. This is important because, while regional 
levels of utilisation may depend to some extent on regional levels of supply, regional 
levels of medical need (as defined by the capacity to benefit) are not influenced by 
regional levels of supply (health professionals and capacity e.g. in terms of hospital 
beds). 
 
Similarly, while levels of utilisation will certainly depend on levels of demand (in 
particular patient preferences for particular interventions), capacity to benefit is, in 
my view, a technical concept that requires no information on preferences. For 
instance, in order to state that some person has a capacity to benefit from hip 
replacement, one might require certain information on medical parameters (e.g. type 
and severity of osteoarthritis) as well as on quality of life (e.g. degree of pain as 
experienced by an individual). However, one does not require information on 
whether the individual “wants” a hip replacement. Such information on patient 
preferences is clearly essential for the decision to provide the intervention. It is 
irrelevant, however, for the judgment as to whether a “capacity to benefit” exists.  
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5.2.3 Capacity to benefit in populations: measurement and interpretation 
To use estimates of PCB as a benchmark to identify unwarranted variation in 
healthcare, one faces three sets of problems: 
1. Defining the condition-intervention pairing i in terms of measurable criteria of 
capacity to benefit from a specific intervention;  
2. Estimating the number of new (incident) cases of i in a general population or 
region k that meet these criteria over a specified time interval (e.g. one year); and 
3. Comparing the PCB estimate with actual utilisation over the same time period. 
 
Each of these problems is characterised by measurement uncertainties. The first 
problem, increasingly the realm of Health Technology Assessment (HTA) agencies in 
many countries (Sorenson et al., 2008), requires criteria which accurately and 
reliably predict improvements in clinical outcomes or quality of life. The second 
problem requires epidemiological methods. In England, health authorities have since 
1990 been mandated to assess the health and care needs of their local populations to 
inform priorities for improving population health (Wright et al., 1998). This has led to 
a field of health services research termed the epidemiology of indications (Frankel, 
1991) which consists of identifying the prevalence and incidence of “cases of the 
condition where treatment would be indicated, tolerated, and desired by the 
particular sufferer, and also approved of in general as a proper use of the health 
budget” (Frankel, 1991: 258). Early on, however, it was pointed out that clinical 
uncertainty about outcomes, heterogeneity among patients in valuing these 
outcomes,5 and effort in conducting high-quality epidemiological studies would likely 
limit the routine use of epidemiologically based needs assessment for healthcare 
planning and purchasing (McKee and Clarke, 1995, McKee, 1996).  
 
                                                                    
5 Even if one can predict with some certainty the probability of an outcome for an individual, each 
outcome may be valued differently. For example, two 65 year-old men with osteoarthritis facing a 
choice between hip replacement and continued pharmacological treatment who are fully informed 
about the benefits and risks of each potential outcome may choose differently because they place 
different values on each outcome.   
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If a credible approximation of PCB is possible, one finally requires reasonably 
complete and accurate data on utilisation. The needs-utilisation comparison could 
then be interpreted as follows: 
 If utilisation exceeds the PCB estimate, then this suggests overuse at the 
population level. 
 If utilisation falls short of PCB, this suggests underuse of beneficial care. 
 If utilisation and PCB are roughly equal, this suggests needs-based care.  
 
For each of the three scenarios above, however, two additional factors are required in 
order to assess the degree of “overuse” or “underuse” in a system. The first factor is 
the appropriateness of clinical indications for care that has actually been provided. 
Audits of service utilisation are therefore necessary to ensure that overprovision to 
people for whom the intervention is not effective is not masked by simultaneous 
unmet need among those who would benefit (Schang et al., 2014a).  
 
The second factor is patient preference. Unwarranted variation in healthcare 
utilisation – manifest in the form of either overuse or underuse – is defined as that 
part of variation that is not explained by population needs or patient preference 
(Wennberg, 2010). The PCB concept provides a normative measure of population 
need for defined interventions. It indicates the range and intensity of services a health 
system would be expected to offer to patients if evidence-based criteria of capacity to 
benefit were being applied (Schang et al., 2014a). Where individuals may place 
different values on the same outcome and the best choice of treatment is thus 
sensitive to patient preferences (Wennberg, 2010, Weinstein et al., 2007), it is not 
desirable to interpret this normative measure of population need as being equivalent 
to the “right (treatment) rate”. The PCB estimate exceeds the appropriate rate of 
intervention by that margin of patients who, if eligible, make an informed choice for 
another option of treatment (including no treatment). Figure 5-1 depicts the 
relationships between the concepts of PCB, patient preference and utilisation and the 
resulting interpretations of underuse and overuse of defined interventions. 
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The aim of this literature review is to take stock of empirical studies that apply the 
PCB approach, guided by the following question: Can estimates of capacity to benefit 
in populations become a feasible and useful benchmark to quantify the discrepancy 
between actual utilisation and population need for a defined intervention?  
 
 
Figure 5-1 Relationship between population capacity to benefit, patient 
preference and service utilisation 
 
 
Legend:  
A + B = Population benchmark for appropriate utilisation (‘right treatment rate’): The 
intervention was clinically indicated and wanted. 
A = Actual utilisation that was appropriate (the intersection of need, preference and 
utilisation): The intervention was clinically indicated, wanted and provided. 
B  = Underuse: The intervention was clinically indicated and wanted, but not provided. 
C = Overuse: The intervention was clinically indicated and provided, but not wanted. 
D = Overuse: The intervention was wanted and provided, but not clinically indicated. 
E = Overuse: The intervention was provided, but neither clinically indicated nor wanted. 
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5.2.4 Comparison of the PCB concept with conventional needs indices and 
standardised utilisation measures 
 
In the literature, various indices have been published to estimate need for health care 
for populations. One well-known example are the needs indices as they have been 
used in the National Health Service (NHS) in England in order to allocate resources to 
small areas (Carr-Hill et al., 1994, Sutton et al., 2002, Morris et al., 2007, PBRA Team, 
2009). 
 
The core feature that distinguishes the PCB measure from such indices is that it starts 
from explicit criteria of capacity to benefit. Conventional needs indices (e.g. Glover et 
al., 2004) are estimated by means of regression models where, firstly, a proxy 
measure of “need for care” in a population (e.g. admission rates, expenditure per 
patient in region k) is chosen. Secondly, the model seeks to explain variance across 
regions in the magnitude of this measure through a range of predictor variables (e.g. 
regional rates of long-term illness, deprivation etc.). Finally, expected rates of the 
chosen proxy measure of “need” for health care are produced for each region.  
 
One of the key problems with this approach is that it does not account for whether 
rates of the chosen proxy measure of “need for care” in a population (e.g. admission 
rates, expenditure per patient in region k) was actually “needed” in terms of whether 
there was a capacity to benefit from care. The PCB measure, in contrast, starts from a 
set of criteria of capacity to benefit. These criteria are ideally derived from high-
quality medical evidence about the effectiveness and safety about a particular 
procedure that has been shown to improve specified patient outcomes. The task is 
then to estimate the epidemiological prevalence of these criteria in a population. 
 
The PCB concept differs from conventional needs indices and standardised utilisation 
measures also in a number of other ways. These differences are summarised in Table 
5-1. 
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Table 5-1 Comparison of the PCB concept with conventional needs indices and 
standardisation of utilisation rates 
 Standardisation Population Capacity to 
Benefit 
Needs indices  
Purpose Performance 
measurement: Adjustment 
for causes of regional 
variations that are not 
attributable to differences in 
health system performance  
Performance 
measurement: 
Benchmark for the region-
specific need for services 
Resource allocation to 
small areas and/or 
providers responsible for 
populations (e.g. general 
practice populations) 
Scope Single procedure or whole 
system 
Single procedure (which 
can be linked to a concrete 
capacity to benefit) 
Typically whole system: 
general need for services 
across the totality of 
procedures and sectors of 
care 
Nature of the 
standard 
An arbitrarily chosen 
standard population (e.g. the 
national average) 
The (absolute) numbers of 
people who would benefit 
from an intervention 
A proxy measure of 
„need“ for services (e.g. 
expenditure or rates of 
admission) 
Guiding 
question(s) 
Which rate of interventions 
can be expected if region k 
had the same [age-, 
morbidity-etc] distribution 
as the standard population? 
How many people in 
region k have a ‘capacity to 
benefit’ from intervention i 
? 
Which „legitimate“ 
predictors of „need“ (e.g. 
age, deprivation) explain 
variations in the proxy 
measure of need, after 
adjusting for supply? 
Model Standardised utilisation = 
(utilisation in region k, 
utilisation in the standard 
population) 
𝑃𝐶𝐵𝑖
𝑘 = (criteria of 
capacity to benefit, 
population) 
Expenditure = (need 
factors, supply factors, 
other variables) 
Nature of 
variables 
included in 
the model 
No variables are required 
apart from a simple 
standardisation variable 
(usually age and/or sex) 
Variables represent 
criteria of capacity to 
benefit. These criteria are 
derived from existing 
clinical guidelines and/or 
HTA evidence. 
Variables that explain a 
specified amount of the 
variance in the proxy 
measure of “need” 
and/or meet other 
criteria are retained. 
Challenges No benchmark for the 
region-specific need for 
services 
Availability of criteria of 
capacity to benefit and 
epidemiological data  
Interpretation: 
Service use < PCB  
Suggests underuse 
Service use > PCB  
Suggests overuse 
Service use ≈ PCB   
Assess appropriateness of 
clinical indications of care 
provided 
No direct relationship to 
the capacity to benefit 
from services  
The chosen proxy 
variable of need (e.g. 
expenditure, admission 
rates) may be 
confounded by local 
supply and other factors: 
Disentangling the effects 
of needs factors 
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 Methods           5.3
The PubMed/Medline, Scopus, Web of Science and Cinahl databases were searched 
using logical combinations (with the Boolean operator “AND”) of the following search 
terms:  “capacity to benefit” AND population; “healthcare needs assessment”; “needs 
assessment” AND “healthcare need”; “Population requirement”; “Healthcare 
requirement”; normative AND “treatment rate”; “needs assessment” AND healthcare 
AND population AND criteri*; “needs assessment” AND healthcare AND population 
AND indication. 
The review included empirical studies published between January 1990 and 2015 
that:  
(i) defined criteria of capacity to benefit from a specific intervention; and  
(ii) applied these criteria to estimate their prevalence or incidence in a defined 
general population.  
 
Studies which assessed morbidity only or sought to identify treatment needs among 
patients in healthcare settings were thus excluded. 
 
January 1990 was chosen as a cut-off date for two reasons. First, in 1990, the National 
Health Service Act in the United Kingdom (UK) for the first time in the UK and 
internationally mandated health authorities in the UK to assess the health and care 
needs of their populations (Wright et al., 1998). This year hence marks an important 
policy development likely to inspire research on this topic. Second, considering the 
advances in the development of HTA guidelines and epidemiological methods during 
the 1990s, earlier studies were deemed to be of less relevance to a present context. 
 
The framework for data extraction focused on the basis for criteria of capacity to 
benefit; methods of epidemiological assessment; and any comparisons with actual 
utilisation. Within these categories, relevant sub-categories were developed from 
repeated reading and comparison of the identified PCB studies. 
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 Results             5.4
22 studies published between 1995 and 2014 reported the results of empirical 
studies of population capacity to benefit (Figure 5-2). Table 5-2 shows the clinical 
areas covered and the countries of origin. The reporting of results (Tables 5-3 to 5-5) 
follows the framework for data extraction. 
 
 
 
Figure 5-2 Literature review process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Records identified 
through database 
searching 
(n = 1109) 
Records identified 
through manual search of 
references 
(n = 4) 
Abstracts screened 
after duplicates 
removed  
(n = 411) 
 
Records excluded 
(n = 379) 
Full-text articles 
assessed for eligibility 
(n = 32) 
Excluded with reasons: 
- No empirical study  
(n = 6) 
- Need for treatment 
was a static model 
input, not the 
quantity to be 
estimated (n=4) Studies included in 
qualitative synthesis 
(n = 22) 
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Table 5-2 Focus and origin of studies 
   
CLINICAL AREA  INTERVENTION  STUDY  
Osteoarthritis                                           
 hip/ knee replacement 
8 Tennant et al. (1995); Fear et al. (1997); Frankel et al. 
(1999); Hawker et al. (2001); Jüni et al. (2003); Milner 
et al. (2004); Yong et al. (2004); Judge et al.  (2009) 
Cancer (various sites)                          
 radiotherapy 
6 Tyldesley et al. (2001); Foroudi et al. (2003); Delaney 
et al. (2005); Usmani  et al. (2005); Jacob et al. (2010); 
Fong et al. (2012)  
Urinary symptoms                              
 prostatectomy 
2 Sanderson et al. (1997); Treagust et al. (2001) 
Cataract                                                       
 cataract surgery 
1 Frost et al. (2001) 
Coronary artery disease                   
 revascularisation 
1 Martin et al. (2002) 
Dental disease                                      
 extractions, dentures, 
restorations 
1 Guiney et al. (2012) 
Stroke                                                               
 preventive, acute,  
rehabilitative services 
1 Hunter et al. (2004) 
Stroke                                                            
 carotid endarterectomy 
1 Ferris et al. (1998) 
Otitis media with effusion               
 ventilation tube surgery  
1 Schang et al. (2014a) 
   
COUNTRY  STUDY BY FIRST AUTHOR 
United Kingdom 13 Frankel Frost Schang Jüni Judge Tennant Treagust 
Sanderson Martin Ferris Milner Fear Yong 
Canada 5 Hawker  Hunter Usmani Foroudi Tyldesley  
Ireland  1 Guiney 
Australia 2 Delaney Jacob 
Cross-national: Australia, 
Canada, Scotland 
1 Fong 
 
 
5.4.1 Defining criteria of capacity to benefit  
Studies from the 1990s and early 2000s struggled with the lack of agreed criteria to 
predict patient benefit from an intervention. Three studies sought to address this by 
using clinical consensus panels (Table 5-3). For instance, Martin et al. (2003) asked 
panellists to rate the likelihood of benefit for different indications for coronary 
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revascularisation based on a nine-point scale in relation to existing trial evidence. 
Nine studies used multi-dimensional composite indices such as the New Zealand 
score which ranges from 0 to 100 and summarises subscores representing degree 
and occurrence of pain experienced by patients, functional limitations, movement and 
deformity, and threats to independent daily living. Eight studies relied on guidelines 
published by professional associations. Two of these included as an additional 
criterion the judgement by clinical examiners conducting the assessment that the 
individual in front of them would likely benefit. Only the two most recent studies 
from 2012 and 2014 (Fong et al., 2012, Schang et al., 2014a) applied criteria of 
appropriateness recommended by an independent HTA institute, the National 
Institute for Health and Care Excellence (NICE) in England.  
 
The criteria of capacity to benefit differed between studies for a given clinical area 
and in part evolved over time. For example, while earlier studies excluded individuals 
with co-morbidities from hip replacement, a more recent study by Judge et al. (2009) 
argued that progress in modern anaesthesia and surgical techniques enabled these 
individuals to in principle benefit from surgery as well. 
 
Due to uncertainty about the “correct” criteria of capacity to benefit, six studies 
undertook sensitivity analyses to examine the impact of different model assumptions 
on the results. One of these studies (Sanderson et al., 1997) applied alternative sets of 
criteria. Among five criteria used to define need for prostatectomy (history of 
retention, comorbidity, symptom type, symptom severity and symptom 
bothersomeness), the authors examined the impact of excluding “symptom 
bothersomeness“ from the list of criteria. Due to uncertainty about the threshold for 
intervention on a given criterion, six studies applied a range of plausible values. For 
instance, as no agreed threshold values existed for the New Zealand score, Frankel et 
al. (1999) chose cut-offs of 43 and 55 points to reflect moderate and severe disease, 
respectively.  
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5.4.2 Estimating the number of incident or prevalent cases  
Only seven studies empirically assessed treatment needs directly in the population 
under study. The rest extrapolated epidemiological information from other 
populations (Table 5-4). For instance, Frost et al. (2001) assessed population 
requirements for cataract surgery in the Avon and Somerset region in England and 
then applied age-sex-specific rates of need to the national level. Ferris et al. (1998) 
applied age-sex-specific rates of ischaemic stroke incidence from the Oxford 
community stroke project and a set of conditional probabilities that would indicate 
the subgroup of people with capacity to benefit from carotid endarterectomy (e.g. the 
proportion of strokes with stenosis given that they are in the carotid territory) to 
estimate district-level rates of need in the former Wessex Regional Health Authority 
area.  
 
The  variables used to extrapolate model parameters or estimated rates of need were 
limited to age and sex in all studies, with one exception: Judge et al. (2009) employed 
a nationally representative survey to identify predictors of need for hip replacement, 
as measured by a modified version of the New Zealand score. Statistically significant 
predictors (age, sex, Index of Deprivation quintiles, rurality and ethnic mix of the 
area) were then replicated in local census data to predict need for hip replacement 
surgery at district level in England. For some significant predictors of need (obesity, 
an individual’s social class), however, no identically defined variables were available 
at district level, thus limiting the use of a more comprehensive set of predictors of 
need.  
 
Five of the fifteen studies that did not assess needs directly performed sensitivity 
analyses to estimate the impact of consequent uncertainty. Methods included using a 
range of highest and lowest plausible estimates, Bayesian simulation and Monte Carlo 
simulation to arrive at credible intervals of population need. 
 
Fifteen studies estimated incident requirements of need for an intervention (the rest 
assessed prevalent need only). Ten of these used longitudinal data from cohort 
studies or registries. Five studies converted prevalence rates obtained from cross-
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sectional studies into incidence rates, using cohort simulation (Sanderson et al., 
1997) or mathematical models of the relationship between incidence and prevalence 
(e.g. Frankel et al. 1999).  
 
All studies used data primarily from the general population, by means of population-
based screening studies, population registries or surveillance systems, national or 
local surveys. Based on either full population coverage or a stratified random sample, 
estimated incidence or prevalence rates were intended to be representative of the 
general population’s age and sex distribution. The national survey used by Guiney et 
al. (2012) was also representative in terms of means-tested income. However, 
response rates of less than 100% with the possibility of data missing not at random 
created a potential threat to the representativeness of the sample. Most studies 
discussed the socio-demographic representativeness of the sample and possible 
sources of bias due to over- or underrepresentation of some population groups. One 
study (Jüni et al., 2003) imputed New Zealand (NZ) scores (which were used as the 
criterion of capacity to benefit from knee replacement) for participants with 
incomplete data. This means that each missing NZ score was replaced by a predicted 
score. The predicted score was obtained from a linear regression model which 
estimated the final NZ scores among participants with complete data from the NZ 
subscores on disability, pain, ability to live independently and multiple joint disease 
as predictor variables. To mitigate distortions in estimates of population need for 
knee replacement, calculations then included both the reported scores of participants 
with complete data and the predicted scores of participants with incomplete data. 
 
In the absence of population data for some model parameters, eight studies relied on 
utilisation data. For instance, Martin et al. (2002) extrapolated the incidence of 
unstable angina from hospital admission rates, assuming a 100% referral rate.  
5.4.3 Comparing estimates of need and utilisation 
Eleven studies compared estimates of incident need with actual utilisation (the rest 
estimated need only; examined the prevalent “backlog“ of need in the system; or 
examined primary and specialist consultations among the population with capacity to 
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benefit from an intervention; Table 5-5). Where guidelines recommended the 
intervention as one option among others, eight studies sought to adjust for patient 
preferences in determining the appropriate level of utilisation. These studies focused 
on classic preference-sensitive conditions (Wennberg, 2010) including hip or knee 
replacement, prostatectomy and radiotherapy. Five studies, which were based on 
primary survey data, asked participants about their willingness to receive the 
intervention if eligible. Two studies applied proportions of women preferring 
radiotherapy over mastectomy or breast conserving surgery from previously 
published Canadian research to the authors’ Australian study context. One study 
adjusted for the proportion of eligible patients who had actually refused surgery as 
recorded in the same cancer registry that was also used to estimate the number of 
incident cases. 
 
If one were to allow for a margin of error of 20% (chosen here merely for illustrative 
purposes), then the studies show a range of findings where the PCB estimate exceeds, 
falls short of or is roughly equal to the actual utilisation rate. Some studies fall in 
more than one category for different sets of modelling assumptions. For instance, 
Frankel et al. (1999) found an excess of 12% to 49% in incident indications for 
primary hip replacement (for a New Zealand score of 55 vs 43, respectively) over 
annual rates of surgery in England. However, adjusting for estimates of patient 
willingness to undergo surgery reduced the estimated excess of potential need over 
actual utilisation to 3% and 11%, respectively. Considerable reductions in estimated 
levels of population need following an adjustment for patient preference were also 
found by Hawker et al. (2001) for arthroplasty and Sanderson et al. (1997) for 
prostatectomy. 
 
Hunter et al. (2004), the only study that modelled the entire spectrum of preventive, 
diagnostic, acute and rehabilitative services for stroke, found a potential underuse of 
prevention programmes alongside apparent overuse of carotid endarterectomy for 
acute stroke and a close match between need and utilisation of pharmacological 
treatment for hypertension (a risk factor for stroke) in Ontario, Canada. 
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Table 5-3 Defining criteria of capacity to benefit 
2.1 BASIS FOR CRITERIA OF CAPACITY TO BENEFIT STUDY BY FIRST AUTHOR 
Evidence-based guidance developed by an 
independent HTA agency 
2 
 
Fong* Schang  
 
Guidance endorsed by professional associations or 
national clinical networks 
8 Delaney Ferris Fong* Foroudi 
Guiney* Hunter Jacob 
Treagust* Tyldesley  
Additive composite indices related to osteoarthritis 
(New Zealand Score, WOMAC, Lequesne index) or 
urinary symptoms (North West Thames Symptom 
Index) 
9 Fear Frankel Hawker Judge 
Jüni Tennant Sanderson* 
Milner Yong 
Threshold levels chosen to reflect moderate and 
severe disease (modelling assumption) 
8 Fear Frankel Judge Jüni Milner 
Tennant Sanderson Yong 
Threshold levels derived from current practice 
to reflect severe disease 
1 Hawker 
Clinical panel rating the appropriateness of 
intervention for individual patients, in relation 
to existing trial evidence  
3 Martin Usmani Sanderson* 
Judgement by clinical examiners conducting the 
epidemiological assessment that individual would 
likely benefit  
2 Guiney* Treagust* 
Not specified in the paper 1 Frost 
 
2.2 SENSITIVITY ANALYSIS  
 
6 
Use of alternative sets of  criteria 1 Sanderson  
Use of different threshold levels  6 Frankel Frost Judge Jüni 
Martin Sanderson  
* Study falls into more than one category.
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 Table 5-4 Epidemiological assessment 
3.1 OVERALL STUDY DESIGN STUDY BY FIRST AUTHOR 
Needs assessment within the 
population under study 
7 Fear Hawker Guiney Milner Tennant Treagust 
Yong  
Extrapolation  15  
Of estimated rates of need: Age-
sex-specific population requirements 
were assessed directly in a local 
population and then extrapolated to 
the national level 
2 Frankel Frost  
Of model parameters:    
Age-sex-specific rates of disease 
incidence and conditional 
probabilities defining the group 
with capacity to benefit from 
treatment were taken from other 
populations 
12 Delaney Ferris Fong Foroudi Hunter Martin 
Jacob Jüni Schang Sanderson Tyldesley Usmani  
Multiple predictors of need for 
hip replacement were estimated 
using a nationally representative 
survey, then replicated at district 
level using census data 
1 Judge 
 
3.2 SENSITIVITY ANALYSIS IN STUDIES USING EXTRAPOLATED DATA  
Deterministic scenario or multiway 
sensitivity analysis using a range of 
highest and lowest relevant estimates 
3 Foroudi Sanderson Usmani  
Bayesian simulation to estimate 
credible intervals for small-area 
predictions of need for hip 
replacement 
1 Judge 
Monte Carlo simulation of joint 
uncertainty in parameter estimates 
2 Delaney Schang  
 
3.3 CASE ASCERTAINMENT IN ORIGINAL DATA SOURCE 
General population study (stratified random sample or full population coverage):  
A. Clinical screening of all people in 
defined age groups or of an age-
stratified random sample living in an 
area 
1 Schang 
B. Mandatory population registry or 9 Delaney Fong Foroudi Jacob Tyldesley Usmani 
148 
 
surveillance system (notifiable cancers, 
stroke, myocardial infarction)  
Ferris Hunter* Martin*   
C. Nationally representative survey: 
self-reported risk factors, symptoms, 
co-morbidities 
2 Hunter* Judge 
D. Nationally representative survey: 
standardised interview and clinical 
assessment 
1 Guiney 
E. Locally representative survey: self-
reported symptoms followed by 
targeted clinical assessment (e.g. of  
people reporting pain in their hip) 
5 Frankel Frost Hawker Jüni Treagust  
G. Locally representative survey: self-
reported symptoms only 
6 Fear Milner Sanderson Tennant Treagust  Yong 
 
Some parameters estimated from  
H. General practice statistics (incidence 
of stable angina) 
 
7 
1 
 
 
Martin*  
I. Hospital admission rates (incidence 
of unstable angina) 
1 Martin* 
J. Hospital-based registries (incidence 
of cancer sub-groups) 
5 Delaney Fong Jacob Tyldesley Usmani  
Foroudi 
 
3.4 TIME INTERVAL STUDIED  
A. Incident need in a population 14  
A.1 Data from prospective cohort 
studies or disease registries 
10 Delaney Ferris Foroudi Fong Hunter Jacob 
Martin Schang Usmani Tyldesley  
A.2 Data from cross-sectional 
studies, with prevalence  converted 
into incidence rates using a cohort 
simulation or the method by Leske 
et al. (1981) 
4 Frankel Jüni Judge Sanderson  
B. Prevalent need in a population 
(cross-sectional assessment only)  
8 Fear Frost Guiney Hawker Milner Tennant 
Treagust Yong 
 
3.5 REPRESENTATIVENESS OF THE ORIGINAL DATA SOURCE/ TREATMENT OF MISSING 
DATA 
 
Study or original data source (for studies 
using extrapolated data) reported on 
demographic characteristics of the 
sample and response rates. 
22 All studies 
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A. Authors did not comment on 
threats to representativeness. 
3 Ferris Hunter Martin  
B. Authors (or the original studies 
they used) concluded the sample was 
sufficiently representative of the 
general population studied in terms 
of age and sex distribution. 
10 Delaney Fear Frost Guiney Jacob Judge Milner 
Tennant Schang Yong 
C. Authors provided a qualitative 
discussion of areas where the sample 
was under- or overrepresenting 
particular groups and the likely 
impacts on the results. 
8 Fong Foroudi Frankel Hawker Sanderson 
Treagust Tyldesley Usmani  
D. Authors performed a quantitative 
correction using imputation to 
account for individuals with 
incomplete data. 
1 Jüni 
* Study falls into more than one category. 
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Table 5-5 PCB-use comparison 
4.1 ADJUSTMENT FOR PATIENT PREFERENCES  8      STUDY BY FIRST AUTHOR 
Based on self-reported willingness to 
undergo the procedure (hip or knee 
replacement, prostatectomy, cataract 
surgery) among patients surveyed by the 
study authors 
5 Frankel Frost Hawker Jüni 
Sanderson 
Based on a retrospective application of an 
estimate of the proportion of women willing 
to undergo radiotherapy rather than 
mastectomy or breast conserving surgery 
from published research 
2 Fong Tyldesley 
Based on the number of patients who were 
actually offered and refused the procedure 
(radiotherapy) in a clinical setting as 
recorded in a population cancer registry 
1 Usmani 
 
4.2 FINDINGS 
   
Incident need to actual utilisation   11  
PCB > actual utilisation by 20 % or more 10 Delaney Ferris* Fong Guiney 
Jacob Martin Schang 
Frankel* Jüni Hunter*  
PCB < actual utilisation by 20 % or more 2 Hunter*  Jacob*  
PCB ≈ actual utilisation  within a margin of 
less than 20% 
 
2 Ferris* Frankel* Hunter*   
Prevalent need to actual utilisation  4  
Potential “backlog“: prevalent PCB > annual 
number leaving the prevalence pool through 
operation or death 
 
 Frost Hawker Milner Yong 
Incident and/or prevalent need and health 
service use other than the intervention for 
which need was assessed 
5  
Patients were asked if they saw a general 
practitioner and/or specialist this year 
 
 Fear Jüni Milner Tennant 
Yong 
Estimation of prevalent or incident need only 6 Foroudi Judge  Sanderson 
Treagust Tyldesley Usmani  
* Study falls into more than one category. 
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5.4.4 Comparing estimates of need and age-standardised rates: example 
for otitis media 
Figure 5-3 illustrates the insights to be gained from estimating PCB over conventional 
age-standardised rates alone. The data come from a study by the author which sought 
to estimate the number of children with capacity to benefit from ventilation tubes 
(VTs) for otitis media with effusion (OME) in England if intervention criteria 
recommended by NICE were being followed (Schang et al., 2014a). VTs are widely 
thought to be overused (Audit Commission, 2011) and clinical audits confirm that a 
large proportion of VTs are not provided in compliance with NICE criteria (Daniel et 
al., 2013). The study however found that, at the same time, there appeared to exist a 
potential net underuse of VTs at the population level, meaning that children who had 
a capacity to benefit from VTs (as defined by NICE criteria) were not treated.  
 
The y-axis shows the comparative utilisation figure (CUF), which is calculated by 
dividing the directly age-standardised rate of VT surgery of each of the 151 Primary 
Care Trusts (PCTs) by the national average as the standard population. Given their 
age composition, PCTs with a CUF of “1” thus have a comparable rate of VT surgery as 
the national average. The x-axis shows the difference between observed rates of VT 
surgery and expected capacity to benefit from VTs for each PCT population (see 
Appendix 5-A for the calculations and Schang et al. (2014a) for details of the 
underlying methods). PCTs in Quadrants I and II exhibit a deficit in relation to their 
local population’s capacity to benefit, suggesting underuse. PCTs in Quadrant III 
display an excess of VTs over the local estimate of need, indicating net overuse.6 
 
The positive correlation between the CUFs and the magnitude of the need-utilisation 
gaps (r = 0.693; p < 0.001) suggests that PCTs with a low age-standardised rate of VT 
insertions are also likely to have a larger need-utilisation gap. If the PCB model 
provides a valid estimate of population need, then this finding is reassuring because it 
implies that, in this particular case, standardised utilisation rates and the 
independent measure of population need point into the same direction. However, 
there are two important caveats. First, for reasons discussed in Schang et al. (2014a), 
                                                                    
6 Note: here only the mean estimates are shown for illustrative purposes. 
152 
 
age was used as the sole predictor of regional incidence of OME. This is a limitation of 
the PCB model because it means that other potential risk factors for OME were not 
taken into account. The consequent uncertainty was, however, examined through 
Monte Carlo simulation. Second, even though the PCB model is imperfect, it does 
provide additional information. PCTs in Quadrant II are above the national average 
(based on which one might be tempted to suspect overuse), but the PCT-specific 
estimate of capacity to benefit nonetheless suggests net underuse at a population 
level. While the CUFs might lead one to focus solely on the vertical distribution of top 
and bottom outliers, the model of need reframes the reference point for identifying 
overuse and underuse and shows that even in PCTs which are close to the national 
average there may be a gap between utilisation and need. 
 
Figure 5-3 Comparative utilisation figures and estimated need-utilisation gaps 
by Primary Care Trust, England, four-year average 2007-2010 
 
  
Legend: 
y-axis: Directly age-standardised rate of ventilation tube insertions for OME divided by the England 
national average as the standard population. 
x-axis: Locally-specific difference between the rate of ventilation tube insertions to expected  
population capacity to benefit (PCB) at Primary Care Trust level, per 10,000 children aged 2-8 years. 
Source: author’s work based on the methodology described in Schang et al. (2014a). 
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5.4.5 Practical relevance for health service planning: comparing PCB with 
a “simple“ model of need 
PCB models require considerable information which must be collected from the 
literature or from other data sources. This raises the question whether estimating a 
full PCB model adds sufficient value and gains in information to aid decision-making, 
or whether a “simple“ needs index might also be adequate. 
 
Figure 5-4 provides a comparison of estimated need-utilisation gaps based on the 
PCB in comparison to a “simple“ needs model. This “simple“ needs model is 
essentially based on the age- and region-specific incidence of OME which persists five 
months after the initial onset (Appendix 5-1). In other words, this model does not 
account for the additional criteria of benefit specified by NICE guidance and their 
epidemiological distribution in a specific population (hearing loss at a specified 
threshold level and bilateralism of the disease). 
 
As Figure 5-4 shows, both models of need are strongly correlated (r = 0.964; p < 
0.001). This is not surprising since the full PCB model includes all the parameters of 
the simple model but, in addition, accounts for the distribution of hearing loss at a 
specified threshold level and bilateralism of the disease. The probability distributions 
assigned to these two parameters (further explained in Chapter 4, Table 4-2) have a 
narrow spread, large emphasis on the mean estimate and are assumed to be identical 
for all regions considered here. This means that the additional two parameters act, 
essentially, as a scaling factor. 
 
The comparison of the two models shows that “simple“ model of need will grossly 
overestimate the number of people with a capacity to benefit from VTs for OME. 
While the mean utilisation-needs gap across all PCTs for the full PCB model is 
estimated to be about -35 (indicating that 35 per 10,000 children in an average PCT 
would have benefitted from VTs but did not receive them), this gap is -535 for the 
“simple“ needs model. Thus, the “simple“ needs model overestimates considerably 
the number of children in “need“ of VTs for OME by a factor of more than 15-fold. 
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The critical contribution of the additional two parameters included in the PCB model 
is, therefore, to help narrow down the population capacity to benefit. For health 
service planning, such information is essential since the “simple“ model of need 
appears to produce blatantly unrealistic estimates. 
 
Figure 5-4 Estimated need-utilisation gaps based on the PCB in comparison to a 
“simple“ needs model, by Primary Care Trust, England, four-year average 2007-
2010 
 
 
  
Legend: 
y-axis: Locally-specific difference between the rate of ventilation tube insertions to a “simple“ model of 
need at Primary Care Trust level, per 10,000 children aged 2-8 years. 
x-axis: Locally-specific difference between the rate of ventilation tube insertions to expected  
population capacity to benefit (PCB) at Primary Care Trust level, per 10,000 children aged 2-8 years. 
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 Discussion         5.5
  
The conventional approach to account for population needs in research on 
geographic variation in healthcare – standardisation of rates for variables associated 
with need – is easy to implement, but fails to indicate whether the range and intensity 
of services expected to be beneficial for a population have been met. Grounded in a 
health economic conception of need for healthcare, the concept of population capacity 
to benefit provides such a benchmark, but its measurement is challenging. The 
following sections discuss the feasibility and potential usefulness of estimating PCB in 
light of the literature review. 
5.5.1 Uncertainty about criteria of capacity to benefit  
As noted in section 5.2, the estimation of PCB requires measurable criteria indicating 
the groups of patients for whom an intervention is likely to do more good than harm. 
For interventions that are known to be highly effective, whose target groups can be 
clearly defined (e.g. in terms of age) and where individual choice is problematic from 
a public health perspective, this may be straightforward. A good example would be 
measles vaccination, since vaccination opponents endanger not only their own but 
also other people’s health as a result of reduced protection afforded by herd 
immunity (Anderson and May, 1990).  
 
Where criteria of capacity to benefit are absent or controversial, there seem to be 
three possible routes. A first route is to introduce a more holistic, patient-centred 
element into the assessment of healthcare needs. In two studies reviewed here, 
focused on dental care (Guiney et al., 2012) and prostatectomy (Treagust et al., 2001) 
clinical examiners were asked to interpret guideline criteria in the light of individual 
cases when assigning the label of a “capacity to benefit“ to a study participant. This 
seems to reflect an attempt to allow for health professionals’ tacit knowledge 
(Polanyi, 1966) which cannot be expressed by explicit criteria. It is possible where 
information on healthcare needs is collected directly in the population studied 
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(rather than extrapolated from other populations). However, this deliberate lack of 
standardisation limits transparency and introduces non-random bias in achieving the 
policy goal of equal opportunity of access for equal need. This route also follows a 
more paternalistic approach to defining capacity to benefit which does not 
necessarily account for a patient’s preferences. 
 
A second route, taken by eight of 22 studies in this review, is to acknowledge the 
uncertainty in our current state of knowledge and to examine the sensitivity of the 
results to different modelling assumptions. For many surgical procedures, the 
threshold above which the intervention produces net benefit is uncertain (McKee, 
1996). Where cases just below or above the threshold may get marginal benefit, it 
seems reasonable to aim for a range of PCB estimates depending on different choices 
of criteria and thresholds rather than a single “right rate“. This may provide valuable 
information for the planning and evaluation of health services if it is performed for 
purposes of learning (using PCB estimates as a “tin opener“) rather than for 
command-control styles of management (using PCB estimates as a “dial“; see Carter 
(1989)). 
 
A third route – and medium to long-term task – is to invest in structures that foster 
the development of better predictors of benefit from health interventions for a range 
of population subgroups. Opportunities to achieve this arise from the growing remit 
of HTA agencies in many countries to conduct comparative and cost-effectiveness 
assessments (Sorenson et al., 2008). Although HTA agencies have so far largely 
focused on pharmaceuticals, they have also accelerated the development of evidence-
based guidance for surgical procedures, medical technologies and, at a much slower 
pace, public health interventions (Sorenson et al., 2008). In some countries, this has 
widened the range of methods used beyond classic RCTs, and their well-known limits 
in ascertaining the real-world effectiveness of interventions (Teutsch et al., 2005), 
towards pragmatic RCTs for complex interventions (Campbell et al., 2000) and cohort 
studies in primary care (Whitehurst et al., 2015). These developments create scope to 
overcome some of the hurdles faced by studies in the 1990s and early 2000s.  
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Clearly, the criteria of PCB depend on current medical knowledge about the benefit 
from and the effectiveness of specific procedures for defined conditions. As the state 
of knowledge evolves, so may criteria of PCB change. It is therefore not surprising 
that, given advances in evidence-based medicine and HTA, criteria of PCB differ over 
time (and also across the studies examined which cover a time span from the mid-
1990s to 2014). This is not necessarily a drawback of this specific method but rather 
a feature of healthcare in general. 
 
5.5.2 Morbidity statistics: accuracy, completeness and routine availability 
Assessing healthcare needs directly in the population studied clearly has the highest 
validity. However, as reflected in the small number of studies which did this, well-
designed epidemiological studies are expensive. The extrapolation of prevalence and 
incidence rates from other populations, adopted by the majority of studies in this 
review, may offer a pragmatic alternative but raises questions about external validity. 
That is, to what extent can one be confident that age-specific incidence rates of, say, 
osteoarthritis in Avon and Somerset in 1999 also apply to other settings or time 
periods? While recommendations exist to judge the transferability of economic 
evaluations across jurisdictions (Drummond et al., 2009), the STROBE statement 
(which seeks to strengthen the reporting of observational studies in epidemiology) 
has been criticised for its lack of detail about how to report on external validity 
(Burchett et al., 2011). The STROBE editors have recently started to address this by 
elaborating on requirements and examples for providing contextual information, but 
they suggest that external validity ultimately remains a matter of judgement 
(Vandenbroucke et al., 2014). Further research on this problem is important because 
the relationship between health, age and other factors may vary between populations 
and is unlikely to be fixed over time (Mason et al., 2015). 
 
Most diseases are multifactorially determined. While some authors of studies that 
extrapolated epidemiological information noted they had taken data from similar 
populations, the underlying components of “similarity“ were rarely defined. Studies 
that applied age-sex-specific incidence rates thus made the implicit assumption that 
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no substantial distortion was caused by known and unknown confounders such as 
differences in ethnic and socio-economic mix, climate or genetic disposition. This 
assumption may not be true. Only five studies attempted to gauge the nature and 
direction of potential bias and its impact on the results through sensitivity analysis. 
This seems a missed opportunity. While modelling results can only be as good as the 
underlying data, methods to handle uncertainty exist (for instance in the quantitative 
risk analysis literature, see Morgan and Henrion, 1990, Frey and Patil, 2002, Cox, 
2007, Cox, 2012) and merit adoption in future studies.  
 
The only study that represented multiple predictors of need beyond age and sex 
(Judge et al., 2009) is part of a growing body of small-area estimation methods in the 
geography literature. In healthcare, these methods seem to have largely been 
employed for the spatial microsimulation of health behaviours and health needs 
(rather than healthcare needs) (Gibson et al., 2002, Smith et al., 2011, Whitworth, 
2013). Where nationally representative surveys and identically defined local census 
data are available, these methods may enable the use of a wider set of predictors of 
healthcare needs. 
 
Self-reported morbidity from surveys, employed by ten studies in this review 
(categories 3.3 C, E and G in Table 5-3) can be useful where criteria of capacity to 
benefit include patient-perceived symptoms such as the degree of joint-related pain 
as a factor in determining the appropriateness of hip replacement. However, self-
reports have well-known limitations where underreporting is an issue, such as with 
hearing problems among children (Schang et al., 2014a). Surveys will also tend to 
indicate only the prevalence of symptoms indicative of need for treatment rather than 
their incidence over a specified time period, which is necessary for evaluating the 
provision of services over the same interval. Although it is possible to estimate 
incidence from prevalence (Leske et al., 1981) and this was done by five studies in 
this review, the underlying models rely on several assumptions about the 
irreversibility of the disease and the constancy of disease and death risks over time 
(Frankel et al., 1999). 
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Potential sources of routinely available information on the incidence of diseases are 
notifiable disease surveillance systems and registries. In Europe, their development 
has however largely been limited to selected diseases including infectious diseases 
and cancer, respectively (Rosenkötter and van Bon-Martens, 2015). In the absence of 
data from the general population, some studies in this review derived incidence and 
prevalence rates from diagnosis and prescription data or from rates of hospital 
admission. Until complete population-based morbidity statistics become available, 
triangulation of the consistency of morbidity data held by healthcare providers, 
insurance funds and disability allowance registers may seem a pragmatic way 
forward (Eurostat, 2014). However, utilisation-based data remains inherently biased 
where people who would benefit do not access healthcare settings in the first place, 
are misdiagnosed or not diagnosed at all (Asthana and Gibson, 2011). “Person 
consulting prevalence“ (the number of people consulting at least once with a specific 
morbidity during a defined period of time such as a quarter; Jordan et al. (2007)) is 
therefore unlikely to represent true population prevalence of a specific disease.  
5.5.3 Need-use discrepancy analysis: towards a health system perspective? 
The studies reviewed here provided little to no information on the context 
surrounding an apparent need-utilisation gap. Because overuse and underuse may 
co-exist, one important way to detect a mismatch of need and utilisation at the 
individual level is to conduct audits of the appropriateness of care provided in 
tandem with population-based studies (Schang et al., 2014a). 
 
As shown in Figure 5-1, patient preference is conceptually distinct from need for 
healthcare as measured by the capacity to benefit. However, the observation in 
several studies (Sanderson et al., 1997, Hawker et al., 2001, Jüni et al., 2003) that 
adjusting for an estimate of the proportion of patients willing to undergo elective 
surgery (here, arthroplasty or prostatectomy) led to considerable reductions in the 
level of care that would be both clinically indicated and wanted shows that PCB 
estimates can hardly be interpreted in isolation of prevailing values among patients. 
If one seeks to evaluate the degree to which service provision is aligned with both 
population needs and patient preferences, then future research should widen the 
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analysis beyond a single procedure towards all treatment options for a given health 
state. PCB estimates would thus indicate the potential maximum workload for each 
setting of care (specialist, primary or community care) while an estimate of the 
distribution of patient preferences (alongside other demand- and supply-side factors) 
would help to understand where and why rates of utilisation exceed or fall short of 
expected levels of population capacity to benefit. 
 
From a methodological perspective, most studies that sought to adjust for patient 
preference did so by asking survey respondents about their stated willingness to 
receive the intervention. A range of other methods exists to measure stated or 
revealed patient preferences, each with distinct challenges in terms of internal 
consistency, ability to represent “true” preferences beyond hypothetical choice 
scenarios, and ability to understand the determinants of patient preferences (Bridges 
et al., 2007). Preferences may depend on various socio-demographic characteristics, 
psychological and cultural dispositions, and the ways in which a medical choice 
problem is framed  (Edwards et al., 2001). Preferences are also likely to evolve with 
changes in technology, in wider society and in an individual’s health state (Ditto et al., 
2006, Fried et al., 2006). One hence needs to be cautious about transferring estimated 
proportions of patients willing to undergo a procedure from different contexts and 
time periods, as it was done by two studies in this review (Fong et al., 2012, Tyldesley 
et al., 2001). 
 Conclusions and policy implications 5.6
Returning to the question asked in this review – can estimates of capacity to benefit in 
populations become a feasible and useful benchmark to quantify the discrepancy 
between actual utilisation and population need for a defined intervention? – two main 
conclusions can be drawn.  
 
First, several peer-reviewed studies have attempted to translate the elusive concept 
of “population need for healthcare“ into an empirical measure of population capacity 
to benefit. While each model is a simplified representation of reality (Pidd, 1996), 
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each of the studies is based on assumptions that can be questioned and revised. The 
synopsis contributed by this literature review suggests a range of feasible routes how 
population benchmarks may be approximated.  
 
Second, PCB estimates may usefully complement conventional standardised rates in 
providing a substantively meaningful reference point for comparative performance 
assessments. While gaps remain in terms of credible criteria of capacity to benefit and 
valid population-based incidence rates, the concept of PCB is operationalised using 
established methods from HTA and epidemiology and both disciplines have made 
great strides over the past years. In health systems which strive to evaluate the 
effectiveness and efficiency of care ultimately in terms of the benefit conferred on 
populations, there is scope in bringing these two fields of health services research 
closer together in the future. 
 
This suggests several implications for policy. To enhance the robustness of estimates 
of PCB, it will be important to strengthen the mandate of HTA agencies and 
independent scientific associations so that standards of good practice can be 
established. Accurate and complete data from the general population is required to 
estimate the incidence of population need for defined interventions. National 
agencies should consider focusing the development of population benchmarks on top 
resource-intensive conditions and use these to support regional healthcare planning 
and surveillance. An example of how this might be done comes from England, where 
NICE has started to develop population benchmarks for some major conditions such 
as care for chronic obstructive pulmonary disease (NICE, 2011) and cardiac 
rehabilitation (NICE, 2013). Finally, computations of PCB should be coordinated with 
clinical audits and with patient preference assessments in order to improve the 
match between population needs, individual preferences and healthcare utilisation. 
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 Commentary in relation to the organising matrix of strategies 5.1
to address ambiguity about the standard for evaluation 
This Chapter has explored how policy-makers and managers might establish 
meaningful standards for evaluation with a technical-evidential approach. To this end, 
the Chapter has defined the concept of population capacity to benefit (PCB) as a 
potential benchmark for population need for defined interventions. On this basis, the 
Chapter has critically reviewed the feasibility and utility of measuring PCB, its 
generalizability across conditions and persisting challenges. 
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 Appendix 5-A. CUF and PCB calculations 5.2
The comparative utilisation figure is the ratio of the number of operations that 
would be expected in a local population if it had the same age structure as the 
standard population, applying the stratum-specific local population rates to calculate 
the expectation, divided by the number of operations in the standard population 
(adapted from the more commonly known comparative mortality figure, see Breslow 
and Day, 1987: 53-63): 
 
𝐶𝑈𝐹 =  
∑ 𝑛𝑗
∗𝐽
𝑗=1   
𝑑𝑗
𝑛𝑗
𝐷∗
 
 
Where 𝑑𝑗  is the number of operations in the jth of J age groups of the local population  
𝑛𝑗  is the number of people in the jth age group of the local population  
𝑛𝑗
∗ is the number of people in the jth age group of the standard population and 
𝐷∗ is the number of operations in the standard population. 
 
All calculations use a four-year average to reduce the impact of random fluctuations 
at a small area level.  
 
Some patients may have been treated in a Primary Care Trust (PCT) region other than 
the one in which they were resident. To take into account patient mobility, VT 
utilisation rates are based on postcode level data rather than hospital level data. This 
means that a patient who is resident in PCT A (as identified by the postcode) but was 
treated in a hospital located in PCT region B is nonetheless assigned to the utilisation 
rate of PCT A. This is done because we are interested in the performance of PCTs, as 
the “stewards“ responsible for ensuring an equitable provision of services in relation 
to medical need (Boyle, 2011), not in the number of operations performed by a 
particular hospital.  
 
Population capacity to benefit model: The epidemiological model (see Schang et al, 
2014a for details) starts from NICE guidance which recommends offering VTs to 
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children who suffer from bilateral OME at a hearing level of +25 dB and for whom 
diagnosis is confirmed after a period of three months. The model uses data from 
population-based longitudinal studies, stratified by age and the cumulative incidence 
of otitis media. The number of new cases of otitis media in any given year 𝑁(𝑂𝑀𝐸) is 
determined by the annual age-specific cumulative incidence (risk) Ij of OME 
multiplied by the susceptible population in a given age group Sj, summed over J 
eligible age groups (2, 3, 4 … to 8 years). The subgroup of cases with bilateral OME 
and a hearing impairment at a threshold level of +25 dB is expressed by 
𝑁 (𝑂𝑀𝐸) = ∑(𝑆𝑗 ∗ 𝐼𝑗 ∗ 𝑃(𝐻𝐿|𝐵𝑖𝑙𝑎𝑡𝑒𝑟𝑎𝑙 𝑂𝑀𝐸) ∗ 𝑃(𝐵𝑖𝑙𝑎𝑡𝑒𝑟𝑎𝑙 𝑂𝑀𝐸|𝑂𝑀𝐸))
8
𝑗=2
 
Where  
P (Bilateral OME | OME) is the conditional probability of bilateral OME given a 
diagnosis of OME 
P (HL | Bilateral OME) is the conditional probability of a hearing level of +25dBgiven a 
diagnosis of bilateral OME 
 
The probability of OME persisting at time t from the onset of OME is modelled as an 
exponential process of the form  
 
P (OME | t) =   
1
 2
𝑡
𝑚
   
Where  
m is the median time to recovery  
t is the total waiting time from the onset of OME  
 
As OME is transitory, the population with capacity to benefit will diminish as time 
passes since the onset of OME. Population capacity to benefit from ventilation tubes 
for OME at five months since the onset of OME is estimated as 
 
PCB (t) = P (OME | t) * N (OME) 
 
 
The “simple“ model of need is defined as  
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𝑁 (𝑂𝑀𝐸, 𝑡) = ∑(𝑺𝒋 ∗ 𝑰𝒋)
𝟖
𝒋=𝟐
 
Where  
N (OME, t)  is the number of children defined to be in “need“ of VTs for OME at t=5 
months after onset 
Ij  is the annual age-specific cumulative incidence (risk) of OME  
Sj is the susceptible population in a given age group 
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Abstract 
 
Where policy ends are contested and means for change are ambiguous, imposing 
central targets on local organisations – what we call hierarchist governance  – is 
problematic. The concept of experimentalist governance (Sabel and Zeitlin, 2012) 
suggests that target setting should rather be conceptualised as a learning process and 
as a dialogue between central government and local organisations. However, it is 
unclear how a constructive dialogue about improvement might be fostered alongside 
attempts to strengthen accountability for results. Drawing on experiences from the 
Scottish HEAT target system, we argue that complementary use of hierarchist and 
experimentalist ideas is possible. We show that the emphasis on experimentalist 
ideas was stronger where ends and means were contested (the case of shifting the 
balance of care for older people) than where both ends and means seemed obvious 
initially (the case of healthcare-associated infections). However, management drifted 
towards the experimentalist realm when rising rates of community-acquired 
infections decreased clarity about effective interventions.  
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 Introduction   6.1
Although few would doubt the value of making explicit the priority areas where 
urgent improvement is needed, translating these priorities into precise, time-bound 
targets that are imposed by central government on local organisations has attracted 
much criticism (Carter, 1989, Greenhalgh et al., 2010, Lawton et al., 2000). This form 
of governance by targets – what we call hierarchist governance – requires “dials” 
(Carter, 1989): accurate measures of performance which unambiguously represent 
desired policy ends (Bevan and Hood, 2006) and whose means of attainment are 
known and available to the organisations under scrutiny (Jacobs et al., 2006a).  Many 
performance indicators in social policy, however, are mere ”tin openers”: measures 
which “do not give answers but prompt interrogation and inquiry, and by themselves 
provide an incomplete and inaccurate picture” (Carter, 1989: 134). This holds in 
particular for ”wicked” problems where goals are contested and means for change are 
ambiguous (Rittel and Webber, 1973). Some have therefore argued that setting 
delusively exact targets for wicked problems such as health inequalities obscures 
complex causal networks and necessary value judgements in determining desired 
levels of achievement (Blackman et al., 2009). 
 
The concept of experimentalist governance (Sabel and Zeitlin, 2012)  suggests that in 
a context of ambiguity over the “correct” targets and means, target setting should 
rather be conceptualised as a learning process and as a dialogue between central and 
local organisations. However, it is still unclear how a constructive dialogue about 
measurement for learning and improvement can be fostered alongside demands for 
accountability for results (Freeman, 2002). The conventional performance 
measurement literature has tended to argue the purposes of “measurement for 
accountability” and “measurement for improvement” ought to be kept separate since 
the former is premised on a culture of judgment against fixed objectives, with a 
consequent need for accurate data, while the latter requires a culture of learning and 
openness, using data that is “good enough” to diagnose and remedy problems 
(Solberg et al., 1997, Freeman, 2002, Davies, 2005). However, while these two 
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purposes of performance measurement have undeniable differences, keeping them 
entirely distinct would ignore the potential value of targets as a policy tool to track 
performance improvements on those wicked policy issues where clear agreements on 
change and measurement of progress might be most needed. 
 
In this paper, we therefore ask how and to what extent a more learning-oriented 
experimentalist logic of setting performance targets might complement a more 
hierarchist philosophy focused on accountability.  We add to a stream of literature in 
public administration that considers the potential for complementarity of seemingly 
dichotomous models of governing public services through deterrence and sanctions 
or through persuasion and support (McDermott et al., 2015). We examine two 
research questions: 
1. Is it possible to disentangle and examine empirically the co-existence of 
hierarchist and experimentalist elements in the same performance management 
regime? 
2. Does the relative emphasis on experimentalist as opposed to hierarchist logics 
differ between policy issues depending on the degree of perceived ambiguity 
over ends and means? 
 
The next section contrasts, in a stylised way, theoretical assumptions underpinning 
hierarchist and experimentalist approaches to target setting. The empirical analysis 
draws on experiences from the Scottish HEAT target system in the National Health 
Service (NHS) which transformed the earlier model of “trust and altruism“ (Bevan et 
al., 2014) and enables exploration of experimentalist ideas in a hierarchical yet 
collaboration-oriented context. We then compare two policy issues. Where ends and 
means were contested (the case of shifting the balance of care for older people; a 
typical “tin opener”), we find a stronger focus on experimentalist ideas in the form of 
locally agreed targets and a focus on local innovation. Where both ends and means 
seemed obvious (the case of healthcare-associated infections; an apparent ”dial”), 
hierarchist elements dominated initially. However, management style drifted towards 
the experimentalist realm when rising rates of community-acquired infections 
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decreased clarity about effective interventions.  We close with implications for policy 
and research.  
 Hierarchist and experimentalist assumptions about setting 6.2
performance targets  
Drawing on principal-agent theory and institutional economics, the hierarchist logic 
of setting performance targets involves a sovereign principal (e.g. a central 
government or regulator) who specifies a set of fixed targets for an agent (e.g. a 
subordinate agency), rewards achievement and sanctions failure (Hood, 1991, Laffont 
and Martimort, 2002). In the public sector, hierarchist target setting became a key 
policy instrument under New Public Management reforms pursued in various 
countries since the 1980s (Hood, 2012, Hood, 2007). It is vividly illustrated by the 
model of “targets and terror” (Bevan and Hood, 2006, Propper et al., 2008) adopted 
by the English Labour Government between 2001 and 2005 where public sector 
organisations were subject to a set of strict performance targets with severe 
consequences for failure. 
 
Experimentalist governance (Sabel and Zeitlin, 2012) has evolved as a critique by 
scholars of the assumptions underlying the hierarchist perspective (Table 6-1) in 
parallel to calls for more deliberation in public management (e.g. Barzelay, 1992, 
Hood and Jackson, 1994). Experimentalist governance has been defined as a 
“recursive process of provisional goal-setting and revision based on learning from the 
comparison of alternative approaches to advancing them in different contexts” (Sabel 
and Zeitlin, 2012: 169). Performance management is conceived as a “learning 
process” whose four elements are linked in an iterative cycle: (i) Centre and local 
actors agree on broad goals and metrics to ascertain their achievement; (ii) local 
actors pursue these goals in their own way while the Centre provides support and 
infrastructure; (iii) local actors report their performance regularly, engage in peer 
review and share learning about “what works”; (iv) goals, means, and decision-
making procedures are periodically revised by a widening circle of actors in response 
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to the problems and opportunities identified in the review process (Sabel and Zeitlin, 
2012: 170).  
 
Experimentalist governance was developed to understand how multilevel governance 
structures in uncertain and heterogeneous contexts can improve performance and 
unblock reform stalemates. This includes policy-making in the European Union on 
areas such as social protection, electricity, telecommunications, occupational health 
and safety, and drug and food safety where the interdependency of member states, 
the European Commission and other stakeholders often precludes formal rule-
making and has led to alternative structures such as the Open Method of 
Coordination, Reference Networks and Joint Action Strategies (Sabel and Zeitlin, 
2008, Fierlbeck, 2014). Experimentalist governance has also been used to analyse 
reforms of complex regulatory settings such as child protective services (Noonan et 
al., 2009) where norms and standards cannot fully be determined ex ante, but require 
revision in the light of individual cases. 
 
The limitations of hierarchist target governance in a context of ambiguity over ends 
and means, and the rationale for an experimentalist alternative, can be summarised 
as follows. First, where ideal ends of policy are contested, scholars claim that 
argument offers a better basis for decision-making than authority (Pires, 2011). 
Because local organisations have an insight into frontline problems that national 
oversight bodies lack, it is argued that “global and local knowledge are mutually 
corrective, not hierarchically ordered” (Sabel, 2004: 181). Setting goals and metrics to 
gauge their achievement is therefore seen as a joint process where official authorities 
“must be prepared to learn from the problem-solving activities of their ‘agents’ ” 
(Sabel and Zeitlin, 2012:175). 
 
Second, where means for implementation are ambiguous, the hierarchist approach 
provides no indication what local organisations are to do. As a consequence, local 
organisations tend to develop various coping strategies (Lawton et al., 2000) but 
there is not necessarily an attempt to make these strategies explicit or learn from 
them at a national scale. Experimentalist governance, in contrast, provides a 
management process which reframes local variation into an experimentalist 
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“laboratory” and into an opportunity to promote innovation. The underlying 
assumption is that where the “best” interventions are not known, learning from the 
range of approaches taken in different localities may help to develop and scale-up 
good practice (Sabel and Zeitlin, 2012). 
 
Third, the hierarchist view of accountability in relation to results implies the need to 
comprehensively specify goals. Since most public services have multiple and 
potentially conflicting goals, incomplete contracts combined with divergent interests 
and informational asymmetries between regulatory authorities and organisations 
under scrutiny risk encouraging gaming on the side of the latter (Bevan and Hood, 
2006) and misinterpretation of complex local production processes on the side of the 
former (Smith, 1995). In search of complete contracts, reforms in England and the 
Netherlands have led to a multiplication of quantitative indicators so as to cover 
“every” aspect of performance, thereby overwhelming the capacities of both central 
and local organisations (Power, 1999, Pollitt et al., 2010).7 Experimentalist 
governance, in contrast, reframes accountability towards the validity of underlying 
processes (Table 6-1). Opening the ”black box” of service delivery by seeking to 
understand how measured indicators are implemented is seen to enable a more 
rounded view of performance and limit the need for a variety of indicators (Noonan 
et al. 2009; Sabel and Zeitlin, 2012).  
 
The stylised comparisons in Table 6-1 and above suggest that hierarchism and 
experimentalism are diametrically opposed in terms of their underpinning 
assumptions about target setting, implementation, and monitoring and 
accountability. Indeed, prior research (Pires, 2011, Sabel and Zeitlin, 2012) has 
tended to portray these logics as competing. However, as Fossum (2012) points out, it 
is not clear yet if experimentalism is mutually exclusive, complementary or 
transformative in relation to hierarchism.  
 
                                                                    
7 In England, for instance, this entailed a cascade effect where 12 central health Public Service 
Agreement targets were translated into 44 targets in the Department of Health’s planning framework 
and finally into 300 targets for local organisations (Collins et al, 2005).  
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Since central government has a democratic mandate to define priorities and hold 
subordinate administrations accountable for the use of resources (Mays, 2006), the 
experimentalist proposal of joint target setting seems at odds with vertical lines of 
accountability as they exist between central government and administrations with 
delegated decision-making powers. However, this does not mean that experimentalist 
governance has nothing to add to hierarchically organised systems.  
 
In this paper, we examine the relationship between hierarchist and experimentalist 
approaches to managing the performance of a publicly financed service that is subject 
to parliamentary scrutiny. We investigate two hypotheses. First, we suggest that 
experimentalist ideas may complement hierarchist target setting so as to address key 
limitations of the latter. While a full adoption of experimentalist governance may not 
be feasible or desirable, we hypothesise that it is possible to examine empirically both 
experimentalist and hierarchist elements in the same performance measurement 
regime. Second, we examine the choice of logic contingent on the degree of perceived 
ambiguity in a policy issue. If experimentalist governance is a valid descriptive theory 
of how systems and organisations manage ambiguity over ends and means, then one 
would expect a stronger focus on experimentalist ideas in a context of ambiguity 
while in a context of (relative) certainty one would expect a more hierarchist 
approach to target setting. 
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Table 6-1 Hierarchist and experimentalist assumptions about the target setting process 
 Hierarchist target setting  Experimentalist governance 
Assumptions 
regarding 
  
Ambiguity about 
ends:  
Target setting  
  
Central government has a legitimate mandate to set 
targets for subordinate administrative bodies. 
Knowledge about goals is contested, provisional and distributed between 
central and local actors. Therefore, target setting should be a joint process 
between central and local actors. 
Ambiguity about 
means:  
Implementation 
of targets 
 Local agents have the necessary (and have in fact 
been chosen for their) specialist expertise to 
implement targets. 
 The role of the state is to design contracts that 
incentivise agents to meet the targets and that 
control the effects of asymmetric information about 
the effort of agents. 
 Means for change are ambiguous.  
 The role of the state is to provide support and infrastructure that 
encourages mutual learning and exchange about diagnosing problems, 
coaching and spread of successful models. 
Monitoring and 
accountability  
Accountability against fixed rules:  
Inspection of results and application of appropriate 
rewards and punishments. 
“Learning-by-monitoring” (inspection of validity of processes): frontline 
organisations repeatedly explain the choices they make for running a 
programme, thus enabling oversight bodies to consider how to correct 
flaws in service delivery at the local level. 
 
Dynamic accountability: Results may deviate from initial goals if justified 
to be a better way to meet the overarching purpose of the system. 
 Sources: authors’ display based on Sabel and Zeitlin (2012); Noonan et al. (2009); Laffont and Martimort (2002). 
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 Methods 6.3
6.3.1 System context and study design 
Scotland offers an interesting testbed to examine experimentalist governance ideas 
within a hierarchical and diverse context. The planning and delivery of health 
services is delegated to 14 territorial NHS Boards who are responsible for £10.9 
billion (of £11.9 billion Government spending on health in 2012/13; Audit Scotland 
(2013: 5)). But while NHS Boards are major budget-holders and have considerable 
powers to shape patterns of service delivery, they remain directly accountable to 
Scottish ministers and subject to central constraints such as the requirement to break 
even in each financial year (Steel and Cylus, 2012). Boards differ widely in terms of 
populations covered (between about 21,500 in NHS Orkney and over 1 million in NHS 
Greater Glasgow and Clyde in 2013; Scottish Public Health Observatory (2014)); 
rurality (ranging from highly urbanised over mixed urban/ rural economies to rural 
and remote islands); deprivation (from deprived inner city to wealthy suburban); and 
geographic size (half of Scotland’s landmass being covered by a single Board, NHS 
Highland). 
 
The model of governance of the Scottish NHS immediately after devolution in 1999 
has been described as one of trust and altruism since local organisations were trusted 
to deliver a high-quality service (Bevan et al., 2014). Ministers have long eschewed 
targets or rankings that inflict reputational damage, rejecting top-down performance 
management in favour of a consensual approach. A strong policy discourse on 
partnership has evolved in relation to a well-organized, powerful medical elite (Greer 
2004) and a lower relational distance between central and local organisations than in 
England (Hood, 2007). In Scotland, senior managers from the different regions “meet 
regularly and have easy access to ministers and officials in the Scottish Government” 
(Steel and Cylus 2012: 26). 
 
Targets for territorial Boards were first introduced in 2002, in the form of the 
Performance Assessment Framework (PAF) (Scottish Executive Health Department 
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2003). The exact number of targets was not known as the PAF referred to other 
policy frameworks; estimates range between a hundred and over two hundred 
targets. An evaluation concluded that there was an “overload from the data collection 
(…) and the risk that PAF might become an end in itself” since it lacked incentives for 
Boards to improve and share good practice (Farrar et al., 2004: ii). 
 
This changed in 2006 when, as Steel and Cylus state, “[u]nfavourable cross-border 
comparisons (…) about performance, particularly on waiting times” (2012: 113) and 
a change in minister led to the introduction of a “tougher and more sophisticated 
approach to performance management” (2012: 114); known as the HEAT (Health 
improvement, Efficiency, Access and Treatment appropriateness) target system. 
Within a hierarchical yet consensual context, this system has now matured over 
almost a decade. It offers a suitable context to investigate empirically the potential co-
existence of hierarchist and experimentalist logics of setting performance targets (our 
first research question).  
 
Since our second research question is concerned with the balance between 
hierarchist and experimentalist logics contingent on the nature of the policy issue, we 
use a comparative embedded case study design (Yin, 2003). This enables us to 
compare, within the broader HEAT target system,  the development of HEAT targets 
for two policy issues which represent opposite ends on a spectrum of ambiguity over 
goals and means (Table 6-2). 
 For the case of healthcare-associated infections (HAI), where both ideal 
performance and the means for change were relatively well-known when targets 
were introduced, one would expect a stronger hierarchist logic. 
 For the case of shifting the balance of care for older people (SBC), where both the 
ideal ends and the means for change were ambiguous, one would expect a 
stronger experimentalist logic. 
 
The second reason for choosing these two policy issues is methodological: Targets 
were introduced in 2006 (SBC) and 2008 (HAI) and have evolved up to the time of 
writing (April 2015), thus enabling a comparison of their development over time. 
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Table 6-2 Case studies 
Policy 
issue 
End (ideal) Means Targets (examples) 
Healthcare-
associated 
infections 
(HAI) 
 
Zero 
infections 
Relatively good 
evidence of 
effective 
interventions 
(e.g. Haley et 
al., 1985) 
Reduce by 2012/13 NHS Boards’ 
staphylococcus aureus 
bacteraemia (including MRSA and 
MSSA) cases to 0.26 or less per 
1,000 acute occupied bed days; 
and the rate of Clostridium 
difficile infections in patients 
aged 65 and over to 0.39 cases or 
less per 1,000 total occupied bed 
days 
Shifting the 
balance of 
care for 
older 
people 
(SBC) 
Unknown 
balance 
between 
hospital and 
community 
care 
Service 
redesign – 
complex and 
little evidence 
(Johnston et al., 
2008) 
Reduce the rate of emergency 
inpatient bed days for people 
aged 75 and over per 1,000 
population, by at least 12% 
between 2009/10 and 2014/15 
 
6.3.2 Data collection and analysis 
To achieve a rounded perspective, the study triangulates multiple sources of data 
including national and local policy documents and interviews (Table 6-3). 
Interviewees were invited following a purposive strategy (Patton, 2002) to capture 
national and local experiences and represent diversity in local contexts. We started 
with an initial group of national and local managers and, using “snowballing” 
techniques, invited 33 people for interview. A total of 31 interviews were conducted 
between June 2014 and February 2015 (two people declined due to time constraints). 
We considered data saturation to be achieved when no new themes emerged after a 
couple of further interviews (Guest et al., 2006). Participants were informed about 
the aims of the research project, encouraged to ask questions and assured of the 
anonymity of their responses. Ethics approval was obtained from the LSE research 
ethics review committee. 
 
Thematic analysis was used to analyse the documentary material and interview 
transcripts (Boyatzis, 1998). This systematic approach consisted of identifying 
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patterns in the data through a process of careful iterative reading and indexing from 
the data, facilitated by the NVivo software programme. The analysis followed the 
theoretical constructs from hierarchist and experimentalist governance and thus 
enabled a form of theory triangulation where the same case is examined through 
different theoretical lenses to see what each perspective adds or omits (Patton, 
1999). To mitigate against misinterpretation, we shared the findings with the 
interviewees who were given the opportunity to comment on the draft and point out 
any factual errors. 
 
Table 6-3 Data sources 
Data source Role in analysis 
National policy documents Policy context and 
developments  
112 Annual Local Delivery Plans (from 2006/07 over seven years for 
all Boards) and other local plans 
Historical, public documents 
agreed with the Government 
in which Boards set out 
risks and management 
strategies for each HEAT 
target 
31 semi-structured interviews lasting 35-90 minutes 
National level: 9 with Scottish Government officials and 
representatives from national organisations: Quality, Efficiency & 
Support Team (QuEST),  HAI Task Force, Health Protection Scotland, 
Joint Improvement Team (JIT) 
Local level: 22 with senior and middle managers from NHS Boards: 
chief executives, heads of performance management, medical 
directors, infection control managers, and operational managers 
- 8 of 14 Boards with a mix of rural/urban, small/larger Boards: 
Greater Glasgow and Clyde; Borders; Tayside; Dumfries and 
Galloway; Shetland; Grampian; Forth Valley;  Lothian 
- 2-4 interviews per Board to obtain different perspectives 
Perceptions not addressed 
in public documents 
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 Findings  6.4
The next sections present the overall HEAT target framework and the comparative 
analysis of policy issues. The theoretical relevance of the findings in relation to 
hierarchist and experimentalist logics is summarized in Table 6-4. 
6.4.1 The HEAT target system 
The choice of HEAT targets is informed by consultations with service user groups, 
professional associations and NHS Boards. Some targets arise from political manifesto 
commitments. Dissatisfaction with the wide range of indicators in the PAF has led to 
an explicit articulation of criteria for selecting HEAT targets: (i) strategic fit with 
Government priorities; (ii) availability of baseline data; and (iii) scope for 
implementation by NHS Boards. The number of targets has been progressively 
reduced from 32 targets in 2006/07 to 14 targets in 2013/14. Each target runs over a 
three-year cycle, after which feedback meetings with NHS managers, health 
professionals and Government officials create the opportunity to revise or abolish 
targets. While the Scottish Government decides on targets (reflecting the hierarchist 
logic), stakeholders do discuss areas where targets add value and raise concerns 
(reflecting the experimentalist logic).  
 
The HEAT target process is led by a Directorate in the Scottish Government which 
agrees annual local delivery plans (LDPs) with each Board and monitors progress 
against these. In LDPs, Boards explain how they plan to attain the HEAT targets and 
the risks they face. A head of performance noted that “LDPs are a way to sensecheck 
with the Scottish Government and raise concerns we see locally”. This reflects the 
experimentalist logic insofar as LDPs may serve as a mechanism to gain an overview 
of local problems that enables the Government to reconsider its policy ambitions. 
Nevertheless, LDPs are drafted in relation to guidance by the Government in line with 
national policy, including the 2020 Vision for Health and Social Care (The Scottish 
Government, 2013), and are signed-off by the Scottish Government. Key informants 
perceived LDPs primarily as the “contract” between Government and NHS Boards 
rather than as tools for dialogue, reflecting the hierarchist logic. 
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In contrast to the PAF, the HEAT target system has institutionalised two routes to 
assure accountability. One is a summative assessment that reflects the hierarchist 
logic of accountability for results. The Government examines progress against the 
LDPs at NHS Board Annual Reviews. In addition, biennial Accountability Reviews are 
conducted by ministers in public where members of the public can ask questions. 
These reviews result in a formal letter from the Cabinet Secretary about areas of 
concern identified which Boards are expected to address. National progress against 
the HEAT targets is reported publicly on the Government’s website Scotland Performs 
which shows comparisons with previous years and with other NHS Boards. There are 
no financial sanctions or forced redundancies when targets are not met.   
 
The other route is a formative assessment that reflects the experimentalist view of 
accountability as valid processes. This takes the form of Mid-Year reviews to gauge if 
Boards are “on track”. Pressure for corrective action can be applied and escalated 
through several mechanisms. At monthly meetings of Board Chief Executives with the 
NHS Chief Executive, performance is routinely discussed in an open forum. Regular 
informal (bilateral) meetings take also place between performance managers from 
the Scottish Government Health and Social Care Directorate and Board staff. If there 
are concerns about a major failure, the Scottish government sends a performance 
support team to Boards to identify problems and point out interventions for 
improvement. To give them a greater degree of credibility, these teams typically 
comprise clinicians, managerial and data management experts seconded to the 
Scottish Government from other organisations, rather than civil servants. The main 
purpose of these teams is to enable early intervention and not allow a system to fail. 
However, respondents highlighted a constant tension in the teams’ dual role of 
providing genuine support and exercising Government control:  
 
“Boards don’t have a choice (…) they develop a joint action plan that is heavily 
scrutinised by the Scottish Government” (Government official). 
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“The process is not comfortable (…) but from my experience it has been respectful and 
positive to diagnose problems with data management we had here (…) and showing 
how other high-performing organisations solve these issues” (senior manager). 
 
Government officials and local managers pointed out that accountability for results 
was a response to perceived opacity of the previous system. However, because this 
evolved within a broader context of public sector reform which emphasised the 
values of partnership and collaboration (see e.g. the report of the Commission on the 
Future Delivery of Public Services (2011)), there was also an increasing commitment 
by the Government to listen to and act on local feedback. Below we explore these 
themes further in the context of HAI and SBC. 
6.4.2 Comparative analysis of policy issues 
Both the rates of HAI and emergency bed days have reduced considerably over the 
past years (Figures 6-1 to 6-3). The change points occurred, approximately, when 
targets where introduced. Although it is not possible to attribute these changes solely 
to the introduction of targets, and there are some notable variations between Boards, 
the trend does indicate that actions taken around this time period have impacted on 
performance.  
6.4.2.1 Healthcare-associated infections: “zero is best“? 
The issue of healthcare-associated infections (HAI) climbed the policy agenda in 2008 
when an outbreak of clostridium difficile (CDI) at the Vale of Leven hospital resulted 
in a major revision of infection control practices. To coordinate national strategy 
development and implementation, the Scottish Government’s HAI Task Force set out 
a multifaceted approach to change, funded with £56 million ring-fenced for three 
years across five broad areas (HAI Taskforce, 2008): standards of practice; culture 
(resulting e.g. in a national campaign to promote “zero tolerance“ for insufficient 
hand hygiene); education (e.g. on prudent use of antibiotics); surveillance and audit 
(e.g. since 2009, the Healthcare Environment Inspectorate has carried out regular 
audits of compliance with national standards); and changes in the physical 
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environment and processes (e.g. the introduction of MRSA screening on admission). 
Action on HAI was also embedded into the Scottish Patient Safety Programme, a large 
Collaborative aimed at improving patient safety. Driven by a political scandal, for HAI 
there was thus from the outset a strong emphasis on national leadership. 
 
Starting in 2008, the HAI Task Force also recommended the introduction of a national 
HEAT target on Staphylococcus aureus bacteraemia (SABs, including MRSA and 
MSSA), based on the knowledge at that time that SABs represented a dominant cause 
of infection. A HEAT target on CDI followed in 2009, once baseline data from 
mandatory surveillance (since 2008) was available.  Proposals for targets are 
inititated by the National Advisory Group, a subgroup of the HAI Task Force whose 
membership includes key professional groups (infection control managers, medical 
directors, and microbiologists employed by Boards). Proposals are passed to the 
Scottish Government for decision. While the Scottish Government thus retains the 
responsibility for setting targets (reflecting the hierarchist logic), proposals are 
initiated by the stakeholders who will implement them (which is closer to the 
experimentalist logic). The implication of this approach, as an infection control 
manager observed, was that targets were “more easily accepted and we are not 
surprised when the target comes“. 
 
Target values, however, were derived from technical information rather than 
consensus; reflecting hierarchist ideas. Initially, targets aimed at a 30 per cent 
reduction of HAIs over a five-year period. This was based on a seminal study on the 
prevention of nosocomial infection in the United States (Haley et al., 1985) which had 
found that a third of hospital infections was avoidable with a defined set of 
interventions including surveillance, having trained infection control staff, and a 
system for reporting infection rates to practising surgeons. Although this study came 
from a different context, it seemed “the best evidence and reference point at the time of  
potential for prevention” (HAI Task Force representative). 
 
Although an ideal rate is known for HAI (zero infections), uncertain effect sizes of 
interventions make it hard to ascertain what levels of quality are feasible in practice. 
With comparable data becoming available from standardised reporting across the 
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United Kingdom and other European health systems, since 2011 levels of 
achievement are determined by “best-in-class“ benchmarking where the Government 
seeks to infer an attainable level of quality for NHS Boards from the best performers 
within Scotland and abroad. The theory underpinning this approach has been 
formalised as yardstick competition (Shleifer, 1985) as a strategy to overcome 
imperfect and asymmetric information about prices, and socially efficient levels of 
cost reduction. A key challenge is to identify genuinely comparable firms which “the 
regulator can expect to be able to reduce costs at the same rate“ (Shleifer, 1985: 320). 
In Scotland, a HAI Task Force representative noted that no adjustments for 
differences in context were made to keep the system transparent. However, as some 
Boards argued that the lowest rate would not be achievable for all Boards, given 
differences in local populations, the HAI Task Force agreed on the roughly 75th 
percentile of the empirical distribution of performance as the minimum target. Those 
performing better were however expected to continue to improve to prevent 
regression towards the minimum target. 
 
Since Boards have integrated responsibility for acute, primary and community care, 
the national target includes all cases of HAI regardless of where they have been 
acquired. Boards’ actions have traditionally focused on hospitals: LDPs over the past 
years emphasise the education and training of hospital staff to prevent the 
transmission of infections. However, while significant reductions in HAI have led to 
increasingly stringent targets consistent with the “best-in-class“ approach, Boards 
reported struggling with a rising proportion of community-acquired infections (CA-
HAIs).8  In interviews, managers commented that CA-HAIs were considerably harder 
to prevent than hospital-acquired HAIs as the latter arise within clear physical and 
managerial boundaries. Many challenged the policy ambition towards increasingly 
strict meanings of quality: “We’re stuck (...) How low can we go in practice? We can get 
lower, but we can never get to zero“ (infection control manager). The Scottish 
                                                                    
8 Community-acquired infections are defined as infections that develop within 48 hours after patient 
admission to hospital. Mentioned by three Boards in 2007/08 (when the SAB target was introduced), 
by 2013/14, all Boards identified the increasing proportion of community-onset SABs as a key risk to 
meeting national targets. For instance, NHS Tayside’s LDPs record that by 2013/14, about 50% of SABs 
were present on admission to hospital, an increase from about 22% of SABs in 2006/07. 
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Government argues however that Boards’ legal mandate includes public health and 
thus has chosen not to exclude CA-HAIs from Boards’ targets. There were, however, 
two sets of alternative responses. 
First, the approach to implementation was refined. Scottish Government leads have 
started to regularly attend local HAI meetings and share “good practice“ from other 
Boards. As an infection control manager commented: “We had some problems with 
community-acquired infections and the Government teams said to us, ‘you might speak 
to Board x and y about this’ (...) this was not a panacea but it was a start“. Further, as 
the epidemiology of CA-HAI is poorly understood and routine national data is lacking 
(Health Protection Scotland, 2014), this has led to a collaborative research 
programme through the Scottish Infection Control Network. A rising number of 
Boards has also begun reaching out beyond hospitals through programmes targeted 
at high-risk groups such as care home residents and intravenous drug users. Central 
guidance on infection control now includes sections on CA-HAI (Health Protection 
Scotland, 2012), and Boards reported referring general practitioners, district nurses 
and care home staff increasingly to this national resource. 
 
Second, the nature of accountability arrangements for HAI seems to have recognised 
the uncertainty in attribution and capacity for change of HAI rates. This includes an 
emphasis on root-cause analysis where staff seek to trace infections back to their 
initial source. Health Protection Scotland has adopted an approach to inspection that 
consists of visiting hospital wards locally to understand why they are not “on target“, 
by observing actual practice: “One Board told us, ‘It cannot be the central lines, not the 
peripheral catheters we checked these’ (…) we observed how audits were conducted and 
it turned out they were not rigorous enough (…) so there was a training to help 
clinicians understand their importance” (Health Protection Scotland representative). 
Especially respondents from smaller Boards also commented that in discussions with 
the Scottish Government, HAI rates were recognised to be sensitive to unpredictable 
fluctuations. 
 
In conclusion, the perception of HAI as an issue where national standards where both 
feasible and desirable has resulted in strongly centrally determined targets. However, 
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as rates approach zero, finding a normative standard seems harder than ever. The 
reframing of the boundaries of the problem from hospitals to the wider community 
has emphasised the value of more learning-oriented approaches to implementation 
and accountability. 
6.4.2.2 Care for older people: a question of “balance“? 
Shifting care out of hospitals into the community became a key policy focus in 2005, 
when the Scottish Government launched the Unscheduled Care Collaborative to tackle 
the growing rate of emergency admissions especially among older people. The 
Collaborative was intended as the overarching approach to engage health 
professionals, service users and carers and provided funding to develop local 
infrastructures, clinical leadership and information management. The Collaborative 
framework (Scottish Executive, 2005) set out the principle that: “change will not be 
delivered by issuing guidance and directives (…) one size does not fit all. Solutions must 
meet local need and circumstance and more importantly actively engage staff in the 
change process” (p.3). The Scottish Government’s (2009a) strategic framework 
Shifting the balance of care re-emphasised shifting the location of care (outside 
hospitals), its focus (from acute to preventive care) and responsibility for its delivery 
(involving non-medical professionals, patients and carers following the principle of 
co-production).  
 
To achieve this ambition, between 2008 and 2011, a Long-Term Conditions 
Collaborative promoted a variety of tools and techniques focused on improving the 
self-management and care pathways for people with long-term conditions and sought 
to support NHS Boards in adapting these tools to their own local contexts (The 
Scottish Government, 2009b). In 2010, the 10-year programme Reshaping Care for 
Older People (The Scottish Government, 2010) established a £70 million Change Fund 
to provide bridging finance for local partnerships involving acute, community, third 
and independent sectors to create joint commissioning strategies. Thus, from the 
outset, policy discourse emphasised local diversity and stakeholder engagement. 
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To serve as strategic measure in  support of these policies, in 2006, a HEAT target on 
reducing multiple re-admissions to hospital for people aged 65 and over was 
introduced. After the usual three-year cycle, a national stakeholder event including 
Government officials, clinicians, service users and Boards concluded that this target 
ignored the fact that some admissions might be unavoidable. “Clinicians were 
concerned this would create a perverse incentive to prevent even necessary admissions 
(...) based on that feedback, the target was reformulated“ (clinical lead). In 2009, an 
alternative target to reduce emergency bed days for people aged 65 and over (later 
narrowed down to the population aged 75 and over) was introduced which seemed to 
signal more clearly the underlying policy ambition: “The target is about minimising 
the time spent in hospital for older people (...) patient experience of care and health 
status often suffer as a result of long hospital stays“ (medical director). This target was 
reaffirmed at the subsequent stakeholder review and has continued up to the time of 
writing. 
 
Rather than imposing a uniform target, the Government agreed levels of achievement 
individually with each Board. This model was adopted because local variations in the 
availability of community care, socio-demographic composition, and previous 
reductions in emergency bed days were perceived as making a single “right rate” 
untenable. A lack of comparable data between Boards also precluded the use of 
benchmarking as for HAI.9 
 
Experimentalism would suggest that setting targets through dialogue requires a 
mutual interest in obtaining challenging yet feasible targets. Since HEAT targets are 
publicly reported and frequently cited to underpin political achievements, the 
Scottish Government has an interest in realistic targets that can be met. However, 
emergency care puts substantial strain on the NHS budget and rising demand due to 
demographic changes challenges the Government’s pledge to protect universal 
coverage (Barbour et al., 2014). This has led to a perception that “the current situation 
                                                                    
9 For historic reasons, NHS Boards classify inpatient beds, especially for long stay treatment, in 
different ways. Boards are at the time of writing in discussion with the Information Services Division 
(ISD) to understand these differences. Consequently, however, one can only compare trajectories i.e. 
relative changes but not absolute levels of achievement. 
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is unsustainable and there is a real need to reorient health services (Government 
official), suggesting a commitment to move beyond merely symbolic targets. The 
incentive for Boards to identify a credible trajectory was, according to our 
respondents, both improved patient experience and financial sustainability, which is 
heavily scrutinised by ministers, Audit Scotland and the Scottish Parliament. The Joint 
Improvement Team (JIT; a partnership involving the Scottish Government, 
NHSScotland, the Convention of Scottish Local Authorities (COSLA), and the Third, 
Independent and Housing sectors) played a key role in building this argument: JIT 
provided Boards with estimates of future needs for hospital beds given demographic 
projections to show how reducing bed days now would mitigate the creation of 
expensive new hospital beds in the future.  
 
The national target of achieving a 12 per cent reduction in emergency bed days 
between 2009/10 and 2014/15 was derived from the aggregation of Board-specific 
targets. These ranged from 0 per cent (for Boards with a relatively low rate of bed 
days who felt further reductions were not feasible) to about 20 per cent over a five-
year period (in Grampian, where larger-scale service redesign was under 
development). Notably, both national and local respondents perceived the process as 
dialogical rather than adversarial: 
 
“We cannot just set the trajectory as we like (...) we look at our historical data and 
suggest what we can do (...) then the Government says ‘we think you can do more here’ 
or ‘you are too ambitious’ and then we go back to the data (...) it is a dialogue really“ 
(planning manager). 
 
“Some Boards seemed very ambitious (...) but some also had an ambitious improvement 
programme so the trajectory was backed up (...) it was a lot about speaking to Boards.“ 
(Government official). 
 
Two fundamental problems in SBC – and initial differences to HAI – were the limited 
evidence of (cost-)effective interventions and Boards’ partial ownership of targets. In 
particular the capacity and quality of social care, funded by local authorities, strongly 
influences Boards’ ability to reduce emergency admissions and achieve timely 
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discharges into community care. In their LDPs, all Boards emphasised the National 
Change Fund as a catalyst to test new models of care, typically in collaboration with 
local authorities. Boards state in their LDPs that the complexity of drivers of 
emergency bed days motivates diversified portfolios of interventions, so as to reduce 
the risks from “putting all eggs into one basket“ (see e.g. NHS Tayside (2011: 27)). 
Packages of interventions differ widely also between Boards. Examples include 
“hospital at home“ and rapid response services; creating a single point of contact for 
patients; use of a national risk prediction tool (SPARRA) to predict emergency re-
admissions; anticipatory care plans for vulnerable patients; telehealth and telecare; 
intermediate models of care to provide specialist assessment; and improved 
discharge planning. 
 
Several national organisations – including the Quality, Efficiency & Support Team 
(QuEST) within the Scottish Government, Healthcare Improvement Scotland and JIT – 
have started to foster the scaling-up of good practice through national events, 
benchmarking initiatives, longer-term programmes geared towards joint strategic 
commissioning and integrated resourcing, and sharing of case studies (see e.g. QuEST 
(Quality and Efficiency Support Team), 2014, JIT (Joint Improvement Team), 2014). 
Although attributing changes to specific interventions remains hard (Steel, 2013), 
many case studies suggest benefits are being realised. For instance, an immediate 
discharge service (IDS) in NHS Tayside that streamlined the referral process to 
reablement services and fostered daily telephone conversations between 
occupational therapists and the IDS coordinator saved over 1,600 bed days in 
2011/12 compared to 2010/11, at an estimated cost saving of £100,562 net of the 
cost of the IDS team (JIT (Joint Improvement Team), 2015). Local managers we 
interviewed noted that these case studies were increasingly valued as a central 
repository of options for local action.  
 
An interesting case study is the trajectory of NHS Borders (Figure 6-3). The data 
suggests that this Board was transformed from a negative outlier in terms of rates of 
emergency bed days in 2007/08 to a positive outlier by 2012/13. The Local Delivery 
Plans over this period suggest that there was an ambitious healthcare improvement 
programme under development. This programme included the following elements: (i) 
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introduction of an anticipatory care planning service and self-management 
programmes to support people to stay at home where possible; (ii) telehealthcare 
home monitoring; (iii) a new contract for GPs focused on patient pathways and 
intended to incentivise reductions in length of stay in community hospitals; (iv) LEAN 
service redesign projects to standardise treatment pathways for common chronic 
conditions (e.g. COPD, heart failure); (v) a discharge transfer policy signed off by NHS 
Borders and the local Community Health partnership to minimise delayed discharges; 
and (vi) the introduction of intermediate care options and improved training of the 
health and social care workforce. These interventions indicate a range of actions that 
have been taken in NHS Borders. Nevertheless, more detailed evaluation of these 
interventions will be needed to understand what exactly made the difference in 
reducing emergency bed days, compared with other Health Boards. 
 
Encouraging local freedom to innovate, with requisite financial and managerial 
support, and then generalising successes across the system, lies at the heart of 
experimentalist governance. However, as highlighted by Audit Scotland (2014), 
various challenges remain: projects tend to be small-scale, often without in-built 
evaluation or plans how to sustain successful projects after initial funding has ended; 
and so far there has been less systematic coordination across NHS Boards to 
understand the reasons for variation in activity and expenditure and to monitor the 
impacts of interventions for older people across Scotland. In interviews, managers 
also commented on the difficulties in adapting interventions from elsewhere to their 
own contexts: “There is still much thinking that ‘we are different in terms of capacity, 
workforce, money’ and clinicians don’t always accept even projects that have shown 
success in other Boards” (planning manager). 
 
In conclusion, because shifting the balance of care for older people was from the 
outset recognised as an issue of local diversity and uncertainty about effective 
interventions, the performance management system focused on the development of 
Board-specific targets and fostering change through local partnerships. While the 
generalisation of local “lessons“ remains challenging, this approach seems to have 
enabled the Scottish NHS to make progress on a complex policy issue. 
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Table 6-4 Hierarchist and experimentalist governance elements in the Scottish HEAT target system 
 System level: HEAT framework 
HAI  SBC  Reflects                   
hierarchist logic 
Reflects 
experimentalist logic 
Ambiguity about ends:  
Target setting  
 
The Scottish 
Government decides on 
target indicators based 
on Government 
priorities. 
Consultation with Boards 
and service user groups 
for target setting and 
revision after a three-
year cycle 
Target values were set centrally 
based on external (until 2010) and 
comparative (from 2011) 
information reflecting a more 
hierarchist orientation. 
Target values were developed 
through dialogue between 
Boards and the Scottish 
Government reflecting a more 
experimentalist orientation. 
Ambiguity about 
means:  
Implementation of 
targets 
LDPs are negotiated as 
“contract“ between 
Government and Boards 
and signed-off by the 
Government. 
LDPs serve to identify 
risks and management 
strategies locally. 
National Taskforce Delivery Plans 
and guidance on infection control 
define standards for local action on 
HAI reflecting a more hierarchist 
orientation. 
With the rise of CA-HAIs: Increasing 
emphasis on networks to share good 
practice, collaborative research, and 
widening involvement of community 
health professionals beyond the 
traditional focus on hospital staff 
reflecting a more experimentalist 
orientation. 
Focus on local innovation 
funded through the Change 
Fund, development of an 
Improvement Collaborative to 
provide an infrastructure for 
improvement, use of case 
studies to share learning 
reflecting a more 
experimentalist orientation. 
Monitoring and 
accountability  
Accountability against 
target achievement is 
done at Annual Reviews 
and through public 
reporting over a 
Government website. 
Diagnostic monitoring 
throughout the year 
serves to identify 
unusual trends and to 
remedy the underlying 
reasons. 
With the rise of CA-HAIs: Increasing 
emphasis on root-cause analysis and 
inspection of local clinical processes 
reflecting a more experimentalist 
orientation. 
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Figure 6-1 Rates of staphyloccocus aureus bacteraemia per 100,000 population 
(SAB, including MRSA and MSSA)  
 
Note: The target was introduced in 2008. Shetland, Orkney and Western Isles are excluded due to 
small numbers. 
Figure 6-2 Rates of clostridium difficile infections for people aged 65+ per 
100,000 population  
 
Source: own display based on Health Protection Scotland (2014). 
Note: The target was introduced in 2009. Shetland, Orkney and Western Isles are excluded due to 
small numbers.
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Figure 6-3 Rates of emergency bed days for patients aged 75+ per 1,000 
population 
 
Source: own display based on ISD Scotland  (2014).  
Note: The target was introduced in 2009. Shetland, Orkney and Western Isles are excluded due to 
small numbers.The stark increase in bed days in Dumfries and Galloway after 2007 is due to the re-
classification of geriatric community beds for general use, so that admissions to these beds are now 
counted which would have previously been excluded. The data for this Board are therefore presented 
as broken series. 
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 Discussion  6.5
Prompted by the limits of a hierarchist approach to target setting for policy issues 
whose “ideal” ends and means for change are ambiguous, this paper has examined 
how more learning-oriented strategies as proposed by experimentalist governance 
scholars might complement the target setting process. In relation to the two 
questions stated in the introduction, the findings suggest the following. 
 
First, hierarchist and experimentalist elements can be shown to exist in the same 
performance management regime (Table 6-4). The experimentalist elements add 
distinct aspects in relation to target setting, implementation, and monitoring and 
accountability that are missing from a purely hierarchist approach (Table 6-1). In 
Scotland, this has led to a performance management system where: central and local 
actors contribute to setting targets; central bodies support local attempts to 
implement change; and local actors are held accountable both for processes and for 
results. This suggests a complementary role of experimentalism (Fossum, 2012). 
Nevertheless, there is also some evidence of tensions or “competition” between the 
two logics. This is illustrated by the ambivalent perception of Government 
performance support teams with their dual mandate for central control and local 
support.  
 
Second, while both logics influenced the management of each policy issue, their 
relative emphasis differed between policy issues and also over time within a policy 
issue. Where targets were informed by the vision of an optimal balance between 
community and hospital care and means for change were ambiguous (care for older 
people; Table 6-2), target setting reflected experimentalist ideas more strongly. Yet, 
central-local discussions were anchored by estimates of demographic projections 
provided by JIT and thus not data-free. Where ends and means were known initially 
(HAI; Table 6-2), scope for avoidability was determined centrally by the Government 
from technical information. However, the National Advisory Group – with 
representatives from Boards – initiated proposals for targets. When the rise of 
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community-acquired infections decreased the initial clarity about the causal 
mechanism and effective interventions, the ideal level of HAI (zero) and the model for 
target setting remained constant. However, a more learning-oriented approach to 
implementation and accountability ensued (Table 6-4). This can be interpreted as a 
partial drift in management style to the experimentalist realm (Figure 6-4). 
 
Figure 6-4 Ambiguity over goals and means in relation to governance style 
 
 
 
The main implication of these findings is that the choice of logic (or the distinct 
combination of logics) can be made on a target-by-target basis. Thinking of 
hierarchism and experimentalism as a property of the performance management 
system as a whole may be analytically too coarse (from a research perspective) and 
neglect opportunities that arise from drawing on the best of both logics (from a policy 
perspective). As this study shows, it is important to look deeper at the level of 
individual targets and at changes within a target over time. Returning to the idea of 
“dials” and “tin openers” (Carter, 1989), this means one can and, arguably, should 
tailor models of governance to the nature of the policy issue. 
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Our findings highlight the need to reconsider the strict separation between purposes 
of measurement for improvement and measurement for accountability advocated in 
the literature on performance measurement in public services (Solberg et al., 1997, 
Freeman, 2002, Davies, 2005). Empirically, it seems possible to combine both 
purposes within a system. Prescriptively, however, should regulators seek to 
integrate experimentalist and hierarchist logics? We have explored the rationale and 
context for adoption of different logics of target setting for two policy issues but not 
their relative effectiveness in facilitating or hindering progress towards achievement 
of targets.  
 
Our study suggests, however, that an integrative model of governance may help to 
recognise the inherent differences between policy issues and also their potential 
dynamics over time. Combining different models of governance may thus serve as a 
strategy to address the unintended consequences of adopting a single model only 
(Goddard et al., 2000). Moreover, within a publicly funded healthcare system where 
government has a legitimate mandate to set priorities and targets (Mays, 2006),  
ignoring demands for accountability in efforts to improve public service performance 
seems unrealistic. Sabel and Zeitlin (2012) suggest that working in the ”shadow of 
hierarchy” within an otherwise experimentalist system retains the possibility of 
hierarchical intervention if actors fail to collaborate effectively. Nevertheless, prior 
research also highlights the danger for more learning-oriented modes of governance 
to be ”crowded out” if regulators deploy sanctions too frequently (Fischer and Ferlie, 
2013, McDermott et al., 2015).  
 
How, then, can different logics be integrated so as to limit any consequential damage? 
While it was outside the scope of our study to examine the preconditions for 
successful integration of different models of governance, the socio-historical and 
institutional context with regard to existing legislative frameworks and prevailing 
norms (Scott et al., 2000) is likely to be very important. Clearly, the choice and 
effective combination of different models of governance will not solely depend on the 
nature of the policy issue in terms of perceived degree of ambiguity over ideal ends 
and means for implementation. The Scottish approach to quality improvement 
evolved within a unique socio-historical context which included an early emphasis on 
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professionally led development of standards and longstanding collaborative 
relationships between central and local organisations (Legido-Quigley et al., 2012, 
McDermott et al., 2015), making it receptive to experimentalist ideas. Our finding that 
it is possible to combine experimentalism and hierarchism may thus not be 
generalisable to a system which is habituated to hierarchist ways of working. 
 
It seems plausible to suggest that experimentalist governance requires a system (i) 
where actors share at least moderate levels of trust if there is to be an open dialogue; 
and (ii) where actors are able to build an infrastructure that fosters deliberation and 
mutual exchange. As Reay and Hinings (2009) argue, the development of 
collaborative relationships can serve as an effective mechanism to manage the rivalry 
of competing logics. However, since in this study we have focused on one system only 
(the Scottish HEAT target system), it makes sense to examine these issues further 
through comparative research; examining for instance Scotland and England where 
target setting has tended to follow a more hierarchist logic focused on accountability 
and deterrence (Bevan and Hood, 2006). 
 
In terms of providing guidance for the design of national performance management 
systems, it is worthwhile to note that experimentalist and hierarchist logics each 
embody potential trade-offs. Locally agreed targets might engender stakeholder 
support and thus mitigate the negative impacts on public service motivation 
documented for hierarchically driven targets (Drucker, 1954, Le Grand, 2010). 
However, they also curiously bypass the objective of a national performance 
management system to enable comparative analyses of how public resources are 
spent. Forecasting based on historical patterns of activity may be a strategy to get 
started as long as no comparable data exists, yet it risks reinforcing the “fallacy of 
comparative difference“ (Marmor, 2012: 20) that no cross-regional comparison at all 
is possible. Benchmarking, in turn, considers the practical feasibility given what top-
performers have achieved (Bogan and English, 1994), but ignores that even top-
performers may have substantial scope for improvement. Transferring estimates of 
the potential for prevention from scientific research may enable a rigourous external 
standard, but reliable estimates of effect sizes of interventions are often unavailable 
(Ernst et al., 2008) or not applicable to other contexts (Cartwright and Hardie, 2012). 
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The relative desirability of hierarchist and experimentalist logics is likely to depend 
on how these trade-offs are managed. 
 
Strategies for successful implementation of experimentalist ideas also merit further 
research. In light of wide geographic variations in the utilisation and outcomes of 
public services such as healthcare (OECD (Organisation for Economic Co-operation 
and Development), 2014), experimentalist governance encourages a guardedly 
optimistic view: it sees local variation as an opportunity to learn from others. 
However, experimentalist governance as described by Sabel and Zeitlin (2012) does 
not indicate how actors can best learn from each other (Pires, 2011). Nor does it 
provide criteria to ascertain that what takes place is indeed learning, a reflective 
practice (Schön, 1987), or emulation only (Fossum, 2012). These challenges were 
evident particularly in the case of care for older people. The two core problems that 
experimentalist governance purports to address – ambiguity over ends and over 
means – will require very different strategies for learning. The former will require 
forms of deliberation about values (Mooney and Blackwell, 2004, Brugnach and 
Ingram, 2012). The latter will require deliberation about what constitutes relevant 
evidence in a specific context (Cartwright and Hardie, 2012).  
 
The experiences in the Scottish HEAT target system lead us to the inspiring and 
optimistic conclusion that setting targets for public service performance does not 
have to end up in a ”targets and terror” model of governance. Targets are a valuable 
policy tool to focus attention on priorities and to clarify policy ambitions with 
reference to improving the quality and outcomes of public services. However, when 
problems are wicked, the hierarchist logic of target setting provides no mechanism to 
engage stakeholders affected by targets and to foster improvement. Local managers 
of the system can benefit and learn from variations between local contexts in a much 
more productive (and democratic) way when they are given the responsibility and 
capacity to search for feasible solutions for their own local circumstances. Future 
research should consider the impact of different models of governance on the 
outcomes of public services and the enabling social and political conditions for 
effective measurement for learning, collaboration and improvement. 
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 Commentary in relation to the organising matrix of strategies 6.7
to address ambiguity about the standard for evaluation 
This Chapter has explored how policy-makers and managers might establish 
meaningful standards for evaluation with a socio-political approach. To this end, the 
Chapter has examined how an experimentalist governance logic focused on learning 
and dialogue between central government and local organisations (Sabel and Zeitlin, 
2012) might complement a more hierarchist philosophy focused on accountability 
when setting performance targets. The Chapter has contributed an empirically-based 
characterisation of the co-existence and potential complementarity of these logics in 
the Scottish HEAT target system. 
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7 CONCLUSIONS 
Geographic variations in rates of hospital admissions, surgical procedures and other 
types of health service utilisation have been widely documented for a range of 
conditions and in various countries (Corallo et al., 2014, OECD (Organisation for 
Economic Co-operation and Development), 2014). However, due to the absence of a 
clear standard for evaluation, the practical and policy significance of this information 
is often unclear. This ambiguity about the standard for evaluation is problematic 
because it risks foregoing potential insights about health system performance, 
defined as the degree to which objectives such as the provision of safe, effective and 
cost-effective services in relation to medical need have been met (Evans, 1990, Hurst, 
2002); because it risks encouraging misinterpretation and causing harm 
(Tanenbaum, 2012); and because reporting data without clear managerial 
implications seems futile and a waste of resources (Spiegelhalter, 1999, Goddard et 
al., 2000). 
 
The aim of this thesis was therefore to investigate how regulators and managers in 
charge of planning, auditing and improving health services might address ambiguity 
about the standard for evaluation. Essentially the thesis argues that ambiguity about 
the standard is a multi-faceted phenomenon that can be tackled through four 
categories of management strategies: managing ambiguity in the absence of a 
standard using a socio-political approach; managing ambiguity in the absence of a 
standard using a technical-evidential approach; determining a meaningful standard 
using a socio-political approach; and determining a meaningful standard using a 
technical-evidential approach. 
 
On the basis of five empirical studies, presented in Chapters 2 to 6, the thesis has 
investigated how strategies within each of these categories might look like. This 
Chapter synthesises the main findings and implications for policy, discusses the 
limitations of the thesis and suggests directions for future research, and offers 
concluding remarks.  
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 Main findings and implications for policy 7.1
This section synthesises the empirical findings in relation to the overarching 
conceptual framework. The resulting implications for policy are summarised in Table 
7-1. The four types of management strategies are not mutually exclusive. A 
comprehensive approach to address ambiguity about the standard for evaluation will 
likely involve both socio-political and technical-evidential elements, and seek to 
determine standards where this is possible and manage ambiguity where standards 
cannot be established. Each of the implications suggested in Table 7-1 is briefly 
discussed below. 
 
Table 7-1 Policy implications 
Strategy Policy implications from findings of this thesis 
1. Manage ambiguity in the 
absence of a standard 
using a socio-political 
approach.  
 Overcome barriers to using information on variations: 
awareness, acceptance, perceived applicability of the information 
and capacity to use the information. 
 Strengthen levers for using information on variations: agree 
responsibilities for action, involve stakeholders and develop 
tools to help clarify which variations are unwarranted. 
2. Manage ambiguity in the 
absence of a standard 
using a technical-
evidential approach. 
 Avoid assigning a single ranking to each unit of assessment in the 
context of performance comparisons based on composite 
indicators. 
 Use ranking intervals and dominance relations to show the 
uncertainty in rankings and the impact of different assumptions 
about weight sets and population denominators on the results. 
3. Determine meaningful 
standards using a 
technical-evidential 
approach. 
 Estimate capacity to benefit in populations to help identify 
underuse and overuse of defined interventions in tandem with 
clinical audits and standardisation of utilisation rates for 
variables associated with need for healthcare. 
4. Determine meaningful 
standards using a socio-
political approach. 
 Choose the logic for setting healthcare targets (hierarchist or 
experimentalist) on a target-by-target basis. 
 Link the evaluation of variations to a management process that 
focuses on the identification of causes of variations and on the 
sharing of good practice between central government and local 
organisations. 
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If one seeks to manage ambiguity in the absence of a standard using a socio-political 
approach, then one must overcome a series of practical barriers to information use 
including awareness, acceptance, perceived applicability and capacity of potential 
users. Agreeing responsibilities for action and involving clinicians in the process 
appear to enable the use of information on variations for strategic problem framing 
and communication. These findings are consistent with those of large-scale reviews of 
programmes in the United Kingdom focused on quality improvement (Dixon-Woods 
et al., 2012) and knowledge mobilisation in NHS organisations (Crilly et al., 2013). 
These reviews demonstrate the importance of involving stakeholders who are 
affected by performance indicators and whose behaviour enables or constrains 
progress. 
 
The apparent tendency among healthcare managers to interpret variations with 
reference to the national average or the top and bottom outliers implies the need for 
appropriate tools to examine which variations are substantively meaningful in terms 
of quality of care, expenditure or both. These tools should enable building a narrative 
why unwarranted variation matters in a particular local context (for examples from 
English Primary Care Trusts, see Schang and Morton, 2012), explaining the drivers of 
variations in patients’ care pathways across all settings of care (Porter, 2010, Porter 
and Teisberg, 2006) and engaging stakeholders in a process to prioritise remedial 
interventions in terms of their impact on population health relative to the required 
expenditure (Airoldi et al., 2014).   
 
To manage ambiguity in the absence of a standard using a technical-evidential 
approach, the use of ranking intervals and dominance relations obtained from ratio-
based efficiency analysis (REA) can help to avoid the forced assignment of a single, 
potentially controversial ranking based on a composite measure of performance to 
each organisation under scrutiny. The REA technique is able to incorporate the full 
set of feasible weights and different choices of population denominator. The size of 
the ranking intervals shows the specific positions an organisation can attain in the 
overall ranking and the sensitivity to different methodological assumptions. The 
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estimated ranking intervals for a given organisation are robust insofar as they are 
bounded by the maximum and minimum possible rankings (say, not better than 3rd 
but not worse than 6th).  
 
There are good reasons, reviewed in Chapter 3, to abstain from developing composite 
measures of performance altogether and instead to report comparative performance 
separately for different indicators (Jacobs et al., 2005, Hauck and Street, 2006). In 
light of the findings of Chapter 2, the creation of composite indicators is likely to 
further complicate local interpretation of this information. A key strategy pursued by 
healthcare managers was to disaggregate data from a geographic level to a lower (e.g. 
provider) level of analysis. This is important as even within hospitals (between wards 
or at a specialty level), the quality of care may differ considerably (Zhang et al., 2013). 
While smaller numbers make the disaggregate data on which this approach relies 
more vulnerable to random fluctuations (Diehr and Grembowski, 1990, Diehr et al., 
1990), it can nevertheless help reveal distinct patterns of clinical practice variation 
which are obscured at a higher level of analysis (NHS Right Care, 2011). If however 
one moves towards even further aggregation in the form of composite indicators, in 
order to compare performance on multiple objectives in a unified way (OECD, 2008), 
then methods of analysis should recognise uncertainty in consequent rankings of 
organisational performance.  
 
To determine a standard using a technical-evidential approach, estimating capacity to 
benefit in populations provides a theoretically sound and feasible benchmark to 
assess the utilisation of services against population needs. Such estimates contribute 
to the debate on suitable tools to evaluate the appropriateness of variations in 
medical practice. In particular, they complement clinical audits (which can identify 
overuse at a patient level, but fail to detect underuse among members of the general 
population who do not access the health service in the first place) and 
standardisation of rates for variables associated with need (which helps to ensure fair 
comparisons between regions which differ in their composition of uncontrollable 
determinants of healthcare need (Nicholl et al., 2013), but does not provide a 
normative benchmark of a level of care that is expected to be beneficial for a specific 
population). To derive estimates of capacity to benefit in populations, it is important 
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to strengthen the development of evidence-based criteria of capacity to benefit and to 
target the collection of  required epidemiological information.  
 
To determine a standard using a socio-political approach, it is possible to tailor the 
model of governance to the degree of ambiguity over ideal ends and means inherent 
in a particular policy issue. As experience from the Scottish HEAT target system 
suggests, an experimentalist logic of governing healthcare performance through 
learning and dialogue may usefully complement a hierarchist logic focused on 
accountability for results when both ideal ends and means for change are ambiguous. 
This finding adds to a growing line of research that explores the potential for 
synergistic benefits between different models of governance (McDermott et al., 
2015). Taken together, these developments challenge the conventional distinction 
between “measurement for improvement” and “measurement for accountability” as 
mutually exclusive purposes of performance measurement (Freeman, 2002). In order 
to move beyond the mere measurement of variations to their management, the 
setting of standards and targets should be linked to a process of identification of 
causes of variations and sharing of good practice between central government and 
local organisations. 
 
This thesis has contributed an analysis of techical-evidential and socio-political 
approaches to managing ambiguity in the absence of a standard and to setting 
meaningful standards for the evaluation of unwarranted variations in healthcare. The 
subsequent section critically discusses the overall limitations of the thesis. 
 Limitations and directions for future research   7.2
The specific limitations of each study were summarised in the respective Chapters 2 
to 6. This section discusses epistemological, contextual and methodological 
limitations of the thesis as a whole and suggests directions for further research on 
this basis.  
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7.2.1 Epistemological approach 
In order to advance knowledge about how to address ambiguity about the standard 
for evaluation, this thesis was grounded in, and built on, different scientific traditions 
in the social sciences. Specifically, the nature of options within the four categories of 
management strategies was explored by drawing on concepts and methods from 
public health and epidemiology, health economics, operations research and public 
administration.  
 
Adopting such an interdisciplinary perspective has advantages and disadvantages. 
Within the scope of this thesis, it was valuable because it enabled the development of 
a richer and more nuanced account of strategies to address ambiguity about the 
standard for evaluation. Insofar as all scientific theories and models are simplified 
representations of reality (Pidd, 1996), each of the concepts and methods applied 
helped to illuminate the research problem from a different angle. Following Smith et 
al. (2009), the thesis takes the view that designers of performance measurement 
systems in healthcare can learn from the distinct insights offered by different fields of 
the social sciences, justifying an interdisciplinary approach. 
 
However, this richness of perspective comes at a cost. In this thesis, it limited the 
ability to analyse in more detail the different facets of the research problem and to 
explore more deeply what different areas of scholarship might offer to this end. 
Following from Chapter 6, for instance, it would be desirable to explore in more depth 
the contextual preconditions and the regulatory implications of adopting an 
experimentalist governance perspective. Following from Chapter 4, future research 
should seek to examine reasons for the apparent discrepancy between the use of 
ventilation tubes and the estimated population capacity to benefit. As identified in 
Chapter 5, the magnitude of these need-utilisation gaps seems to differ across regions 
and it would be important to explain why this is the case. To do this, one could draw 
on quantitative and qualitative methods to understand the actual pathways patients 
take and to assess the impact of and interaction between local supply structures, 
patterns of medical practice and commissioning policies. Answering these questions 
went beyond the scope of this thesis and provides fascinating and worthwhile 
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directions for future inquiry.  
7.2.2 System context: Aligning the level of analysis with the locus of 
decision making 
Two studies included in this thesis were set in the English NHS (Chapters 2 and 4) 
and two focused on the Scottish NHS (Chapters 3 and 6). The English NHS and the 
Scottish NHS provide a special and, in theory, ideal context for analyses of geographic 
variations in healthcare. Both NHS systems are characterised by a territorial 
administrative structure where decision-making is delegated to local organisations in 
charge of planning and purchasing health services. The level of analysis (Primary Care 
Trusts and, as from April 2013, Clinical Commissioning Groups in England and Health 
Boards in Scotland) is therefore consistent with the locus of responsibility for action. 
In other words, analyses of geographic variations are meaningful in terms of ensuring 
accountability for the use of resources and for instigating action for improvement.  
 
The concepts and models adopted in this thesis are in principle generalisable to all 
types of health systems, regardless of their governance mechanisms for the planning, 
financing and provision of services. However, in systems where no authorities with a 
geographic basis for healthcare planning exist, it will be more difficult to achieve a 
close linkage between the measurement and the management of variations in 
healthcare.  
 
In a recent report to the US Institute of Medicine, Newhouse et al. (2013) question the 
usefulness of reporting information on variations at a geographic level since, in the 
United States, this does not reflect the level where decisions about service planning 
and provision are taken. In many European countries, the mandate for decision-
making tends to be fragmented between stakeholders (e.g. national and local levels of 
government, healthcare payers, hospitals and physicians), policy areas (primary, 
secondary and tertiary care, public health and pharmaceuticals) and policy tasks 
(implementation, provision, finance, regulation, and framework legislation) (Adolph 
et al., 2012). As a result, geographically based analyses may complicate problems of 
attribution insofar as it is unclear whose performance is being evaluated. Moreover, 
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payment and other incentives that are based on average outcomes in some 
geographic area rather than targeted at specific decision-makers (healthcare payers, 
hospitals, physicians, patients) are likely to be misdirected and fail to reduce 
unwarranted variations in the appropriateness and efficiency of service provision 
(Newhouse et al., 2013).  
 
For future research, this implies the need to reconsider the policy relevance of 
publishing information on variations at a geographic (e.g. district) level, an 
increasingly popular practice in many countries in the form of Atlases of Variation 
(Right Care, 2011) and cross-national projects such as those by the OECD (2014). In 
order to align the level of analysis with the locus of decision making, future research 
might follow three directions.  
 
First, research might concentrate on analyses of variations in the quality and cost of 
care between healthcare providers (e.g. hospitals, ambulatory physicians). This is 
widely done (e.g. Hauck et al., 2012, Gutacker et al., 2013, Castelli et al., 2015) and 
undoubtedly valuable where providers are indeed the responsible decision-makers. 
However, provider-level analyses are inherently limited where quality and cost of 
care is the result of shared efforts across multiple (e.g. primary, hospital, social) care 
sectors, as it is typically the case in caring for people with multiple and chronic 
conditions (Nolte and McKee, 2008).  
 
Second, analysts might focus on actual patient flows between ambulatory providers 
and hospitals. In the United States, a response to critiques of geographically based 
analyses has led to a methodology intended to derive physician-hospital clusters in 
which patients receive most of their care (Bynum et al., 2007, Bynum and Ross, 
2013). The units of analysis are hence “networks” of ambulatory physicians and 
hospitals which are defined empirically based on the extent to which they share 
patients. This might overcome the arbitrariness of spatial analyses insofar as it 
focuses on patterns of actual decision-making and care coordination. However, this 
approach is entirely empirical and provides at best an indirect means of linking 
analysis and action for improvement (e.g. by making providers aware of their 
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membership in a “network” so as to compare the quality of information exchange, 
patterns of utilisation and outcomes with other “networks”). 
 
A third direction lies in examining the effects of policies which result in the creation 
of organisations which are accountable for a broader spectrum of care for their 
populations, such as Accountable Care Organisations in the United States (Epstein et 
al., 2014, Luft, 2012). In countries where a specific geographic level of analysis does 
not correspond to administrative structures for decision making, these organisations 
provide more meaningful units of analysis and potential loci to achieve high-value 
care than a focus on single providers. The findings of this thesis will be more relevant 
to entities where the measurement of variations can be directly linked to decision 
making. 
7.2.3 Methodological considerations 
The research was conducted using a mix of qualitative and quantitative methods. The 
methods chosen have different strengths and weaknesses which have been 
summarised in the respective Chapters 2 to 6. In principle, qualitative and 
quantitative approaches should meet similar fundamental requirements. Both should 
be conducted in a systematic and transparent manner to demonstrate how 
conclusions were reached, and both should generate internally valid results 
(Creswell, 2003), defined as the “degree to which findings correctly map the 
phenomenon in question” (Devers, 1999: 1157). This section discusses some cross-
cutting challenges encountered during the research with regard to validity and 
validation of the findings. 
 
In the more qualitatively oriented Chapters 2 and 6, data collection and analysis were 
guided by the concept of triangulation, a core strategy in qualitative research to foster 
internal validity of the results (Yin, 1999, Patton, 1999, Wisdom et al., 2012). 
Triangulation seeks to achieve a balanced perspective by means of a systematic 
comparison of insights gained from applying different theoretical lenses or different 
methods of data collection and analysis (Yin, 1999, Patton, 1999). Chapters 2 and 6 
both used forms of method triangulation. Based on a national survey followed by 
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local interviews, Chapter 2 was able to gain an overview of barriers faced and 
strategies adopted in different Primary Care Trusts and to subsequently explore these 
issues in more depth through interviews. Chapter 6, in turn, used a concurrent review 
of formal national and local policy documents and more informal, interview-based 
perceptions of national and local managers. Both Chapters relied, if possible, on 
multiple respondents per organisation. In addition, Chapter 6 triangulated stylised 
accounts of two theoretical logics of target setting; experimentalist and hierarchist 
governance. These strategies were valuable because they enabled a clearer 
understanding of what was gained or omitted from each perspective. 
 
However, triangulation does not guarantee findings will be accurate; these can only 
be as good as the underlying data. In times of major structural reorganisation in the 
English NHS, this was particularly a problem for the study reported in Chapter 2 in 
the form of a low response rate to the national survey. Through a telephone follow-up 
of non-respondents, it was possible to achieve a response rate of 35% (53 of 151 of 
PCTs). However, while the findings showed a wide range of responses to the NHS 
Atlas, it was not possible to conclude whether the distribution of these responses was 
representative of the totality of PCTs. Finding relatively unobtrusive methods of 
investigation that enable a comprehensive understanding of local experiences while 
minimising the burden on the organisations studied should be a priority for future 
research. 
 
Validation in qualitative research is usually understood in terms of scrutinising the 
credibility of the findings (Patton, 2002). Because qualitative research is intended to 
understand people’s experiences in context, the group that is best positioned to judge 
if this intention has been are achieved are the actors within the specific research 
setting themselves. To mitigate against selective evidence use and misinterpretation 
by the researcher, the findings of Chapters 2 and 6 were therefore shared with the 
interviewees and survey respondents who were given the opportunity to comment 
on the draft and point out any factual errors. This process helped to clarify some 
issues raised in the initial interviews and also revealed new directions for the 
analysis. 
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In the more quantitatively oriented Chapter 3, the phenomenon to be measured was 
the robustness of performance rankings to alternative sets of assumptions about 
quality measure weights and choices of population denominator. However, there are 
other assumptions performance comparisons should be robust to. For instance, in a 
context of funding under weighted capitation, the impact of environmental influences 
on measured quality indicators should have already been compensated for by the 
resource allocation formula. In practice, however, formula funding provides 
inevitably imperfect compensation for uncontrollable circumstances faced in 
different local contexts (Smith, 2003). Further research of this problem in a 
performance measurement context will be important.  
 
Another assumption concerns the choice of healthcare quality measures, measured in 
Chapter 3 as Boards’ relative success in avoiding quality measures experienced by 
patients. However, performance comparisons also require some concept of the 
benefit or ”value-added” (Goldstein and Spiegelhalter, 1996) that is produced by the 
different local health systems. This information was not available from existing 
quality indicators. Chapters 4 and 5 sought to respond to this limitation by examining 
a specific methodology, capacity to benefit in populations, which might help in 
moving towards a measure not of the actual benefit produced by the health system 
but, as an essential precondition, of the potential for benefit from healthcare.  
 
The epidemiological model developed in Chapter 4 and, as Chapter 5 shows, existing 
attempts to estimate population capacity to benefit from a defined intervention 
generally, faced a number of limitations and challenges. These include, most notably, 
the lack of contemporary, comprehensive epidemiological data on the incidence of 
specific diseases and the consequent need to extrapolate such information from other 
populations and time periods. With one exception (Judge et al., 2009), all studies – 
Chapter 4 included – extrapolated rates of the incidence of a particular disease based 
on age. Age-specific incidence rates were then adjusted for the proportion of people 
fulfilling additional criteria of capacity to benefit from a defined intervention. In the 
case of ventilation tubes for otitis media with effusion, for instance, these criteria 
included bilaterality of the disease; a hearing level of +25 dB; and time elapsed of 
three months from the initial diagnosis (NICE Guidance, 2008). 
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For the epidemiological model in Chapter 4, this was a pragmatic and defensible 
choice insofar as the relationship between the incidence of otitis media with effusion 
and age, with two substantial peaks around two and five years of age and 
considerably lower incidence rates for other age groups, is well-established and most 
reliably documented (Zielhuis et al., 1990b). However, in spite of the vast literature 
on otitis media, it was not possible to obtain credible estimates of how much of the 
variation in rates of the incidence of OME is explained by age. Since most diseases are 
multifactorially determined, applying age-specific incidence rates to other 
populations hence risks introducing bias due to omitted variables (Mason et al., 
2015). Future research should strive to take more predictors of incidence into 
account, examine how much of the variation in incidence rates is explained by the 
chosen predictors and investigate consequent uncertainty in estimates of population 
capacity to benefit through sensitivity analysis. 
 
Finally, the method of validation of models to estimate capacity to benefit in 
populations merits discussion. Recommendations by the International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR) define validation as the process 
of checking “how well the model reproduces reality” (Eddy et al., 2012: 843). 
However, since the purpose of the model in Chapter 4 was to estimate a standard that 
is independent of reality (i.e. observed rates of utilisation), empirical validation of the 
model against actual practice would have been fundamentally misconceived. The 
approach to validation therefore involved a combination of face validation and 
verification of the internal and technical consistency of the model (Eddy et al., 2012). 
This involved examining the extent to which the structure of the model and the 
parameter estimates corresponded to the current state of knowledge, as judged by 
people with expertise in the field. This was done by conducting a structured “walk-
through” (Eddy et al., 2012: 846) in which the separate parts of the model were 
explained in detail to a panel of experts. 
 
Even with an open and transparent approach to model validation, some uncertainty 
may remain. Chapter 4 addressed this by using a structured approach to expert 
elicitation of fractiles of subjective probability distributions (O'Hagan et al., 2006) 
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which were used as inputs in the model for a Monte Carlo simulation. Following the 
expert workshop, results of the discussion were summarised and sent to the 
participants for comment and revision. By their nature, these estimates were 
subjective. However, in the absence of relevant evidence from the literature, this 
approach provided a justifiable alternative.  
 
As Box and Draper (1986: 424) lucidly put it, “Essentially, all models are wrong, but 
some are useful”. The contribution of this thesis has been to investigate a series of 
technical-evidential and socio-political models and strategies intended to address 
ambiguity about the standard for evaluating the appropriateness of variations in 
healthcare utilisation. While these models are not perfect, they have the potential to 
provide a useful stimulus for health policy and management and for future research. 
 Concluding remarks and outlook 7.3
With increasing pressures on healthcare budgets, evidence of considerable and 
persistent variations in medical practice offers the opportunity to achieve better 
outcomes for patients and populations by reducing the inappropriate and inefficient 
use of resources, to be invested in care of higher value. A fundamental precondition to 
realise this opportunity lies however in defining and evaluating which variations are 
unwarranted. By definition, this requires a standard of “good” as opposed to “poor” 
performance. 
 
Addressing ambiguity about the standard for evaluation is certainly not the only, but 
definitely an essential step if one seeks to move from the mere measurement of 
variations to their management. Both technical-evidential and socio-political 
strategies are required to make this information useful to regulators and managers in 
charge of planning, auditing and improving the performance of health systems. In the 
absence of such management strategies, information on variations in healthcare 
utilisation will likely fail to achieve the anticipated impact on improving health 
system performance. 
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In the years and decades to come, health systems will be hard pressed to deliver care 
that is affordable, of high quality, and accessible to those who would benefit. Using 
information on geographic variations in healthcare utilisation offers the prospect to 
help track progress towards the attainment of these objectives. How we measure 
unwarranted variations in healthcare and how we manage the health system’s ability 
to improve performance in an effective, efficient and responsible manner will remain 
an enduring task. 
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